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ABSTRACT 
DNA is subject to attack by DNA damaging agents from both environmental and 
endogenous sources.  In response to DNA damage, living organisms enhance expression 
of many related genes to facilitate DNA repair and survival.  The SOS response is a well-
understood prokaryotic regulatory cascade that controls the expression of more than 30 
genes in response to DNA damage.  However, in eukaryotic organisms from simple 
budding yeast to human, such a regulatory network has not been reported. 
Previous research in our laboratory found that among DNA repair mutants of 
Saccharomyces cerevisiae, only rad6 and rad18 defective in the post-replication repair 
pathway significantly affected DNA damage induction of several genes examined.  Rad6 
and Rad18 form a ubiquitin conjugation-ligase complex and are required for the cellular 
tolerance to damaged DNA.  Since the Rad6-Rad18 complex binds to single-stranded 
DNA, it may act as a DNA damage sensor required for the activation of DNA damage-
induced transcription.  We performed microarray analysis and found that the induction of 
up to 379 genes, including those involved in DNA repair, control of replication and 
transcription, regulation of the cell cycle and cell metabolism, are compromised in the 
rad6 and rad18 mutants.  Although Rad6/Rad18 monoubiquitinates proliferating cell 
nuclear antigen (PCNA) following DNA damage to initiate a damage tolerance response, 
PCNA ubiquitination is not required for DNA damage induction.  In budding yeast, cell-
cycle checkpoints are involved in the control of DNA damage induction of gene 
expression through phosphorylation of a protein kinase Rad53 by two pathways 
represented by Rad24 and Sgs1.  The Rad6-Rad18 complex appears to function in the 
Rad24 pathway and parallel to Sgs1.  We further demonstrated that the Rad17 subunit of 
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the 9-1-1 complex is subject to Rad6/Rad18- and DNA damage-dependent mono-
ubiquitination and that the Rad17-Lys197 residue with flanking sequences homologous to 
Lys164 of PCNA is absolutely required for the DNA damage induction by Rad6-Rad18.  
Hence, by ubiquitinating two DNA clamps, PCNA and 9-1-1, the Rad6-Rad18 complex 
plays a central role in the cellular response to DNA damage by coordinating translesion 
synthesis, error-free bypass, homologous recombination, as well as transcriptional 
regulation, reminiscent of roles of RecA in E. coli cells. 
Several individual genes have also been examined in this study to elucidate the 
regulatory mechanisms acting on specific DNA damage-inducible genes.  In the 
microarray analysis, DDI2 and DDI3, two identical genes located in duplicated 
chromosomal regions, were identified due to the highest induction ratio (122-fold) after 
MMS treatment.  Interestingly, DDI2/DDI3 can only be highly induced by SN2-type 
alkylating agents.  Promoter deletion analysis mapped the putative upstream acting 
sequence (UASDDI2) responsible for 40% of basal expression and 90% of induced 
expression by MMS. 
The CRT10 gene was identified through screening of the yeast deletion library for 
hydroxyurea (HU) resistance.  CRT10 encodes a putative 957 amino acid, 110 kDa 
protein with a leucine repeat and a WD40 repeat near the N-terminus.  Deletion of CRT10 
resulted in an enhanced resistance to HU reminiscent of the inactivation of two other 
ribonucleotide reductase (Rnr) suppressors, CRT1 and SML1, which regulate Rnr activity 
at transcriptional and translational levels, respectively.  Epistasis analysis indicates that 
CRT10 belongs to the CRT1 pathway but not the SML1 pathway.  Indeed, deletion of 
CRT10 enhanced the survival of the mec1 null mutant and increased basal level and DNA 
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damage-induced expression of RNR2 and RNR3, suggesting that Crt10 regulates RNR 
genes at the transcriptional level.  Furthermore, the dun1 mutation is epistatic to crt10 
with respect to both HU sensitivity and RNR gene expression.  Interestingly, the 
expression of CRT10 itself is induced by DNA damaging agents and this induction 
requires DUN1, suggesting that CRT10 plays a role in cellular response to DNA damage 
and replication blocks.  The CRT10 function appears to be achieved by positive 
regulation of the CRT1 transcript level, indicating that CRT10 is a component of the 
regulatory circuit. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1.    DNA damage and repair pathways 
DNA is the carrier of genetic information in most organisms.  In general, 
alterations in the chemistry or sequence of DNA are appropriately considered to be DNA 
damage.  Any damage to the molecular structure of DNA has the potential to cause 
genomic instability, mutagenesis or even cell death.  Unfortunately, DNA damage is 
unavoidable: DNA is continually exposed to insults resulting from exogenous and 
endogenous DNA damaging agents as well as by challenges posed by DNA replication.  
Therefore, it is not surprising that cells have evolved a multitude of mechanisms to 
remove the damaged DNA and restore the normal nucleotide sequence and DNA 
structure.  
 
1.1.1. DNA damage 
DNA damage is normally divided into two major classes, namely endogenous 
DNA damage and environmental DNA damage.  Endogenous DNA damage includes the 
DNA damage caused by reactive species generated during cellular metabolism, 
hydrolytic damage and DNA replication errors.  Environmental DNA damage is referred 
to that caused by physical and chemical agents generated outside cells. 
In vivo, DNA reacts with oxygen and water, leading to many spontaneous DNA 
lesions.  Cytosine can spontaneously deaminate to uracil, thus resulting in G·C to A·T 
mutations.  Adenine and guanine can also deaminate but at rates much lower than 
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cytosine deamination (Friedberg et al., 2006).  Oxidation of DNA by reactive oxygen 
species (ROS) which are generated in the cells by normal aerobic metabolism is one of 
the major types of endogenous DNA damage.  Oxidative DNA damage is the main cause 
for cancer and neurological diseases in human, and it is closely related to the normal 
process of ageing.  The ROS abstracts hydrogen atoms from the deoxyribose sugar or is 
added to double bonds of DNA bases, therefore causing oxidised base residues, base 
losses and single-strand breaks (Bjelland and Seeberg, 2003).  Insertion of an incorrect 
base during DNA replication is another source of DNA alteration, resulting in a 
nucleotide mismatch.  Although many DNA polymerases can synthesize DNA with great 
accuracy, the intrinsic error frequency for DNA replication polymerases is still between 
10-6 and 10-7 (Kunkel and Bebenek, 2000).  In addition, under conditions such as an 
imbalanced dNTP pool (Kunkel et al., 1982) or the absence of certain accessory proteins 
(Kunkel et al., 1979), the error rate is increased by 100-1000 fold.  
Many environmental DNA damaging agents induce a variety of DNA lesions.  
Two major physical DNA damaging agents are ionizing radiation and UV irradiation.  
Modified DNA bases and strand breaks constitute the two major classes of DNA damage 
by ionizing radiation.  Ionizing radiation can directly break DNA strands through 
absorption of the radiation energy, and most of the lethal effects can be attributed to these 
lesions (Ward, 1988).  Furthermore, radiation can lead to the formation of molecules, 
such as ·OH radicals, by acting with water or other surrounding molecules, and these 
species cause several kinds of DNA lesions (Friedberg et al., 2006).  As for UV 
irradiation, it frequently causes cyclobutane pyrimidine dimers (CPD) and pyrimidine-
pyrimidone photoproduct (6-4 PP).  DNA cross-links, DNA-protein cross-links and 
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strand breaks are also observed after UV irradiation, but much less prominently 
(Friedberg et al., 2006).   
There are many chemical agents that can damage DNA.  For example, alkylating 
agents such as methyl methanesulfonate (MMS), N-methyl-N’-nitro-N-nitrosoguanidine 
(MNNG) and ethyl methanesulfonate (EMS) are electrophic compounds with affinity for 
nucleophilic centers in DNA (Friedberg et al., 2006).  Numerous potential reaction sites 
for alkylation have been identified in all four bases with different affinity: in adenine, N1, 
N3, N7 and N6; in guanine, N1, N3, N7, N2 and O6; in cytosine, N3, N4 and O2; in 
thymine, N3, O2 and O4 (Friedberg et al., 2006).  The alkylating adducts can block DNA 
synthesis or form mismatches leading to transition mutations (Lindahl et al., 1988; 
Loveless, 1969; Preston et al., 1986), therefore alkylating agents (e.g. MMS) are 
frequently used in DNA repair studies as DNA damaging agents and will be often 
referred to in this thesis.  Cross-linking agents such as cisplatin and nitrogen mustard can 
form intrastrand cross-links or interstrand cross-links, thus completely blocking DNA 
replication and transcription (Eastman, 1987; Kohn et al., 1966).  Moreover, some 
chemicals like the anti-tumor antibiotic bleomycin and enediyne induce hydrogen 
abstraction from DNA, leading to a mixture of strand breaks and abasic sites (Povirk, 
1996). 
 
1.1.2. DNA repair pathways 
DNA repair is the cellular response to DNA damage that restores the altered 
nucleotide sequence and DNA structure to its native state (Friedberg et al., 2006).  The 
major pathways include base damage reversal, base excision repair (BER), mismatch 
repair (MMR), nucleotide excision repair (NER), recombination repair and 
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postreplication repair (PRR).  These DNA repair pathways are highly conserved from 
bacteria to mammals.  In the vast majority of cases, proteins that carry out these repair 
pathways are conserved in structure and function in eukaryotes, as well as in some cases 
in bacteria.  Defects in these pathways would lead to an accumulation of mutations in 
genomic DNA so as to increase the frequencies of mutagenesis and cell death.   
 
1.1.2.1.  Base damage reversal  
Base damage reversal is usually carried out by a single polypeptide enzyme, 
which catalyzes a single-step reaction to repair the damaged DNA (particularly damage 
to the nitrogenous bases) (Friedberg et al., 2006).  A good example of this pathway is the 
enzymatic photoreactivation (EPR) of base damage caused by UV irradiation.  As 
mentioned before, adjacent pyrimidines would be covalently linked to form CPD or (6-4) 
PP when DNA is exposed to UV irradiation.   These photoproducts can interfere with 
DNA replication and transcription, thus threaten the viability and normal functions of 
cells (Moore and Strauss, 1979; Setlow et al., 1963; Villani et al., 1978).  EPR can 
specifically reverse the pyrimidine dimers to native pyrimidine monomers. This process 
is catalyzed by photolyases which require light in a particular range of wavelengths.  In 
late 1960s, a yeast mutant defective in EPR established the existence of the PHR1 gene 
(Resnick, 1969).  The PHR1 gene encodes a 66kDa pyrimidine dimer DNA photolyase 
which is able to catalyze EPR (Sancar, 1985; Yasui and Langeveld, 1985).  Later 
research showed that the transcription of PHR1 is induced by various DNA damaging 
agents (Sebastian et al., 1990). 
In addition to EPR reversing base damage caused by UV irradiation, some 
alkylation base damage can also be directly reversed by enzyme-catalyzed processes.  For 
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example, O6-methylguanine-DNA alkyltransferase (O6-MGT) can transfer methyl groups 
from alkylation damage products O6-methylguanine to protect cells against DNA 
alkylation damage (Samson and Cairns, 1977; Samson et al., 1986; Sassanfar and 
Samson, 1990).  The predicted amino acid sequences of bacterial, yeast and human O6-
MGT genes are highly conserved (Xiao et al., 1991). 
 
1.1.2.2.  Base excision repair (BER) 
BER is a process to remove damaged bases from DNA and replace them with 
pristine sequences.  BER is the major repair pathway against DNA damage such as 
deaminated, oxidized, alkylated bases and abasic sites which are normally generated by 
reactive oxygen species or alkylating agents (Memisoglu and Samson, 2000), and it is 
probably one of the most highly conserved and most frequently used DNA repair modes 
in nature. 
BER is a multi-step process in which the first step is recognition and removal of 
the damaged base.  DNA glycosylase removes the damaged base through cleavage of the 
N-glycosylic bond connecting the base and the sugar-phosphate backbone.  The second 
step is incision at the resulting abasic (or AP) site. AP endonuclease (APE) recognizes an 
AP site and cleaves the DNA phosphodiester backbone on the 5' side of the AP site, 
leaving a 3'-hydroxyl terminus and a 5'-deoxyribose phosphate (dRp) terminus flanking 
the nucleotide gap.  Replacement of the missing nucleotide(s) is the third step.  This 
repair step can proceed via two sub-pathways that utilize different subsets of enzymes: 
one is short-patch BER that involves replacement of 1 nt; the other is long-patch BER 
that involves gap-filling of 2–6 nt.  In short-patch BER, polymerase β removes the 5'-dRp 
moiety by its intrinsic dRp lyase activity and adds one nucleotide into the repair gap.  In 
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long-patch BER, polymerase δ/ε extends the repair patch and displaces several 
nucleotides to create a 5'-flap that is cleaved by the flap endonuclease FEN1 to create a 
ligatable nick. The last step is sealing of the final nick (Chan et al., 2006; Fortini et al., 
2003; Memisoglu and Samson, 2000; Wilson and McNeill, 2006). 
 
1.1.2.3.  Mismatch repair (MMR) 
 MMR targets base-base mismatches, and it is essential to all organisms since it 
maintains the stability of the genome during repeated duplication.  Defects in the 
mismatch repair pathway elevate spontaneous mutability 50 to 1000 fold (Kolodner, 1996; 
Schofield and Hsieh, 2003).   
MutS, MutL, MutH, and UvrD, which are essential components of the MMR 
pathway, were identified in E. coli through the genetic studies of mutants that showed 
elevated mutation levels (Cox et al., 1972; Wagner and Meselson, 1976).  MutS initiates 
repair by binding to the mismatch base, then forms a heteroduplex complex with MutL to 
activate a methyl-directed endonuclease system, which incises at the hemimethylated 
dam site of unmethylated strand with MutH and UvrD (Au et al., 1992; Iyer et al., 2006; 
Modrich and Lahue, 1996).  MutS and MutL homologs have been identified in all 
eukaryotic organisms, including yeast, mouse and human.  However, no MutH  and UvrD 
homologs have been found in eukaryotic genomes (Jun et al., 2006).  In eukaryotic cells, 
the MMR pathway requires not only MutS homologs (MSH2-6) and MutL homologs 
(MLH1-3, PMS1) but also proliferating cell nuclear antigen (PCNA), exonuclease I 
(ExoI), replication protein A (RPA), and the DNA polymerase δ (Flores-Rozas et al., 
2000; Longley et al., 1997; Ramilo et al., 2002).  
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1.1.2.4.  Nucleotide excision repair (NER) 
NER is a complex process to remove many helix-distorting lesions such as UV or 
UV-mimetic agent-induced damage and chemical adducts.  NER begins with the specific 
recognition and verification of damage, and then removes a 24-32 base oligonucleotide 
from the strand containing the lesion through incision on both 5’ and 3’ sides.  At the end, 
the resulting single-strand gap is filled by DNA synthesis and ligation.   
In E. coli, UvrA, UvrB, and UvrC can locate a lesion and carry out a dual incision 
to remove a segment of nucleotides containing the damage.  In eukaryotes, from yeast to 
human cells, more delicate protein complexes are used to carry out NER.  For example, 
in budding yeast, at least seven proteins (Rad1, Rad2, Rad3, Rad4, Rad10, Rad14 and 
Ssl2) are required for recognition and incision of damaged DNA (Prakash et al., 1993).  
In human cells, XPA, RPA, the XPC-hHR23B complex, 6-9 subunits of  the TFIIH 
complex, and two nucleases, XPG and the heterodimeric ERCC1-XPF, are required for 
excision of damage, and another dozen or so polypeptides are needed for the repair 
synthesis step (Lindahl and Wood, 1999).   
Two modes of NER can be distinguished: repair of lesions over the 
nontranscribed strand of active genes or inactive regions of the genome is referred to 
global genome repair (GGR); lesions in the transcribed strands are removed by 
transcription-coupled repair (TCR).  Studies showed that TCR removes lesions much 
faster than GGR does.   
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1.1.2.5.  Recombination repair  
Recombination repair is the only DNA repair pathway which is able to repair 
double-strand breaks (DSBs).  Recombination repair is classified into two categories: 
homologous recombination (HR) and non-homologous end joining (NHEJ).   
HR uses an intact homologous region as the template to carry out DNA repair.  
Based on the repair mechanisms, it can be further divided into four sub-categories, 
namely the DSB repair model of Szostak, synthesis-dependent strand annealing (SDSA), 
break-induced replication (BIR), and single-strand annealing (SSA).    HR requires genes 
in the RAD52 epistasis group, such as RAD50, RAD51, RAD52, RAD54, RAD55, RAD57, 
RAD59, MRE11, and XRS2.  RAD52 is required for all forms of HR, while RAD51, 
RAD54, RAD55, RAD57 and RAD59 are only involved in certain forms (Aylon and 
Kupiec, 2004).  HR is the prevalent mechanism for repairing DSBs in S. cerevisiae. 
NHEJ directly ligates two broken DNA ends with no or minimal homology.  
Since no intact DNA template is involved in this process, it might be error-prone.  NHEJ 
requires the DNA-end binding Ku complex, a DNA-dependent protein kinase (DNA-
PKcs), potential DNA-end processing enzymes and the XRCC4–ligase IV complex 
(Ataian and Krebs, 2006; Burma et al., 2006; Daley et al., 2005).  In mammalian cells, 
NHEJ is the predominant mechanism for quick response to DSBs, and most DSBs are 
repaired by this pathway rather than HR.  
 
1.1.2.6.  Post-replication repair (PRR) 
Studies in the early 1970s found that mammalian cells were able to complete 
DNA replication in the presence of persisting damage on the parental strand (Lehmann, 
1972).  Hence, a mechanism called post-replication repair (PRR) was suggested, which 
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refers to a DNA damage tolerance pathway that permits lesions bypass during replication 
and delayed repair.  The PRR pathway encompasses two sub-pathways, namely, the 
error-free pathway and the error-prone pathway.  The error-prone pathway employs 
translesion DNA synthesis (TLS) which can replace the replicative polymerase by non-
essential polymerases capable of replicating over damaged regions of DNA with reduced 
fidelity.  The error-free pathway is likely to rely on an undamaged homologous template 
derived from the newly made daughter strand (template switch) or from the homologous 
chromosome (strand exchange) for bypassing lesions (Barbour and Xiao, 2003; 
Broomfield et al., 2001; Laan et al., 2005).   
In E. coli, PRR relies on some SOS  response controlled gene products to act in 
RecA-mediated homologous recombination and TLS for lesion bypass (Friedberg et al., 
2006).  PRR of S. cerevisiae is controlled by the Rad6/Rad18 complex, and PRR is often 
called the RAD6 epistatic pathway.  The PRR is initiated by the binding of the 
Rad6/Rad18 complex to a single-strand DNA gap formed at a stalled replication fork.  
The Rad6/Rad18 complex is capable of mono-ubiquitinating PCNA (encoded by POL30) 
at Lys164 and results in error-prone repair which involves the TLS polymerases Polη 
(encode by RAD30) and Polζ (encoded by REV3 and REV7) (Hoege et al., 2002; Stelter 
and Ulrich, 2003).  Acting together with Rad6/Rad18, the Rad5, Mms2/Ubc13 complex 
is also able to poly-ubiquitinate PCNA at Lys164 to form K63-linked poly-ubiquitin 
chains.  Poly-ubiquitination of PCNA will lead to error–free PRR pathway which could 
involve template switching with Rad51-independent strand exchange (Hoege et al., 2002; 
Pfander et al., 2005).  Yeast PCNA can also be alternatively modified by the small 
ubiquitin-related modifier protein SUMO at K164 (major SUMO acceptor site) or K127 
(minor SUMO acceptor site), and this process requires the SUMO ligase Siz1.  
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Sumoylation of PCNA could process a recombination-dependent error-free pathway, 
which would require Rad51 and would be inhibited by Srs2 (Papouli et al., 2005; Pfander 
et al., 2005).  Almost all yeast PRR pathway genes have mammalian homologs, including 
hREV1, hREV3, hREV7, hRAD30/XPV/Polη, hRAD30B/Polι, HR6A, HR6B, hRAD18, 
hMMS2 and hUBC13.  Some of these genes are able to functionally complement the 
corresponding yeast null mutants, hinting the same mechanisms might apply to 
mammalian PRR (Broomfield et al., 2001).   
 
1.2.   The SOS regulatory network in E. coli  
Under normal growth conditions, it is not necessary to maintain a high level of 
DNA repair activities in cells.  However, after exposure to DNA-damaging agents, both 
prokaryotic and eukaryotic cells activate stress responses which result in specific 
alteration in patterns of gene expression and an active inhibition of cell division.  
When E. coli cells are subjected to DNA damage, about 48 unlinked genes are co-
ordinately induced through a complex SOS regulatory network (Courcelle et al., 2001).  
The increased expression of these SOS genes results in the elaboration of a set of 
physiological responses such as an enhanced capacity for recombination repair and 
excision repair, enhanced mutagenesis (due to error-prone TLS), and inhibition of cell 
division.  These responses have been termed the SOS responses (Friedberg et al., 2006).    
 
1.2.1. Current model for transcriptional control of the SOS response 
The SOS regulatory network is controlled by two proteins, RecA and LexA (Cox, 
2003; Janion, 2001).  LexA is a transcriptional repressor which binds to SOS boxes 
located near or inside the operator site of the SOS-induced genes.  SOS boxes are often 
 11
palindromic structures with a high degree of identity in nucleotide sequence.  An ideal 
symmetrical consensus sequence (TACTGTATATATATACAGTA) was derived from 
the analysis of a pool of SOS boxes (Berg, 1988).  The sequence distinction in SOS boxes 
allows LexA repressor to bind to operators with different strengths (Lewis et al., 1994).  
The binding of LexA prevents accessibility to RNA polymerase so as to inhibit the 
transcription initiation.  LexA is likely to interact with DNA via its N-terminal domain, 
and the C-terminus of LexA is required for its dimerization.  The dimerization of LexA is 
essential for its ability to repress SOS-regulated genes in vivo (Bertrand-Burggraf et al., 
1987; Hurstel et al., 1986; Hurstel et al., 1988; Little and Hill, 1985; Schnarr et al., 1991).  
Meanwhile, LexA is able to undergo a slow intramolecular  self-cleavage termed 
autodigestion, and the rate significantly increases upon interaction with RecA (Little, 
1984; Little, 1991; Little, 1993).      
The RecA protein of E. coli has at least three functions in the SOS response.  It 
not only plays a role in the regulation of DNA damage induction, but also directly 
participates in TLS and homologous recombination.  Following DNA damage, DNA 
synthesis becomes discontinuous and ssDNA is produced by failed attempts to replicate 
damaged DNA.  In the presence of ATP, RecA binds to the ssDNA region and form the 
helical RecA-ssDNA nucleoprotein filaments.  LexA then diffuses to deep grooves in the 
RecA-ssDNA filaments and interacts with them in a manner that results in autocatalytic 
cleavage of LexA at a scissile peptide bond located between Ala84 and GLy85.  
Cleavage of LexA inactivates its ability to be a repressor, thus releasing the genes from 
transcription repression.  As cells begin to recover from the inducing treatment by various 
DNA repair and tolerance processes, the regions of ssDNA disappear, and thus the 
inducing signal is eliminated.  Without the cleavage stimulated by RecA-ssDNA 
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filaments, the pool of LexA is boosted, which leads to repression of the transcription of 
the SOS regulon genes and a return to the uninduced state (Friedberg et al., 2006; 
Walker, 1984). 
 
1.2.2. The inducing signal for SOS response 
Since the SOS response can be induced by a wide variety of chemicals and some 
conditions, it has been a challenge to determine the nature of the signal(s) responsible for 
SOS induction.  Many studies suggest that the DNA lesions themselves are not sufficient 
to induce the SOS response.  The initial study took advantage of a dnaC28(Ts) uvrB 
double mutant (Salles and Defais, 1984).  In this mutant strain, the initiation of DNA 
replication is temperature sensitive.  When temperature is shifted to 42oC (the non-
permissive temperature), cells can still complete the existing round of replication but can 
not initiate a new round.  UvrB is a component of the UvrABC endonuclease, and the 
uvrB mutation inactivates the NER pathway so that the UV-induced lesions will not be 
removed. Under permissive temperatures, the UV irradiation treatment can successfully 
induce an SOS response in the mutant.  However, when shifting to the non-permissive 
temperature, no SOS response is observed in this mutant after UV irradiation, indicating 
that the mere presence of UV irradiation-induced lesions is not sufficient to promote an 
SOS response (Salles and Defais, 1984).  Meanwhile, this research also suggests that the 
SOS response induced by UV requires an active replication fork, supporting the model 
that DNA replication leaves gaps where elongation stops at damage-induced lesions, and 
thus allows the ssDNA to activate SOS response.  In addition,  bleomycin, an agent 
known to produce DNA single-strand breaks can induce the SOS response in such a case 
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(Salles and Defais, 1984).  This result further provides evidence that ssDNA rather than 
DNA lesions is required for the SOS response.   
The question arises as to why the single-stranded regions normally presented on 
the lagging strand during normal DNA replication do not activate the SOS response.  The 
reason is kinetic, namely, RecA might not polymerize on this DNA region, or perhaps 
can not displace the single-strand binding (SSB) protein from it (Sassanfar and Roberts, 
1990).  The hypothesis is consistent with some studies on altered RecA protein.  It has 
been found that strains containing a recA441 mutation activate the SOS response even 
without any DNA damaging treatment (Phizicky and Roberts, 1981).   The RecA441 
protein can bind ssDNA more tightly than the wild type RecA protein.  Thus it is possible 
that  RecA441 activates the SOS response by polymerizing on the lagging-strand gaps in 
normal replication (Phizicky and Roberts, 1981).  Similarly, a recA730 mutation results 
in constitutive SOS induction in the absence of DNA damage.  The fact that RecA730 is 
more proficient than the wild-type RecA protein in the competition with SSB for ssDNA 
binding sites, also supports this model (Lavery and Kowalczykowski, 1992). 
 
1.2.3. Fine tuning in the induction of the SOS response 
SOS RecA/LexA regulatory system provides E. coli with a rapid transcriptional 
response to the presence of DNA damage.  Furthermore, during SOS induction, the 
timing, the duration and the level of induction are diverse for different LexA regulated 
genes, suggesting a fine tuning mechanism in the SOS induction.  The fine tuning is 
possibly determined by at least four parameters: (i) the binding affinity of LexA for the 
SOS box in the operator region; (ii) the number of SOS boxes in the operator region, (iii) 
the location of the SOS box relative to the promoter and (iv) the strength of the promoter. 
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After exposing E. coli cells to DNA damaging agents, genes with operators that 
bind LexA relatively weakly are the first to turn on fully.  For example, uvrA, uvrB, ruvA, 
ruvB, recN, and sulA are induced within 5 minutes after 40 J/m2 UV radiation (Courcelle 
et al., 2001).  uvrA and uvrB encode proteins involved in NER; recN, ruvA and ruvB 
encode proteins used for recombination repair; the protein product of the sulA gene can 
temporarily arrest cell division so that it gives the bacteria time to complete the repair of 
damaged DNA.  After the activation of loosely controlled SOS genes, if the damage can 
not be fully repaired by NER and homologous recombination, genes with operators that 
are tightly controlled by LexA will be turned on.  For example, research shows that the 
full induction of umuC and umuD is not observed until 20 minutes after UV irradiation 
(Courcelle et al., 2001).  Similar to LexA, the protein encoded by umuD also has a latent 
ability to autodigest, and the autodigestion is strongly stimulated by the interaction 
between the RecA/ssDNA nucleoprotein filament and UmuD (Nohmi et al., 1988).  
UmuC and a post-translationally processed form of UmuD (UmuD’) serve as a mutagenic 
lesion-bypass DNA polymerase.  This last response allows the survival of E. coli after 
severe DNA damage, but at the expense of introducing errors into the genome.  
In the SOS regulatory network, the transcription of the key regulatory gene recA 
is also regulated by LexA, thus forming a delicately controlling circuit.  recA has one 
SOS box which is located between the -35 and -10 region of the promoter, and LexA can 
bind to this region to prevent the initiation of transcription (Schnarr et al., 1991).  
Relative binding affinity experiments have shown that LexA binds to the recA operator 
more strongly than the operators of many other SOS regulon genes such as uvrA, uvrB 
and uvrD (Schnarr et al., 1991).  Accordingly, it allows an intermediate inducible state 
between an uninduced state and a fully induced state.  A low amount of inducing signal 
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thus can lead to the activation of some of the SOS functions, such as uvr+ dependent 
NER, without substantial amplification of the RecA protein.  When the inducing signal is 
not limiting, the expression of recA will be induced and result in a full induction of SOS 
genes.  Furthermore, the strong repression of lexA to recA ensures a fast return to the  
uninduced state once the level of the inducing signal begins to decrease (Walker, 1984). 
In addition to two central regulators RecA and LexA, recent studies have shown 
that some other proteins are also involved in the subtleties of SOS induction.  All these 
proteins affect SOS regulation by modulating RecA-ssDNA stability.  RecX can block 
the assembly of RecA-ssDNA filament while not affecting the disassembly through 
capping the assembly ends (Drees et al., 2004).  As a result, it strongly inhibits RecA-
mediated DNA strand exchange, ATPase, and coprotease activities.  The recX gene is 
located 76bp downstream of recA, and these two genes belong to the same operon.  recX 
is co-transcribed with recA, however recX transcription is down regulated with respect to 
recA by an intrinsic transcription terminator that is located between the recA and recX 
coding sequences.  Despite the presence of this terminator, a recA–recX message 
resulting from transcriptional read-through is detected at a level of 5–10% of the recA 
message (Pages et al., 2003).  RecX is barely detected during vegetative growth, but 
robust expression of recX is detected after treating cells with DNA damaging agents 
(Stohl et al., 2003).  The maximal recX expression is observed at a later time than 
maximal expression of RecA after UV irradiation (Courcelle et al., 2001).  All these 
observations suggest that RecX is likely involved in the subtle regulation which helps 
shut off the SOS induction response. 
Early studies have reported  that DinI can destabilize the RecA-ssDNA filament at 
higher concentration (typically 50–100-fold above the natural RecA concentration) and 
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inhibit all activities of RecA (Voloshin et al., 2001; Yasuda et al., 1998).  Therefore, DinI 
was initially thought to assist the SOS-induced cells return to a steady state.  In contrast, 
recent research has shown that DinI is also able to stabilize the RecA-ssDNA filament so 
as to prevent its disassembly when present at concentrations that are stoichiometric with 
those of RecA or somewhat greater (Lusetti et al., 2004).  Furthermore, DinI-mediated 
stabilization affects RecA-mediated UmuD cleavage rather than RecA-mediated ATP 
hydrolysis and LexA co-protease activities (Lusetti et al., 2004).  It indicates that DinI 
could have a biological role in fine-tuning the activity of UmuD in order to limit SOS 
mutagenesis. 
 
1.2.4. The role of DNA helicases and nucleases in SOS induction 
A critical step in the SOS signalling mechanism is the production of a RecA-
ssDNA filament, and this step requires DNA helicases and nucleases.  Either the RecFOR 
or the RecBCD pathway is necessary for SOS induction after UV irradiation (Ivancic-
Bace et al., 2006).  In E. coli, SOS induction immediately after UV irradiation is 
dependent on the RecFOR pathway.  The RecFOR pathway includes a DNA helicase 
RecQ, a nuclease RecJ, and the RecFOR complex which facilitates RecA loading (Lusetti 
et al., 2006). It has been suggested that the pathway may assist RecA binding to single-
stranded gaps.  RecQ was reported to be needed for fast degradation of the LexA 
repressor (Hishida et al., 2004).  This observation leads to a model in which RecQ 
unwinds the template duplex in front of a stalled fork on the leading strand, and then 
switches over to the lagging strand to generate single stranded DNA on the lagging strand 
template, allowing formation of the RecA filament in the 5’ to 3’ direction for SOS 
induction (Heyer, 2004; Hishida et al., 2004).   
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RecBCD, also known as Exonuclease V, contains helicase, 5'-3' exonuclease, and 
RecA loading activities.  It can directly load RecA on the processed double-strand break 
ends (Singleton et al., 2004).  SOS induction after UV irradiation in recFOR mutants is 
not completely eliminated but is delayed  and is dependent on the RecBCD enzyme 
(Hegde et al., 1995; Renzette et al., 2005; Thoms and Wackernagel, 1987; Whitby and 
Lloyd, 1995).  Accordingly it has been proposed that SOS induction requires the 
RecBCD when the double-strand break ends appear later because of nucleotide excision 
repair and replication fork collapse after UV irradiation (Ivancic-Bace et al., 2006).      
   
1.3.  DNA damage induction in S. cerevisiae  
The budding yeast S. cerevisiae is a simple unicellular eukaryotic organism, but it 
shares the complex internal cell structure of plants and animals.  Much like E. coli as the 
model prokaryote, it is the most intensively studied eukaryotic model organism for the 
mechanisms of DNA damage repair and the regulation of DNA damage response.  S. 
cerevisiae shares many of the technical advantages that permit rapid progress in the 
molecular genetics of prokaryotes, such as rapid growth, dispersed cells, the ease of 
replica plating and mutant isolation, a well-defined genetic system, a highly versatile 
DNA transformation system, numerous selective markers and easy gene manipulation 
(Sherman, 1997).  The genome of S. cerevisiae was completely sequenced in 1996.  It is 
composed of about 13,000,000 base pairs and 6,275 genes, and about 5,800 of these are 
believed to be true functional genes.  It is estimated that 23% of yeast genes have 
homologs in  human genome, and 30% of known genes involved in human diseases have 
yeast orthologs. 
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1.3.1. The DNA damage-inducible genes in S. cerevisiae 
Like E. coli, when treating yeast cells with DNA damaging agents, numerous 
genes are transcriptionally induced.  Many damage inducible genes in yeast were 
reported on the single-case based study.  For example, in the study of DNA repair 
pathways, many genes in various yeast repair and tolerance pathways were identified to 
be DNA damage inducible (Friedberg et al., 2006).  The PHR1 gene involved in 
photoreactivation was reported to be induced by UV irradiation (Sebastian et al., 1990).  
The MAG1 gene in BER is inducible by alkylating agents (Chen et al., 1990).  The yeast 
NER genes RAD2 (Robinson et al., 1986; Siede et al., 1989), RAD7 (Jones et al., 1990), 
RAD16 (Bang et al., 1995) and RAD23 (Madura and Prakash, 1990) were characterized 
by a moderate degree of enhanced transcription after UV irradiation.  In the 
recombination repair pathway, RAD51(Basile et al., 1992) and RAD54 (Cole et al., 1987) 
are damage inducible.  Both  RAD6 (Madura et al., 1990) and RAD18 (Jones and Prakash, 
1991) in PRR are induced by DNA-damaging treatments.    
For genome-wide approaches, early studies used either differential plaque 
hybridization with cDNA from treated and untreated cells (McClanahan and McEntee, 
1984) or a random lacZ fusion genomic library (Ruby and Szostak, 1985) to identify 
genes that are induced by DNA damaging agents.  In McClanahan and McEntee’s 
research, radiolabelled cDNA probes were generated from poly(A+) mRNA that was 
harvested from control, UV-treated, and 4NQO-treated cells.  In addition, a λ library 
containing yeast genomic fragments was constructed and replica plates containing ~100 
plaques each were made.  When the probes were applied to the plaques, expression was 
determined by comparing the intensity of labelled probe bound between the control and 
treated samples.  All together, they screened ~9000 genomic clones and identified four 
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DNA damage responsive (DDR) genes (McClanahan and McEntee, 1984).  Ruby and 
Szastak constructed a random library in which yeast genomic DNA fragments were 
cloned into vectors bearing the lacZ coding sequence.  Thus, each vector contains the 
fusion of “unknown” yeast genes (or segments) with the gene encoding β-galactosidase.  
Using nearly 8000 independent lacZ fusion clones, they compared β-gal activity over 
various DNA-damage inducing treatments (4-Nitroquinoline-N-oxide, UV, methotrexate, 
and gamma-irradiation).  A total of 6 damage inducible (DIN) genes were identified 
(Ruby and Szostak, 1985). 
Although these two early screening studies were significant to the field of damage 
induction, later studies suggested that these screens are biased for detecting genes with 
high induction ratios. High through-put analysis of global transcriptional responses to 
DNA damage has been made possible by the development of DNA microarray 
technologies.  A DNA microarray (also known as DNA chip) is a high-density array of 
DNA spots that contain addressable complementary sequences to many or most genes in 
a genome.  The chip is hybridized with fluorescently tagged nucleic acids, representative 
of expressed transcripts.  Imaging and computational analysis are used to monitor relative 
transcript levels for thousands of genes simultaneously (Fry et al., 2005; Schena et al., 
1995).  Microarray studies provide a much deeper understanding of the DNA damage-
induced transcription in budding yeast.   
By using a DNA microarray, Jelinsky and Samson (Jelinsky and Samson, 1999) 
reported that 325 genes of 6,218 ORFs (5.2%) increase more than 4-fold in transcript 
level after exposing yeast cells to the alkylating agent MMS at 0.1% for 1 hour.  These 
genes can be categorized into seven groups: DNA repair, detoxification, cell cycle, signal 
transduction, cell wall biogenesis, membrane transport and protein degradation.  
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Obviously, not only DNA repair genes and cell cycle regulation genes are regulated in 
response to DNA damage but also the genes involved in many other cellular processes.  
Later, the same laboratory determined the transcriptional continuum of yeast cells treated 
with different MMS doses and time courses (Jelinsky et al., 2000).  More than 1000 
genes were found to be up-regulated in response to MMS treatment.  Interestingly, many 
of the genes induced by MMS treatment were also induced in response to the arrest of 
cells in the stationary phase.  Thus there appears to be an overlap of responsive genes 
under two different stressful conditions, MMS exposure and stationary growth arrest.  
This might imply the existence of a general stress response pathway in budding yeast.  
Additionally, the transcriptional profiles were determined in yeast cells exposed to 5 other 
damaging agents: MNNG, BCNU, γ-ray, 4NQO, and the oxidizing agent t-BuOOH.  
Surprisingly, extensive differences were found between the transcriptional profiles 
induced by each of the six damaging agents.  These differences may be explained by the 
fact that a microarray analysis just represents a simple snapshot of the transcriptional 
response to DNA damaging agents.  A more extensive kinetic analysis will be helpful to 
find the overlap of responsive genes to different types of DNA damage.  
In fact, studies on DNA damage-inducible genes imply that the damage induction 
in yeast seems not to be agent specific but rather occurs after treatment with a variety of 
DNA damaging agents.  The PHR1 gene is a noteworthy example whose transcription is 
induced by different DNA damage agents, including some that result in types of DNA 
damage which are not substrates for the protein.  PHR1 encodes a subunit of DNA 
photolyase which specifically removes UV-induced pyrimidine dimers (Sancar, 1985; 
Yasui and Langeveld, 1985).  Since the Phr1 photolyase repairs exclusively pyrimidine 
dimers caused by UV irradiation, DNA lesions that are caused by agents like MMS are 
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obviously not substrates for the activated Phr1.  However, the transcription of PHR1 is 
induced not only by UV and the UV mimetic agent 4NQO but also by MMS, MNNG, 
bleomycin, and cis-diamminedichloroplatinin (Sancar, 2000; Sebastian et al., 1990).    
Another example is MAG1, which encodes the 3-methyl-adenine DNA glycosylase 
involved in protecting DNA against alkylating agents (Chen et al., 1989; Xiao et al., 
1996).   It is not surprising that the transcription of MAG1 can be induced by MMS (Chen 
et al., 1990; Jia et al., 2002; Liu and Xiao, 1997).  Nevertheless, it is also induced by 
hydroxyurea (HU) which results in depletion of deoxyribonucleotide pools and stalls at 
the replication forks (Liu and Xiao, 1997).  Based on these observations, it seems likely 
that DNA damage induction is regulated by a global damage response pathway rather 
than a DNA lesion-specific pathway in budding yeast.   
 
1.3.2. The pathways that regulate DNA-damage induction in S. cerevisiae  
The transcriptional response to DNA damage in budding yeast shows that many 
genes are co-ordinately regulated in response to DNA damage.  However, there is no 
evidence for a single regulon which is equivalent to the SOS regulon in E. coli for all 
DNA damage inducible genes.  Therefore, it is probably safe to assume that there exist 
signal transduction pathways that detect DNA damage and convert damage signals into 
specific increases in the level of gene expression.  According to the data from previous 
research, a putative model is proposed for signal transduction pathways: they consist of 
sensors, transducers and effectors (Bachant and Elledge, 1998).  The sensors are proteins 
which initially sense the damaged DNA, and initiate the signaling response.  Transducers 
can be activated by the DNA damage signal passed from the sensors, then amplify and 
relay the signal to the downstream effectors.  The ultimate effectors execute the 
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regulation of transcription, and they are likely to be transcription factors which directly 
influence the levels of gene expression. 
Sensors are the least known part in this model.  So far, proteins which initially 
sense the DNA damage and initiate the signaling response are totally unknown.   It is also 
unclear whether a limited number of sensors recognize the common DNA damage 
intermediates such as ssDNA (like RecA in the SOS response) or many different sensors 
detect each type of DNA lesion.   Some proteins in yeast, such as the catalytic subunit of 
DNA polymerase ε (Pol2), share some of the properties expected for sensors, such as the 
potential to interact with DNA and the ability to activate the transcription of some 
damage-inducible genes (Navas et al., 1995).  However, these data are obtained from 
single-case studies, and no published evidence indicates that they can activate the 
transcription of DNA damage inducible genes co-ordinately. 
Conversely, the transducers are better characterized than sensors.  Most of the 
transducers are protein kinases which can be activated by the DNA damage signal passed 
from the sensors, then amplify and relay the signal to the downstream effectors.  In S. 
cerevisiae, protein kinases Mec1, Rad53 and Dun1 are necessary for the transcriptional 
response of many genes to DNA damage, and they appear to be transducers in the 
regulation network (Allen et al., 1994; Gasch et al., 2001; Kiser and Weinert, 1996; Zhou 
and Elledge, 1993).  Meanwhile, Mec1, Rad53 and Dun1 are also DNA damage 
checkpoint kinases (Elledge, 1996).  In addition, another DNA damage checkpoint 
protein Rad9 has also been reported to regulate the DNA damage induction of genes 
(Aboussekhra et al., 1996).   Clearly, it suggests that the DNA damage checkpoint 
pathway contributes to the expression of genes that respond to DNA damage.  The 
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relationship between DNA damage checkpoints and DNA damage induction will be 
discussed in the following section. 
The first level of this signal transduction kinase cascade in budding yeast consists 
of Mec1 that belongs to the phosphatidylinositol 3-kinase family (PI-3K).  Mec1 is 
required for the activation of Rad53 through PIKK-dependent phosphorylation of 
consensus PIKK sites within Rad53 (Ma et al., 2006; Pellicioli and Foiani, 2005).  
Activation of the serine/threonine protein kinase Rad53 is an essential intermediary step 
in yeast DNA damage responses which include delaying cell cycle progression, 
promoting repair processes, stabilization of stalled replication forks and inducing 
transcription (Branzei and Foiani, 2006).  The protein kinase Dun1 is one of the identified 
targets of Rad53, and the activation of Dun1 requires phosphorylation by Rad53 (Chen et 
al., 2006).  Dun1 was originally identified as a DNA-damage uninducible (dun) mutant 
defective in the induction of genes encoding ribonucleotide reductase (RNR) in response 
to DNA damage (Zhou and Elledge, 1993).  Genome wide expression research showed 
that deletion of DUN1 affected the expression of >1000 genes in response to both MMS 
and ionizing radiation, and the response in the dun1Δ mutant is largely the same as the 
response seen in the mec1 mutant, suggesting that most of the Mec1-dependent effects on 
genomic expression are mediated by the downstream Dun1 kinase (Gasch et al., 2001).  
The mechanism employed by Dun1 for DNA damage induction seems to be quite diverse 
and awaits to be elucidated. 
In the transcriptional response to DNA damage, the main mechanism employed is 
likely to be the regulation of transcription initiation.  The downstream effectors are 
therefore expected to be transcription factors which directly influence transcription 
initiation.  In a later section, selected examples will be introduced in which traditional 
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promoter analysis has provided insights into the molecular mechanisms of DNA damage-
induced transcription. 
 
1.3.3. DNA damage checkpoint pathway and DNA damage induction regulatory 
pathway  
The DNA damage checkpoint mutants were first isolated by their phenotypes that 
fail to delay progression into mitosis after irradiation with x-rays (Rowley et al., 1992; 
Weinert and Hartwell, 1988; Weinert et al., 1994).  These mutants showed radiation 
sensitivity, and the sensitivity could be largely restored by re-imposing a delay by other 
means.  Hence the DNA damage checkpoint pathway was initially defined as a non-
essential regulatory pathway that slows down or arrest cell cycle progression in response 
to DNA damage, allowing time for DNA repair (Hartwell and Weinert, 1989).  However, 
this historic definition is inadequate to explain the function of this pathway completely.  
It is now suggested that the checkpoint pathway comprises a subroutine integrated into 
the larger DNA damage response that regulates a multifaceted response (Figure 1-1) 
(Zhou and Elledge, 2000).  Besides arresting cell cycle progression, the DNA checkpoint 
pathway has been shown to promote DNA repair (Mills et al., 1999), control telomere 
length (Ritchie et al., 1999), activate transcription (Elledge, 1996), and trigger apoptosis 
in metazoan cells (Roos and Kaina, 2006).  In a broad sense, DNA damage checkpoints 
regulate the DNA damage responses co-ordinately, including DNA damage induction.  
To avoid confusion on the definitions, Zhou and Elledge  (Zhou and Elledge, 2000) refer 
to the entire pathway as “the DNA damage response pathway” and use “the checkpoint 
branch” for components specially involved in controlling cell-cycle progression. 
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Figure 1-1.  The general outline of the DNA damage response signal transduction 
pathway.  Adapted from the review article “The DNA damage response: putting 
checkpoints in perspective” (Zhou and Elledge, 2000). 
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1.3.4. Molecular mechanisms of transcriptional regulation of yeast damage 
inducible genes 
 
1.3.4.1.  Regulation of ribonucleotide reductase (RNR) genes  
 Regulation of RNR genes is the best-known example of eukaryotic transcriptional 
response to DNA damage.  Ribonucleotide reductase is an enzyme converting nucleoside 
diphosphates (NDP) into deoxynucleoside diphosphates (dNDP), which represents the 
rate limiting step in the production of four dNTPs for DNA replication and repair 
(Elledge et al., 1993; Jordan and Reichard, 1998; Reichard, 1988).  Any failure to control 
the amount and balance of dNTP pools will lead to mutagenesis or cell death.  
Ribonucleotide reductase is an α2β2 tetramer, and four genes, RNR1-4, encode the 
subunits of budding yeast ribonucleotide reductase.  RNR1 and RNR3 encode alpha (large) 
subunits, while RNR2 and RNR4 encode beta (small) subunits (Elledge and Davis, 1987; 
Elledge and Davis, 1990; Huang and Elledge, 1997).  Expression of these genes are all 
inducible at the level of transcript accumulation by DNA damaging agents (Elledge and 
Davis, 1989; Elledge and Davis, 1990; Huang and Elledge, 1997). 
The transcriptional level of RNR3 gene is very low under normal conditions.  
However, when treating yeast cells with DNA damaging agents such as UV, MMS and 4-
NQO, the transcriptional level of RNR3 can be induced 100 to 500 fold (Elledge and 
Davis, 1990).  In order to discover the mechanisms of induction, a series of mutants have 
been isolated that cause constitutive expression of RNR3 (crt mutants) (Zhou and Elledge, 
1992).  These negative regulators of RNR3 expression are divided into two groups: 
indirect regulators that result in endogenous DNA damage or a state of metabolic stress 
such as nucleotide depletion which induces the upregulation of RNR3, and direct 
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regulators involved in the entire signal transduction pathway, including transcription 
factors.  The CRT1, TUP1 (CRT4) and SSN6 (CRT8) genes encode direct negative 
regulators binding to the RNR3 promoter.  A second screen was carried out in the same 
laboratory for the mutants that disrupt the ability of DNA damage to induce transcription 
of RNR3, and these genes were designated DUN for DNA-damage uninducible (Zhou and 
Elledge, 1993).  The nonessential serine/threonine protein kinase Dun1 was isolated in 
this screen.  Genetic analysis of crt1Δ, tup1Δ and ssn6Δ showed that these mutants were 
epistatic to the dun1Δ mutant, providing a strong genetic verification that CRT1, TUP1 
and SSN6 function downstream of DUN1 (Huang et al., 1998).  Combined with the 
evidence that Mec1 and Rad53, as upstream kinases of Dun1, are necessary for the DNA 
damage induction of RNR3 (Huang et al., 1998), the signal transduction regulation 
pathway for RNR3 is clear. 
In response to DNA damage or replication blocks, the Rad53 protein kinase is 
activated via a Mec1-dependent pathway, and activated Rad53 further phosphorylates the 
protein kinase Dun1.  The Mec1-Rad53-Dun1 kinase cascade culminates in the 
phosphorylation of Crt1.  Crt1 is a DNA-binding protein which binds to a 13-bp 
consensus sequence termed X-box.  Multiple X-box related sequences of different 
strength can be found in the promoter region of RNR3, RNR2 and RNR4.  Crt1 is able to 
recruit the general repressor Tup1-Ssn6 complex to depress the transcription of RNR 
genes.  In the presence of DNA damage or replication blocks, Crt1 is phosphorylated by 
Dun1 and loses the ability to bind to X-box, leading to transcriptional induction of RNR 
genes (Figure 1-2). 
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Figure 1-2.  Transcription control of RNR gene expression in budding yeast.  In 
response to DNA damage or replication arrest, checkpoint kinases Mec1, Rad53 and 
Dun1 are activated and phosphorylate the Crt1 repressor.  The phosphorylated Crt1 loses 
affinity for its binding sequence, thus the transcription of RNR genes is increased. 
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Surprisingly, multiple X boxes were also identified in the CRT1 promoter.  Data 
from mutated X-boxes showed that they confer CRT1-dependent repression on CRT1 
itself (Huang et al., 1998).  The expression level of CRT1 is very low under normal 
growth conditions but is inducible by DNA damaging agents.  Interestingly, the X-boxes 
in the CRT1 promoter consist of one with very weak binding strength and one with very 
strong affinity to Crt1.  Thus, it is likely that a weak induction of CRT1 immediately 
occurs upon the presence of DNA damage which provides a buffer against spurious 
transcriptional activation of the pathway.  Delayed full activation ensures a rapid 
restoration of the basal repressed state when the DNA damage is repaired (Huang et al., 
1998). 
Crt1 mediates repression by recruiting the general repressor Tup1-Ssn6 complex 
to RNR promoters via its N-terminus (Huang et al., 1998; Li and Reese, 2000).  Tup1-
Ssn6 recruitment establishes a nucleosomal array over the promoter of RNR3 with a 
positioned nucleosome  occupying  the  TATA  box to  block access by the  general    
transcriptional machinery (Li and Reese, 2000; Li and Reese, 2001; Sharma et al., 2003).  
The depression of RNR3 expression correlates with the disruption of nucleosome position.  
In response to DNA damage signals, the hyperphosphorylated Crt1 loses the ability to 
bind to the RNR3 promoter, and the Tup1-Ssn6 complex is not recruited to the promoter 
region.  Consequently, chromatin structure is remodelled, which increases the 
accessibility of DNA to transcription factors.  The chromatin-remodeling of the RNR3 
promoter requires a number of general transcriptional factors, such as TBP-associated 
factors (TAFIIS), and RNA polymerase II.  Furthermore, the remodeling is also dependent 
on the SWI/SNF complex which possesses a DNA-stimulated ATPase activity and can 
destabilize histone-DNA interactions in an ATP-dependent manner (Sharma et al., 2003).  
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The preinitiation complex (PIC) components TFIID and polymerase assist in the 
recruitment of the SWI/SNF complex to the RNR3 promoter, and retain the SWI/SNF 
complex at the remodeled promoter. 
Recently, more regulatory factors were found to be involved in the damage 
induction of RNR genes.  Wtm1 and Wtm2 have been reported to modulate expression of 
RNR3 (Tringe et al., 2006).  Moderate overexpression of both genes or high level 
expression of WTM2 alone upregulates RNR3-lacZ in the absence of DNA damage.  In 
response to HU and γ-ray, the expression level of RNR3 is attenuated by 45% in wtm2Δ 
mutants, but not in wtm1Δ mutants.  Wtm2 was found to directly associate with the RNR3 
promoter, and the association correlates with its ability to increase constitutive RNR3 
expression.  So far, it is still unknown how Wtm2 increases RNR3 transcription.  From 
some observations, it is hinted that WTM2 gene might enhance RNR3 transcription by 
participating in chromatin remodeling (Tringe et al., 2006). 
The CCR4 gene encodes a component of the major cytoplasmic deadenylase, 
which is involved in mRNA poly(A) tail shortening (Tucker et al., 2001).  A strain 
defective in CCR4 displayed particular sensitivity to the Rnr inhibitor HU (Woolstencroft 
et al., 2006). The ccr4Δ dun1Δ double mutants exhibited irreversible hypersensitivity to 
HU, and simultaneous overexpression of RNR2, RNR3 and RNR4 partially rescued the 
HU hypersensitivity of a ccr4Δ dun1Δ strain, suggesting that CCR4 and DUN1 function 
in different branches to regulate the activity of Rnr.  It has been found that Ccr4 regulates 
CRT1 mRNA poly(A) tail length and may subtly influence Crt1 protein abundance.  
Since ccr4Δ and chk1Δ exhibited epistasis in several genetic contexts, it is likely that 
Ccr4 and Chk1 act in the same pathway to overcome replication stress (Woolstencroft et 
al., 2006) 
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1.3.4.2. PHR1 
The budding yeast PHR1 gene encodes a photolyase that repairs specifically and 
exclusively pyrimidine dimers which are the most frequent lesions introduced to DNA by 
UV irradiation (Sancar, 1985).  The transcription of PHR1 is induced by various DNA 
damaging agents.  Three transcriptional regulatory elements have been defined within the 
PHR1 promoter region: an upstream activating sequence (UAS), an upstream repressing 
sequence (URS) and an upstream essential sequence (UES) (Sancar et al., 1995).  A 22-
bp interrupted palindrome comprises UASPHRI , and  it is responsible for 80-90% of basal 
and induced expression.  It alone can activate transcription of a CYC1 minimal promoter 
but does not confer damage responsiveness (Sancar et al., 1995).  URSPHR1 consists of a 
39-bp region that includes a 22-bp palindrome.  Deletion or specific mutations of 
URSPHR1 increases basal level expression but decrease the induction ratio.  It functions as 
a strong URS and confers a low level of damage inducibility when placed in the context 
of a heterologous gene (Sancar et al., 1995).  The UESPHR1 is required for efficient 
derepression when URSPHR1 is present.  Deletion of URSPHR1 also eliminates the 
requirement for UESPHR1 for transcriptional activation (Sancar et al., 1995). 
Three proteins have been identified that regulate the expression of PHR1 by 
binding to the upstream regulating elements.  Ume6 is a bifunctional transcriptional 
regulator which is involved in several metabolic pathways (Strich et al., 1994).  It is a 
positive regulator of PHR1 transcription and binds specially to the UASPHR1 (Sweet et al., 
1997).  Multiple copies of Ume6 enhance expression of PHR1; however, the effect of 
deletion is growth phase dependent.  Deletion of UME6 reduces the expression of PHR1 
during vegetative growth, but only at a distinct phase (Sancar, 2000; Sweet et al., 1997).  
Rph1 and Gis1 are two DNA damage-responsive repressors of PHR1 transcription, which 
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are 35% identical at the overall amino acid sequence level (Jang et al., 1999; Sancar, 
2000).  Both Rph1 and Gis1 contain two putative zinc fingers that are > 90% identical 
overall and completely identical in the DNA binding loop, and they regulate the DNA 
damage induction of PHR1 through binding to URSPHR1.  Deletion of both RPH1 and 
GIS1 is required to fully derepress PHR1 in the absence of damage, suggesting that they 
are functionally redundant.  In vitro footprinting and binding competition studies indicate 
that the sequence AG4 (C4T) within the URSPHR1 is the binding site for Rph1p and Gis1p 
(Jang et al., 1999). 
Induction of PHR1 expression is controlled by a DNA damage signal transduction 
pathway.  Serine and threonine residues of Rph1 can be phosphorylated, and the 
phosphorylation of Rph1 increases in response to DNA damage.  The DNA damage-
induced phosphorylation requires DNA damage checkpoint proteins Rad9, Rad17, Mec1 
and Rad53, indicating that the phosphorylation of Rph1 is under the control of the Mec1-
Rad53 DNA damage checkpoint pathway (Kim et al., 2002).  Furthermore, deletion of 
DUN1, TEL1 and CHK1 doesn’t affect the phosphorylation of Rph1.  These observations 
imply that DNA damage induction of PHR1 is regulated by a potentially novel damage 
checkpoint that is distinct from the Mec1-Rad53-Dun1 protein kinase cascade implicated 
in the DNA damage-inducible transcription of RNR genes.  Based on results of a co-
immunoprecipitation (co-IP) assay, Rad53 seems not to physically interact with Rph1, 
indicating the existence of another kinase(s) in the Mec1-Rad53-Rph1 pathway (Kim et 
al., 2002).  The identity of the kinase(s) is at present unknown. 
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1.3.4.3. MAG1 and DDI1   
MAG1 encodes a 3-methyladenine DNA glycosylase that initiates BER to remove 
lethal lesions such as 3-methyladenine caused by alkylating agents.  The transcription of 
MAG1 is not only induced by DNA alkylating agents such as MMS, but also by UV and 
HU (Chen et al., 1990; Liu and Xiao, 1997).  By analyzing the DNA sequence 
immediately upstream of MAG1, another DNA damage inducible gene, named DDI1 for 
DNA Damage Inducible, was identified (Liu and Xiao, 1997).  Like MAG1, DDI1 is also 
induced by MMS, UV, 4NQO and HU.  Furthermore, both genes require a similar dosage 
for the maximum induction, and the fold of induction is similar (Liu and Xiao, 1997).  
MAG1 and DDI1 lay in a head-to-head configuration and are transcribed 
divergently.  The expression of MAG1 and DDI1 is controlled by two functionally 
opposite regulatory elements, UAS and URS, through an antagonistic mechanism (Liu 
and Xiao, 1997).  A UASMAG1 and  a URSMAG1 have been identified in the promoter 
region of MAG1 (Xiao et al., 1993).  The expression of DDI1 was reported to be 
negatively regulated by a URSDDI1 in its promoter region (Liu and Xiao, 1997).  The 
intergenic region between MAG1 and DDI1 also contains cis-acting elements that co-
regulate the expression of both genes.  In the common promoter region, UASDM, which 
contains two 8-bp tandem repeat sequences 5’-GGTGGCGA-3’, is required for the 
bidirectional expression of MAG1 and DDI1 (Liu and Xiao, 1997).  With a yeast one-
hybrid screen using the UASDM as a bait, a transcriptional activator called Pdr3 was 
isolated (Zhu and Xiao, 2004).  Deletion of PDR3 reduced both basal-level expression 
and DNA damage induction of MAG1 and DDI1.  In addition,  deletion of PDR3 does not 
further affect MAG1 and DDI1 expression if UASDM is deleted, indicating that UASDM is 
indeed the target of Pdr3 activation (Zhu and Xiao, 2004).  Furthermore, another 
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transcriptional activator Rpn4 was shown to be required for both MAG1 and DDI1 
expression (Jelinsky et al., 2000).  However, Rpn4 does not appear to bind UASDM.  
Moreover, deletion of RPN4 does not alter MAG1 and DDI1 expression in the pdr3 
mutant cells, suggesting RPN4 acts upstream of PDR3 (Zhu and Xiao, 2004).  Deletion of 
PDR3 and RPN4 has no effect on the basal-level and DNA damage-induced expression 
of PHR1, RNR2 and RNR3.  Meanwhile, the regulators of RNR genes Crt1, Tup1/Ssn6 
and the regulators of PHR1 gene Rph1 and Gis1 are not involved in the control of MAG1 
expression (Zhu and Xiao, 2001).  Hence, it seems that all three sets of well-studied yeast 
damage-inducible genes (RNR, PHR1 and MAG1-DDI1) have distinct regulators and that 
the regulatory mechanisms are also different from each other. 
The DNA damage induction of MAG1 and DDI1 is also controlled by DNA 
damage checkpoints.  Mutation of POL2, MEC1 or DUN1 reduces the DNA damage 
induction of MAG1 (Zhu and Xiao, 1998; Zhu and Xiao, 2001).  Thus, it suggests that 
MAG1 is regulated by the POL2-MEC1-RAD53-DUN1 checkpoint pathway.  However, 
in both dun1Δ mutant and mec1Δ mutant, DDI1 are fully induced by MMS treatment.  
While in pds1Δ sad1-1 (rad53) and pds1Δ dun1Δ double mutants, the DNA damage-
dependent induction of DDI1 is significantly inhibited compared to the respective single 
mutants (Zhu and Xiao, 2001).  PDS1 encodes an anaphase inhibitor and functions in 
DNA damage checkpoints.  PDS1 and RAD53-DUN1 may form two parallel branches in 
DNA damage checkpoints (Gardner et al., 1999; Schollaert et al., 2004).  This suggests 
that the PDS1 and MEC1-RAD53-DUN1 checkpoint pathways may function redundantly 
in the control of DDI1 expression (Zhu and Xiao, 2001).  
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1.4. DNA damage induction in mammalian cells 
Compared with budding yeast, the transcriptional responses to DNA damaging 
agents in mammalian cells are more complex.  The complexity is not only due to the 
larger and more intricate genomes of mammalian cells compared to yeast cells,  but also 
to a greater range of possible downstream responses (Friedberg et al., 2006).  Firstly, the 
presence of a damaged cell in a tissue may initiate an extracellular communication of 
damage response.  Secondly, mammalian genes that are activated in response to DNA 
damage include those genes involved in DNA repair and repair-associated processes, as 
well as genes encoding secreted growth factors, growth factor receptors, protective 
cytoplasmic enzymes, and proteins normally associated with tissue injury and 
inflammation (Eckardt-Schupp and Klaus, 1999; Friedberg et al., 2006; Herrlich et al., 
1992; Kastan et al., 1992; Keyse, 1993; Weichselbaum et al., 1991).  Thirdly, if the 
damage is too severe to be fixed, mammalian cells will initiate programmed cell death, 
namely, apoptosis or autophagy.  Conversely, budding yeast as a unicellular lower 
eukaryote does not undergo apoptosis, or only in a rudimentary form (Ludovico et al., 
2005; Weinberger et al., 2003).  A number of genes involved in apoptosis are 
transcriptionally regulated in response to the cell death signal. 
 
1.4.1. The transcriptional response to DNA damage in mammalian cells 
Although DNA damage induction in mammalian cells is more complicated than 
that in budding yeast, the pathways involved in the regulation of DNA damage induction 
in yeast and mammalian cells are still evolutionarily conserved.  Like yeast, the well-
conserved DNA damage checkpoint pathways play a role in DNA damage induction in 
mammalian cells.  The regulatory pathways are also signal transduction pathways 
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consisting of sensors, transducers and effectors.  In these signal transduction pathways, 
the identities of the sensors are not yet known, whereas much is known about the signal 
transducers.  ATM and ATR kinases, CHK1 and CHK2 kinases are well-documented 
transducers. 
 
1.4.1.1.  ATM and ATR 
The ATM (Ataxia-telangiectasia mutated) gene was identified as the gene 
mutated in the human genomic instability syndrome ataxia telangiectasia (AT) (Savitsky 
et al., 1995).  Both ATM and ATR (ATM and Rad3-related) belong to the PI-3K family, 
and they exhibit sequence similarity to Tel1 and Mec1 in the budding yeast.  These two 
proteins play a key role in mammalian DNA damage checkpoints.  The ATM and ATR 
associated kinase activities are enhanced in response to DNA damage.  ATM responds 
primarily to DSBs induced by IR, while ATR plays important roles in response to 
damages caused by UV and HU(Abraham, 2001; Kurz and Lees-Miller, 2004; Yang et al., 
2003).  However, there is no strict division between the signals for the two protein 
kinases, since ATM also functions in some UV responses (Hannan et al., 2002; Yang et 
al., 2003).   So far, it is still not very clear how these two kinases are activated by DNA 
damage.  Several mechanisms have been proposed for the activation: a) activation 
through interaction with damaged DNA, b) activation through interaction with proteins of 
the DNA repair complex, c) a combination of both (Wahl and Carr, 2001; Yang et al., 
2004).  Based on some observations, it has been speculated that ATM might be activated 
through interactions with an altered chromatin structure due to strand breaks rather than 
direct binding to DSB (Bakkenist and Kastan, 2003; Bartek and Lukas, 2003).  The 
activation of ATR might be different from that of ATM.  ATR binds to UV-damaged 
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DNA with higher affinity than to undamaged DNA (Unsal-Kacmaz et al., 2002).  In 
addition, damaged DNA stimulates the kinase activity of ATR to a significantly higher 
level than undamaged DNA.  Nevertheless, the mechanism for ATR activation remains to 
be elucidated. 
Following DNA damage, many proteins aggregate at the damage sites, thus 
forming nuclear “foci”.   ATM and ATR can be found in these foci within 5 minutes of 
the damage occurring.  Other proteins found in the foci include DNA repair proteins, 
chromatin structure proteins and transcriptional factors (Yang et al., 2003).  This suggests 
that the central role of ATM and ATR is DNA damage response. 
 
1.4.1.2.  CHK1 and CHK2 kinases 
CHK1 and CHK2 are two protein kinases which act downstream of ATM and 
ATR in the damage checkpoint pathways.  CHK2 is the homolog of Rad53 in budding 
yeast, and CHK1 shares homology with the budding yeast Chk1.  In human and other 
vertebrates, CHK1 and CHK2 appear to have unique functions but show a high degree of 
cross-talk and connectivity.  CHK2 is rapidly phosphorylated and activated in response to 
replication blocks and DNA damage in an ATM dependent manner (Matsuoka et al., 
1998).  After exposure to ionizing radiation, ATM directly phosphorylates CHK2 at 
Thr68 and the residues in the ST/QT cluster, and induces autophosphorylation  in CHK2 
(Ahn et al., 2000; Lee and Chung, 2001; Ward et al., 2001).  Moreover, phosphorylation 
of CHK2 by ATM occurred exclusively at the DSB sites.  Unlike the case for other DNA 
repair proteins, the phosphorylated CHK2 is able to move rapidly through the nucleus.  
Forced immobilization of CHK2 impairs its stimulating effect on p53-dependent 
transcription (Lukas et al., 2003).  It indicates that CHK2 migrates from the DNA 
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damage regions to its physiological targets after phosphorylation by ATM.  Human 
CHK1 is phosphorylated at Ser317 and Ser345 in response to UV irradiation or HU 
treatment.  The phosphorylation is inhibited in ATR-deficient cells.   Mutants of CHK1 
containing S317A and S345A are poorly activated in response to replication blocks and 
DNA damaging agents (Zhao and Piwnica-Worms, 2001).  In addition, phosphorylation 
of CHK1 on Ser-317 in response to IR is markedly reduced in the cells lack of  ATM, 
and the expression of ATM can correct this defect (Gatei et al., 2003).  In contrast, the 
phosphorylation of CHK1 in response to HU and UV is ATM-independent. 
 
1.4.2. Effectors in the DNA damage induction 
Transcription factors are the ultimate effectors which directly influence 
transcription in signal transduction pathways.  The specific activation of a number of 
transcription factors has been observed in mammalian cells following UV irradiation or 
ionizing radiation. 
 
1.4.2.1. The p53 transcription factor 
The p53 protein is known as a “guardian of the genome” because of its crucial 
role in mediating the cellular responses to genotoxic stress (Levine, 1997).  It is a 
sequence-specific transcriptional factor which functions as a potent tumor suppressor.  
p53 both positively and negatively regulates the expression and activity of many genes 
involved in cell cycle arrest, DNA synthesis and repair as well as apoptosis.  Inactivating 
mutations in the p53 gene are found in 50% of cancers, while the other half are thought to 
contain mutations in components associated with the p53 pathway  (Coutts and La 
Thangue, 2006; Friedberg et al., 2006). Germline mutations of p53 cause Li-Fraumeni 
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syndrome (LFS) which predisposes patients to spontaneous tumor formation (Malkin, 
1994). 
The p53 protein forms a homo-tetramer when it functions as a transcription factor, 
and a 53-amino-acid carboxy-terminal domain is responsible for the tetramerization.  Its 
DNA binding domain is mapped to residues 102-292 (Pavletich et al., 1993) (Figure 1-3).  
The consensus binding site of p53 shows a striking internal symmetry, consisting of two 
copies of the 10-bp motif 5'-PuPuPuC(A/T)(T/A)GPyPyPy-3' separated by 0-13 base 
pairs. The binding of p53 requires both copies of the motif, and any subtle alterations in 
the motif cause loss of affinity for p53 (el-Deiry et al., 1992). 
 
1.4.2.1.1. The activation of p53 
Under normal conditions, p53 is kept in a latent inactive state and retains low 
protein levels through the regulation of protein stability.  Following DNA damage and 
other stresses, such as ribonucleotide depletion (Linke et al., 1996), p53 is activated and 
undergoes a significant increase in protein stability primarily by post-translational 
modifications. 
 HDM2, the human homolog of murine double minute 2 (Mdm2) oncoprotein, is a 
key regulator of p53 in human cells (Bottger et al., 1997; Brooks and Gu, 2006; Coutts 
and La Thangue, 2006).     Mdm2   binds  to  the  N-terminal  region of  p53 to  block  the 
interactions between p53 and transcriptional co-activators and ubiquitinate p53.  
Accordingly, the transcriptional activity of p53 is repressed, and ubiquitinated p53 is 
targeted for proteosomal degradation (Haupt et al., 1997; Kubbutat et al., 1997).  In 
response to DNA damage, ATM and ATR are activated and directly  phosphorylate p53  
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Figure 1-3.  The functional domains of human p53.  The transactivation domain and 
the Src homology-3-like (SH3) domain are located at the N-terminus of p53.  The central 
core contains the DNA-binding domain, and the C-terminus contains nuclear localization 
and export signals, a regulatory domain and the tetramerization domain. Numbers 
indicate residue number.  Adapted from (Bode and Dong, 2004). 
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on Ser15 which is in the transactivation domain (Banin et al., 1998; Canman et al., 1998; 
Tibbetts et al., 1999).  Their downstream kinases CHK1 and CHK2 phosphorylate p53 on 
Ser20 which is within the Mdm2-binding region (Hirao et al., 2000).  Furthermore, some 
other distinct protein kinases phosphorylate p53 at different serine or threonine sites at 
the N-terminus (Bode and Dong, 2004).  Phosphorylation of p53 at the N-terminus 
disrupts the binding of Mdm2 so as to stabilize the protein.  The phosphorylated p53 also 
shows increased binding activity to its specific DNA sequence and the ability to recruit 
co-activators (Hupp and Lane, 1994; Lambert et al., 1998).  In addition, phosphorylation 
promotes phosphorylation and acetylation on the C-terminus of p53.  So far, 17 
phosphorylation sites have been detected in human p53 in response to DNA damage 
induced by ionizing radiation or UV irradiation (Bode and Dong, 2004).  The presence of 
multiple phosphorylation sites may help fine tune the activation of p53.  Interestingly, the 
transcription of mdm2 is regulated by p53, thus an autoregulatory feedback loop is 
involved in the tight regulation of p53 (Barak et al., 1993).  Moreover, HDM2 is rapidly 
phosphorylated on Ser395 by ATM after ionizing radiation treatment.  The 
phosphorylated HDM2 may be less capable of mediating degradation of  p53 (Maya et 
al., 2001). 
CBP (cAMP response element-binding protein) and p300 are histone acetylases 
that not only acetylate chromatin but also many transcription factors, including p53 
(Chan and La Thangue, 2001).  In response to DNA damage, the phosphorylation of 
Ser15 in p53 enhances the binding of p300/CBP and pCAF (p300/CBP-associated factor) 
to the N-terminus of p53 so that they acetylate the C terminus of p53 on the lysine 
residues (Lambert et al., 1998; Liu et al., 1999).  These lysine residues are also targets of 
Mdm2 ubiquitination, suggesting a potential competition between acetylation and 
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ubiquitination.  Hence acetylation of p53 by p300/CBP and pCAF might negatively affect 
Mdm2-mediated ubiquitination and increase p53 stability.  Furthermore, CBP/p300 also 
acetylates Mdm2 in its C-terminal RING-finger domain (Wang et al., 2004).  This 
modification is likely to impair E3 ligase activity of Mdm2, thus it serves as an additional 
mechanism for the inactivation of Mdm2.  Additionally, p300/CBP bound to p53 
acetylates nucleosomes in p53 response elements, resulting in chromatin modifications 
required for p53 transcriptional activation  (Espinosa and Emerson, 2001). 
It is well known that genotoxic stresses, such as ionizing radiation and UV 
irradiation, result in the nuclear accumulation of p53.  Stress-induced nuclear 
accumulation is probably due to an inhibition of nuclear export.  As discussed before, p53 
binds to its response elements as a homo-tetramer.  In its C-terminal tetramerization 
domain, a highly conserved nuclear export sequence (NES) is responsible for the export 
of p53 from the nucleus (Stommel et al., 1999).  Mutations in the NES lead to a 
predominantly nuclear localization of p53.   Meanwhile, these mutations also prevent the 
formation of p53 tetramers.  Crystal structure analysis reveals that NES is exposed and 
should be a suitable substrate for an export receptor when p53 is monomeric or dimeric, 
but is buried in p53 tetramers (Stommel et al., 1999).  These observations suggest a 
mechanism for the tight connection between p53 structure and function following DNA 
damage.  The enhanced stability of p53 improves the formation of p53 tetramers, thus 
increasing both p53 nuclear accumulation and binding to response elements (Wahl and 
Carr, 2001). 
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1.4.2.1.2. p53-mediated gene expression 
Since p53 is a sequence-specific transcriptional factor, the transcriptional 
transactivation might be its primary function in DNA damage responses. Both the DNA-
binding domain and the transactivation domain are indispensable for its tumor 
suppression function.  Mice with an allele encoding changes at Leu25 and Trp26 in p53, 
which is known to be essential for transcriptional transactivation, exhibit the same 
predisposition to tumor formation as the isogenic mice with a p53-null allele (Jimenez et 
al., 2000).  Inactivating mutations in the DNA binding domain of p53 has been shown to 
be one of the main causes that lead to tumor formation (Cho et al., 1994; Pietenpol et al., 
1994). 
Two strategies has been carried out to identify biologically important genes which 
are transcriptionally regulated by p53 (Nakamura, 2004).  The first approach is the 
differential display method and cDNA microarray analysis.  The data from microarray 
analysis show that the p53-mediated transcription vary widely among cell lines and 
individuals (Burns and El-Deiry, 2003; Friedberg et al., 2006; Maxwell and Davis, 2000; 
Mirza et al., 2003; Okada et al., 2003; Sax et al., 2003; Zhao et al., 2000).  From these 
studies, p53 appears to regulate the transcription of more than 1000 genes in response to 
DNA damage.  The second approach is based on the idea that p53 is able to directly 
regulate genes through binding p53 responsive elements in promoter regions or within 
introns.  According to GenBank annotation and a computationally derived transcript map, 
a p53 target gene database of human genes shows that the promoters of 4,852  genes 
contain at least one p53 consensus binding sequence (Wang et al., 2001).  Recently, the 
promoter regions bound to p53 were screened during DNA damage through chromatin 
immunoprecipitation (ChIP) coupled with CpG island (CGI) microarray analysis, (Krieg 
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et al., 2006).  The screen identified promoters of 199 genes which are directly bound by 
p53 in response to DNA damage.  Binding of p53 to these target genes is partially 
dependent on a functional DNA binding domain, and the expression of these genes varies 
a great deal in response to stress (Krieg et al., 2006). 
Taken together, the following 6 groups of genes are transcriptionally regulated by 
p53: (i) genes with a role in DNA repair, such as the ribonucleotide reductase gene p53R2 
(Tanaka et al., 2000), NER genes GADD45, XPC and XPA (Adimoolam and Ford, 2002; 
Hwang et al., 1999; Tan and Chu, 2002), MMR genes hMSH2 (Scherer et al., 2000) and 
PCNA (Krieg et al., 2006; Xu and Morris, 1999);  (ii) genes regulating cell cycle 
progression, including p21 (Li et al., 1994), GADD45 (growth arrest and DNA damage 
inducible) (Kastan et al., 1992), hCDC4b (Kimura et al., 2003) , cyclin K (Mori et al., 
2002) and p53RFP (p53-inducible RING-finger protein) (Ng et al., 2003); (iii) genes 
involved in oxidative stress, such as the ALDH4 gene (aldehyde dehydrogenase 4) 
(Nakamura, 2004); (iv) genes that function in apoptosis, such as genes encoding death 
domain proteins Bax, PUMA and Noxa; BCL2 family members; FAS, KILLER/DR5 and 
PIDD, genes in the death receptor pathway; PERP gene encoding a membrane protein 
(p53 apoptosis effector related to PMP-22); and APAF-1 gene (apoptosis protease 
activator apoptotic activating factor 1) (Shen and White, 2001; Slee et al., 2004; Wahl 
and Carr, 2001); (v) genes influencing the extra-cellular matrix or cytoskeleton, such as 
the collagen genes (Bian and Sun, 1997; Eizenberg and Oren, 1991; Zhao et al., 2000) 
and cytokeratin genes (Cui and Donehower, 2000; Kazachkov et al., 1996; Zhao et al., 
2000); (vi) genes inhibiting angiogenesis, e.g. TSP1 (thrombospondin 1) (Dameron et al., 
1994) and BAI1 (brain- specific angiogenesis inhibitor 1) (Nishimori et al., 1997). 
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1.4.2.1.3. Molecular mechanisms for transcriptional activation by p53 
p53 may promote transcription by three possible mechanisms.  First, p53 binding 
to its responsive elements recruits chromatin remodeling factors, histone transacetylases 
and methyltransferases to facilitate the initiation of transcription.  For example, several 
subunits of the human SWI/SNF complex bind to p53, and the SWI/SNF complex is 
necessary for p53-driven transcriptional activation (Lee et al., 2002).  As mentioned 
before, histone transacetylases p300/CBP and pCAF bind to the N-terminus of p53 and 
further acetylate nucleosomes in the promoter region, resulting in chromatin 
modifications required for transcriptional activation.  The involvement of protein arginine 
methyltransferases PRMT1 and CARM1 in p53 function have been demonstrated (An et 
al., 2004).  These coactivators directly interact with p53 and modify cognate histone 
substrates to promote the initiation of transcription.  Secondly, p53 stimulates 
transcription via enhancing the recruitment of the basal transcription factors TFIIA and 
TFIID on the promoter region.  p53 induces a conformational change over the promoter 
region to form a more stable and active TFIIA-TFIID-DNA complex, which may lead to 
enhanced assembly of the rest of the factors of the transcription machinery (Xing et al., 
2001). Thirdly, p53 may directly interact with the components in the mediator complex to 
facilitate the formation of a pre-initiation complex (Gu et al., 1999; Zhang et al., 2005). 
 
1.4.2.2. The AP-1 transcription factor complex 
AP-1 (activator protein-1) is a complex of sequence-specific transcriptional 
activators consisting of the proteins of the FOS and JUN families (Angel and Karin, 
1991).  All three JUN variants (c-Jun, JunB and JunD) and four FOS variants (c-Fos, 
FosB, Fra-1 and Fra-2) belong to the basic leucine zipper (bZIP) superfamily of DNA 
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binding proteins, and they are homologous to transcription factor Gcn4 in budding yeast.  
FOS and JUN make up AP-1 by forming a homodimer, a heterodimer or a complex with 
closely related transcription activators such as ATF-2 (activating transcription factor 2) 
(Angel and Karin, 1991).  In addition, Maf (musculoaponeurotic fibrosarcoma oncogene 
family ) proteins can heterodimerize with JUN or FOS to make up AP-1 (Kataoka et al., 
1994; Swaroop et al., 1992).  The heterodimer of c-Jun with c-Fos exhibit the highest 
transcriptional capacity since this complex is the most stable dimer, although this varies 
depending on promoter context (Chen et al., 1998; Kouzarides and Ziff, 1988).  The AP-1 
transcription factor complex is highly responsive to genotoxic stress.  Following exposure 
of mammalian cells to different DNA damaging agents, the DNA-binding and 
transcription activities of AP-1 are significantly elevated, resulting in the enhanced 
transcription of at least 250 genes involved in DNA repair, cell cycle regulation and 
tumor progression (Davis et al., 1998; Frame et al., 1991; Hayakawa et al., 2004; 
Sahijdak et al., 1994). 
The activity of AP-1 is regulated at two levels: synthesis of new AP-1 
components or activation of a pre-existing AP-1 complex through post-translational 
modification (Karin, 1995).  The transcription of most genes encoding AP-1 components 
is rapidly activated within 15 to 20 minutes after UV irradiation so that FOS and JUN are 
described as “immediate-early-response genes” (Treisman, 1992).  AP-1 can bind to two 
cis-elements (nt. -190 to -180 and -71 to -64) in the c-jun promoter to activate the 
transcription of c-jun itself after UV treatment (Devary et al., 1991).  The regulation of c-
fos transcription is more complex.  Several cis-elements mediate c-fos induction in 
response to DNA damage, including the cAMP responsive element (CRE) recognized by 
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AP-1 (Treisman, 1992).  All these observations indicate a positive-feedback loop on the 
transcription level for the regulation of AP-1 activity. 
 Like p53, the activity of AP-1 is regulated by post-translational modification.  
Phosphorylation of Ser63 and Ser73 in the transactivation domain of JUN by  JUN N-
terminal kinases (JNK) potentiates its ability to activate transcription as either a 
homodimer or a heterodimer with FOS (Deng and Karin, 1994; Derijard et al., 1994; 
Pulverer et al., 1991).  ATF can be phosphorylated on Thr69 and Thr71 within its N-
terminal transactivation domain by JNK as well, and this phosphorylation upregulates the 
transcriptional activity of ATF (Gupta et al., 1995). 
Multiple signal transduction pathways contribute to the phosphorylation of AP-1.  
Ionizing radiation induces the phosphorylation of c-Jun in normal fibroblasts but not in 
AT fibroblasts, suggesting that ATM plays a role in the phosphorylation of JUN (Lee et 
al., 1998).  JNK can be activated through phosphorylation by MEKK1 (MEK kinase 
kinase 1)-MKK4 (MAP kinase kinase) kinase cascade.  MEKK1 in turn is activated by 
ABL which is a tyrosine kinase stimulated by ionizing radiation (Kharbanda et al., 2000; 
Kharbanda et al., 1995).  ABL is a downstream target of ATM, and phosphorylation at 
Ser465 by ATM is required for ABL kinase activity in the cellular response to ionizing 
radiation (Baskaran et al., 1997).  This ATM –mediated pathway is not activated by UV 
irradiation. 
Following UV irradiation, a signal transduction pathway originating from the cell 
membrane regulates the phosphorylation of AP-1.  UV irradiation activates the growth 
factor and cytokine receptors on the cell membrane, e.g. epidermal growth factor (EGF) 
receptor, interleukin (IL)-1 receptor, insulin receptor, platelet derived growth factor 
(PDGF) receptor and tumor necrosis factor-α (TNF-α) receptor, resulting in clustering 
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and internalization of these receptors (Rittie and Fisher, 2002; Rosette and Karin, 1996).  
Activation of cell surface cytokine and growth factor receptors subsequently activate 
small GTP-binding protein family members Ras, Rac, and Cdc42 to trigger downstream 
ERK, JNK and p38 MAPK signalling pathways.  JUN and ATF are subject to 
phosphorylation by JNK, ERK and p38 MAPK. 
 
1.4.2.3. The E2F transcription factor family 
E2F transcription factors normally are heterodimers consisting of a subunit of the 
E2F family and a subunit of the DRTF1 protein (DP) family.  In mammals, the E2F 
family includes eight proteins (E2F1-8), and there are three proteins (DP1, DP2/3 and 
DP4) in the DP family (DeGregori and Johnson, 2006; Du and Pogoriler, 2006).  E2F1-6 
require dimerization with one of three DP proteins to form functional transcription factors, 
whereas recently identified E2F7 and E2F8 (in mouse) exhibit little homology to their 
traditional counterparts and function independently of DP proteins (Christensen et al., 
2005; de Bruin et al., 2003; Logan et al., 2005; Maiti et al., 2005; Milton et al., 2006; 
Rogers et al., 1996; Wu et al., 1995).  All E2F1-6 and three DP proteins possess a 
conserved DNA binding domain and one dimerization domain.  Conserved domains for 
transcriptional activation and pocket protein binding are present only in E2F1–E2F5.  Rb 
(Retinoblastoma) and/or the other pocket proteins, p107 and p130, can bind to E2F1-5 
and block the ability of an E2F-DP heterodimer to activate transcription. 
Early studies showed that E2F transcription factors plays a critical role in 
organizing the G1/S transition by regulating the transcription of genes required for entry 
into S phase (La Thangue, 1994; Ohtani et al., 1995).  Recently, global ChIP–chip assays 
of E2F4 and E2F1 revealed that E2F transcription factors directly regulate genes of seven 
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functional groups: cell cycle regulation, DNA replication, DNA repair, DNA damage and 
G2/M checkpoints, chromosome transactions, and mitotic regulation (Ren et al., 2002).  
DNA repair genes regulated by E2F are involved in the full spectrum of repair processes, 
including MMR(MSH2, MLH1), BER(UNG), NER(RPA3), homologous recombination 
(RAD51 and RAD54) and NHEJ(DNA-dependent protein kinase).  Additionally, a linkage 
has been observed between the processes of DNA replication and repair in mammalian 
cells, indicating that their expression is co-regulated through E2F (Ren et al., 2002). 
Like p53, E2F1 is stabilized by UV irradiation and ionizing radiation (Blattner et 
al., 1999).  The degradation of E2F1 is mediated by the ubiquitin proteasome pathway 
(Campanero and Flemington, 1997).  Similar to p53, the ubiquitination of E2F1 also 
depends on MDM2.  Moreover, MDM2 interacts with E2F-1 via the same domain that it 
interacts with p53.  Therefore it suggests that E2F-1 is upregulated in a manner similar to 
p53 in response to DNA damage and Mdm2 appears to play a major role in this pathway 
(Blattner et al., 1999).  In response to DNA damage, E2F-1 is targeted and 
phosphorylated by ATM/ATR and CHK2 (Lin et al., 2001; Stevens et al., 2003).  Both 
ATM and ATR can directly phosphorylate E2F1 at Ser31 (Lin et al., 2001).  The 
phosphorylation increases protein stabilization, resulting in the accumulation of E2F1.  
The DNA damage-induced accumulation of E2F is blocked in either E2F Ser31Ala 
mutant or ATM kinase dead mutant (Lin et al., 2001).  After treating cells with DNA 
damaging agents, CHK2 can also phosphorylate E2F-1 at the Ser364 residue (Stevens et 
al., 2003).  Phosphorylation by CHK2 increases the E2F-1 level by an extended half-life 
of E2F.  Phosphorylation on Ser364 possibly decreases the physical association between 
MDM2 and E2F-1 since Ser364 is positioned close to the MDM2 binding domain in 
E2F1.  By comparing the effects of E2F-1 wild type with E2F-1 Ser364Ala mutant on 
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E2F-responsive promoters, the transcription activity of an E2F-1 point mutant is 
significantly lower than that of E2F-1 wild type, even though protein levels were similar 
(Stevens et al., 2003).  It seems that phosphorylation of E2F-1 by CHK1 is functionally 
important for both the stability of E2F-1 and the ability of E2F-1 to activate transcription 
(Stevens et al., 2003).  Most interestingly, several E2F binding sites exist in the CHK1 
promoter.  Overexpression of E2F-1 can induce the expression of CHK1, implying a 
positive feedback loop in the DNA damage response (Carrassa et al., 2003). 
Similar to p53, E2F-1 is also regulated by acetylation.  In response to DNA 
damage, E2F-1 is acetylated at Lys117, Lys121 and Lys125 by the p300/CBP-associated 
factor P/CAF and to a less extent by p300/CBP itself (Martinez-Balbas et al., 2000).  
Acetylation of E2F-1 by P/CAF increases its DNA-binding ability, transcriptional 
activation capacity and protein half-life (Martinez-Balbas et al., 2000).  Moreover, both 
acetylation and phosphorylation of Ser31 by ATM/ATR are required for efficient 
recruitment of E2F-1 to its target promoter after DNA damage (Pediconi et al., 2003).  
Thus, E2F-1 acetylation seems to be connected with phosphorylation in directing E2F1 to 
the promoters of target genes in response to DNA damage. 
 
1.5. The transcriptional repression in the DNA damage response 
Compared with genes whose expression is up-regulated in response to DNA 
damage, the down-regulated genes mostly remain unexplored.  Actually, the 
transcriptional repression of some genes could also play an important role in cellular 
recovery from DNA damage.  In the E. coli SOS response, diminished transcript levels 
have been clearly evident in some operons after UV irradiation (Courcelle et al., 2001).  
These operons control metabolism of carbon sources, lipid synthesis in membrane or 
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septum formation prior to cell division (Courcelle et al., 2001).  The microarray assays in 
budding yeast have also shown that the transcription of some genes is repressed after 
treatment with DNA damaging agents (Gasch et al., 2001; Jelinsky et al., 2000; Jelinsky 
and Samson, 1999).  The biological functions of these genes include nucleotide synthesis, 
assembly of ribosomal proteins and promotion of cell cycle progress.  Collectively, these 
data suggest that cells may down-regulate some unnecessary metabolism and protein 
synthesis in response to DNA damage and slow down cell cycle progression to provide 
more time for damage repair through repressing the transcription of certain genes. 
To date, the regulatory mechanism of transcriptional repression in response to 
DNA damage is not well understood.  In E. coli, a large number of genes in wild type 
cells, but not in the lexA defective mutants, show reduced transcript levels after UV 
irradiation, suggesting that lexA is involved in inhibiting gene transcription in response to 
DNA damage (Courcelle et al., 2001).  In mammalian cells, some transcriptional factors, 
such as p53 and E2F as discussed above, can actually function as both transcriptional 
activators and transcriptional inhibitors.  p53 mediates transcriptional repression through 
interference with the basal transcriptional machinery (Ragimov et al., 1993; 
Subbaramaiah et al., 1999)  and other transcriptional activators (Hoffman et al., 2002; 
Lee et al., 1999), or alternation of chromatin structure by recruiting proteins such as 
histone deacetylases (Mirza et al., 2002; Murphy et al., 1999).  The mechanism for the 
repression activity of p53 is not clear.  Given that phosphorylation of p53 at Ser386 
appears to be necessary for transcriptional repression (Hall et al., 1996), the post-
translational modification of p53 may contribute to its repression activity.  It is also very 
possible that subtle differences within the p53-binding site itself may play pivotal roles in 
the repression activity of p53 (Ho and Benchimol, 2003). 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1. Bacterial culture and storage 
The E. coli strain DH10B (Gibco/BRL, Grand Island, NY, USA) was used for 
bacterial transformation.  Transformed cells were cultured in LB liquid or agar media 
(1% Bacto-tryptone, 0.5% Bacto-yeast extract, 0.5% NaCl and 2% agar for plates) 
containing 100 μg/ml of ampicillin (Amp).  For short-term storage (2 or 3 months), 
transformed cells were stored on LB + Amp plates.  For long-term storage, transformed 
cells were grown overnight in 900 μl of LB + Amp and immediately placed in a –70oC 
freezer after mixing with 100 μl of DMSO. 
 
2.2.  Preparation of competent cells 
E. coli competent cells for electroporation were prepared as suggested in the 
BioRad E. coli Pulser (BioRad, Hercules, CA, USA) manual.  One liter of culture was 
incubated at 37oC until an OD600nm of 0.6 was reached.  The culture was centrifuged at 
2000 xg for 5 minutes in a Beckman GSA rotor and the pellet was resuspended in 500 ml 
of 10% ice-cold sterile glycerol.  The centrifugation was repeated 4 times, with each 
pellet resuspended in a reduced volume; the last pellet was resuspended in 4 ml of ice-
cold, sterile 10% glycerol.  The cells were aliquoted into 1.5 ml eppendorf tubes to a 
volume of 25 μl, and were quickly placed in the –70oC freezer for storage. 
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2.3. Bacterial transformation 
 All bacterial transformations in this study were carried out by the electroporation 
method.  The DNA to be transformed was added to E. coli competent cells and the cell 
mixture was transferred to a pre-chilled electroporation cuvette (BioRad, Hercules, CA, 
USA).  After a brief incubation on ice, the cells were exposed to a voltage of 1.8 kV (for 
cuvettes with 0.1 mm width) using the E. coli Pulser (BioRad).  Four hundred microliters 
of SOC medium was added to the cuvette after electroporation.  The cells were 
transferred to a 1.5 ml eppendorf tube, incubated at 37oC for half an hour, spread on LB + 
Amp plates and incubated at 37oC overnight.  
 
2.4. Rapid preparation of plasmid DNA 
 Plasmid amplification and isolation was performed following the methods as 
described (Sambrook and Russell, 2001).  Single colonies were inoculated into 1.5 ml LB 
+ Amp liquid media and grown overnight at 37oC.  Cells were collected by centrifugation 
and the pellet was resuspended  in 350 μl of STET (8% sucrose, 0.5% Triton X-100, 50 
mM EDTA pH 8.0, 10 mM Tris-HCl pH 8.0).  After mixing with 20 μl of lysozyme (10 
mg/ml; Sigma, St Louis, MI, USA), the mixture was quickly placed in a boiling water-
bath for 40 seconds, followed by centrifugation for 10 minutes.  The pellet was removed 
with a toothpick, and 8 μl of 5 M NaCl and 2 volumes of 95% ethanol were added to the 
sample to precipitate the DNA. 
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2.5. Agarose gel electrophoresis and DNA fragment isolation 
 For analysis of plasmid and genomic DNA, a 0.8% agarose gel was used in this 
study.  Gels were run in 1 x TAE buffer (40 mM Tris-acetate, 2 mM Na2EDTA) and 
stained with 0.5 μg/ml ethidium bromide (EtBr).  DNA was visualized under UV light.  
The method of DNA fragment isolation from agarose gels was adapted from 
Wang and Rossman (Wang and Rossman, 1994).  After enzyme digestion, the sample 
was electrophoresed through a 0.6% agarose gel and stained with EtBr.  The band of 
interest was identified using an UV-transilluminator and cut out of the gel.  A 0.5 ml 
microcentrifuge tube was pierced at the bottom, and packed with chopped cheesecloth.  
The gel slice containing the DNA fragment was placed into the prepared tube, which was 
inserted into another 1.5 ml tube, left it in the –70oC freezer for 20 min and spun for 10 
minutes at 16,000 xg.  The flow through was extracted with an equal volume of 
phenol/chloroform (1:1) and then with chloroform. The DNA in the upper aqueous phase 
was precipitated by ethanol and resuspended in H2O.  
 
2.6. S. cerevisiae strains and cell culture 
 The S. cerevisiae strains used in this thesis are listed in Table 2-1.  Yeast cells 
were cultured at 30oC either in a rich YPD medium or in a synthetic dextrose (SD) 
medium.  YPD is a standard, complex medium composed of 1% Bacto-yeast extract, 2% 
Bacto-peptone and 2% glucose.  SD medium is used for selective growth of yeast 
auxotrophs.  It contains 0.67% yeast nitrogen base without amino acids, 2% glucose, and 
addition of any necessary auxotrophic supplements.  The necessary auxotrophic 
supplements includes 30 mg/L L-isoleucine, 150 mg/L L-valine, 20 mg/L adenine 
hemisulfate salt, 20 mg/L arginine HCl, 20 mg/L L-histidine HCl monohydrate, 100 
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mg/L L-leucine, 30 mg/L lysine HCl, 20 mg/L L-methionine, 50 mg/L L-phenylalanine, 
200 mg/L L-threonine, 20 mg/L L-tryptophan, 30 mg/L L-tyrosine, 20 mg/L L-uracil.  
Any of the above auxotrophic supplements can be omitted to provide a selection media 
for yeast transformation.  The auxotrophic supplements were made as 100 × stocks and 
added into media prior to autoclaving.  To make plates, 2% agar was added to either YPD 
or SD medium prior to autoclaving. 
 Yeast cells can be stored for up to four months on plates sealed with parafilm at 
4oC.  For long-term storage, yeast cells were grown in an appropriate liquid medium (rich 
or minimal media) at 30oC overnight.  0.7 ml of the culture was added into 0.3 ml of 50% 
sterile glycerol and then stored at -70oC. 
 
2.7. Yeast transformation and targeted gene disruption 
 Yeast cells were transformed using a dimethyl sulfoxide (DMSO)-enhanced 
method as described (Hill et al., 1991).  A 2 ml culture of yeast cells was grown 
overnight at 30oC in rich media (or appropriate minimal media), and subcultured into 3 
ml of fresh media.  When the yeast cells reached a mid-logarithmic phase of growth, they 
were pelleted by centrifugation.  The yeast cells were washed in 400 μl LiOAc solution 
[0.1 M lithium acetate, 10 mM Tris-HCl (PH 8.0), 1 mM EDTA], and resuspended in 100 
μl of the same solution.  Five microliters of denatured carrier DNA (single stranded 
salmon sperm DNA 2 mg/ml) and 1-5 μl of transforming DNA were added and mixed 
well.  After incubation  at  room  temperature  for  5  minutes,     280 μl  of  50%  of  
PEG4000  (50% polyethylene glycol 4000 in LiOAc solution) was added and mixed by 
inverting  the tube  4-6  times.     After the  transformation  mixture  was  incubated for 45  
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Table 2-1.  Saccharomyces cerevisiae strains 
Strain Genotype Source 
DBY747 MATa  leu2-3,112 ura3-52 his3-Δ1 trp1-289 D. Botetein 
HK578-10A MATa ade2-1 can1 -100 his3-11,15 leu2-3112 trp-1-
1 ura3-1 
H. Klein 
HK578-10D MAT α ade2-1 can1-100 his3-11,15 leu2-3112 trp-1-
1 ura3-1 
H. Klein 
BY4741 MATa his3 leu2 met15 ura3 Invitrogen 
Y190 MATa gal4 gal80 his3 trp1 ade2-101 ura3 leu2 
ura3::GAL1-lacZ lys2::GAL1-HIS3 
D. Gietz 
SX46A MATa ade2(ochre), ura3-52, his3-532, trp1-289 W. Siede 
WXY9216 DBY747 with mag1Δ::hisG Laboratory stock 
WXY9555 DBY747 with rad2Δ::TRP1 Laboratory stock 
WXY814 DBY747 with apn1Δ::HIS3 apn2Δ::LEU2 Laboratory stock 
WXY1164 DBY747 with rad51Δ::HIS3 Laboratory stock 
WXY9387 DBY747 with rad52Δ::LEU2 Laboratory stock 
WXY9376 DBY747 with rad6Δ::LEU2 Laboratory stock 
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WXY9326 DBY747 with rad18Δ::TRP1 Laboratory stock 
WXY9444 DBY747 with rad18Δ::LEU2 Laboratory stock 
WXY1248 HK580-10D with srs2∆::LEU2 Laboratory stock 
WXY1297 HK580-10D with rad18∆::LEU2 srs2∆::HIS3 Laboratory stock 
BY4741 
siz1∆ 
BY4741 with siz1∆:: KanMX4 Invitrogen 
BY4741 
rad18∆ 
BY4741 with rad18∆:: KanMX4 Invitrogen 
WXY1190 DBY747 with rad24Δ::HIS3 This study 
WXY1198 DBY747 with sgs1Δ::LEU2 This study 
WXY1184 DBY747 with rad24Δ::HIS3 sgs1Δ::LEU2 This study 
WXY1185 DBY747 with rad18Δ::TRP1 sgs1Δ::LEU2 This study 
WXY1186 DBY747 with rad18Δ::TRP1 rad24Δ::HIS3 This study 
DSY1330 SK1 MATa ho::LYS2 lys2 ura3 trp1::hisG 
Leu2::hisG arg4-Bgl1 his4-X RAD53-6×MYC-KANR 
D. Stuart 
WXY1179 DSY1330 with rad18Δ::TRP1 This study 
WXY1180 DSY1330 with sgs1Δ::LEU2                               This study 
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WXY1181 DSY1330 with rad24Δ::LEU2 This study 
WXY1182 DSY1330 with rad18Δ::TRP1 sgs1Δ::LEU2 This study 
WXY1183 DSY1330 with rad18Δ::TRP1 sgs1Δ::LEU2 This study 
WXY2760 DBY747 with rad17Δ::HIS3 This study 
WXY2307 DBY747 with rad18Δ::LEU2 rad17::HIS3 This study 
WXY2763 DBY747 with sgs1Δ::LEU2 rad17::HIS3 This study 
WXY2769 DBY747 with  rad17-K197R This study 
WXY2779 DBY747 with  rad17-K197R  sgs1Δ::LEU2 This study 
WXY1101 DBY747 with pol30Δ::HIS3 with YCpT-POL30 Laboratory stock 
WXY1187 DBY747 with pol30Δ::HIS3 with YcpT-pol30-
K164R 
Laboratory stock 
SX46A-
Rad17-Myc 
SX46A with RAD17-13×Myc::KanMX4 W. Siede 
WXY1152 BY4741 with crt10Δ::KanMX Invitrogen 
WXY1153 BY4741 with crt1Δ::KanMX Invitrogen 
WXY1154 BY4741 with crt1Δ::KanMX crt10Δ::LEU2 This study 
WXY1155 BY4741 with dun1Δ::KanMX Invitrogen 
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WXY1156 BY4741 with dun1Δ::KanMX crt10Δ::LEU2 This study 
WXY1157 HK578-10A with crt10Δ:: LEU2 This study 
WXY1158 HK578-10D with crt10Δ::LEU2 This study 
U952-3B MATa sml1Δ::HIS3 R. Rothstein 
U953-61A MATa mec1Δ::TRP1 sml1Δ::HIS3 R. Rothstein 
U960-5C MATa rad53Δ::HIS3 sml1-1 R. Rothstein 
WXY1159 U952-3B with crt10Δ::LEU2 This study 
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minutes at 30oC, 39 μl of DMSO  was added,  followed  by a  5-minute heat  shock in  a 
42oC waterbath.  Yeast cells were then washed with sterile double distilled water (ddH2O) 
and resuspended in 100 μl of ddH2O.  The resuspended cells were plated on the 
appropriate minimal media.  
 For targeted gene deletion, plasmid DNA was digested with restriction enzymes, 
precipitated by ethanol and resuspended in ddH2O prior to transformation.  The 
transformants were verified by southern hybridization for target gene disruption. 
 
2.8.  Yeast genomic DNA isolation and Southern hybridization 
 To isolate genomic DNA for Southern hybridization, a protocol developed by 
Hoffman and Winston (Hoffman and Winston, 1987) was used.  Yeast cells from liquid 
culture were collected by centrifugation and resuspended in 200 μl of extraction buffer 
[2% TritonX-100, 1% SDS, 0.1 M NaCl, 1 mM EDTA, 0.01 M Tris HCl (pH 8.0)].  One 
hundred microliters of phenol, 100 μl of chloroform and 0.3 g of acid-washed glass beads 
were added to the cell mixture.  The tube was then vortexed for 3 minutes (2 minutes for 
isolating plasmid DNA) at top speed.  After a 5-minute centrifugation at top speed 
(16,000 xg), the top aqueous layer was transferred to a clean eppendorf tube.  To 
precipitate DNA, 2 volumes of 95% ethanol were added. The tube was stored at -20oC for 
30 minutes and centrifuged for 15 minutes at top speed.  The DNA pellet was dried and 
resuspended in 200 μl of ddH2O, and then treated with 5 μl of RNase A (10 mg/ml stock) 
at 37oC for 10 minutes.  The DNA was precipitated by adding 2 volumes of 95% ethanol 
and resuspended in 50 μl of ddH2O. 
 For Southern hybridization, genomic DNA was digested by appropriate restriction 
enzymes, and the DNA fragments were separated on a 0.8% agarose gel.  The gel was 
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then treated in a solution of 0.25 M HCl for 10 minutes for depurination, in 0.4 M 
NaOH/0.6 M NaCl for 30 minutes for denaturation, and in 1.5 M NaCl/0.5 M Tris-HCl 
(pH 7.5) for 30 minutes for neutralization.  The DNA was transferred from the gel to a 
nylon-based membrane (GeneScreen Plus, DuPont) in the presence of 10x SSC (3M 
NaCl, 0.3 M tri-sodium citrate, pH 7.0) overnight. 
The following day, the membrane was placed into a hybridization bottle with 5 ml 
of pre-hybridization solution [2x SSC, 10% dextran sulphate, 5x Denhardt’s solution (50 
× stock: 10 g Ficoll400, 10 g polyvinylpyrrolidone, 10 g bovine serum albumin; ddH2O 
added to a total volume of 500 ml), 50% formamide, and 1% SDS] and incubated at 42oC 
in the hybridization oven for at least 2 hours.  Before hybridization, 50 μl of boiled 
carrier DNA (2 mg/ml) and 60 μl of probe were added to the prehybridization solution.  
The membrane was then incubated with the probe overnight at 42oC.  The membrane was 
washed twice for 5 minutes at room temperature in 2x SSC/0.1% SDS and washed twice 
for 30 minutes each at 65oC in 0.2x SSC/ 0.1% SDS.  The membrane was then exposed to 
an X-ray film at -70oC with an intensifying screen.  
The DNA probe was labelled with 32P-dCTP using the Random Primer Labelling 
kit (Gibco/BRL, Grand Island, NY, USA).  
 
2.9. Plasmids and plasmid construction 
Plasmid manipulation was performed using enzymes purchased from Invitrogen 
(Carlsbad, CA, USA) or New England Biolabs (Beverly, MA, USA) as recommended by 
the manufacturers. 
 Plasmids used for the detection of β-galactosidase (β-gal) activity, including 
YEpMAG1-lacZ and YEpDDI1-lacZ have been described previously (Liu and Xiao, 1997; 
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Xiao et al., 1993; Zhu and Xiao, 1998).  Plasmids pZZ2 [YCp, URA3, RNR3-lacZ, (Allen 
et al., 1994)] and pZZ18 [YCp, URA3, RNR2-lacZ, (Allen et al., 1994)] were obtained 
from Dr. S. Elledge (Harvard Medical School, Boston, MA, USA) and utilized to 
determine RNR3 or RNR2 expression using a β-gal assay. 
 Sources of plasmids to make rad18∆ ::LEU2 (Xiao et al., 2000) and 
rad17∆::HIS3 strains (Zhu and Xiao, 1998) have been described.  Plasmid pPW∆SGS1 
(Watts, 2006) was obtained from Dr. I. Hickson (University of Oxford, UK) and the 
sgs1∆::LEU2 disruption cassette was released by NcoI-PstI digestion. 
 To create the rad24∆ strain,  RAD24 genomic DNA was cloned into pTZ18R and 
a 1.64-kb EcoRV-NcoI fragment containing most of the RAD24 open reading frame 
(ORF) including the start codon was deleted and replace by the 1.05-kb HIS3 gene from 
YDp-H (Berben et al., 1991).  The rad24∆::HIS3 cassette was released by BglII-HpaI 
digestion. 
To construct plasmid pGBT-Rad17 for the yeast two-hybrid assay, the RAD17 
ORF was amplified by PCR from genomic DNA with primers RAD17-1 (5’-
CCCGGGGATCCGTATGCGAATCAACAGTGAGCTAG-3’) and RAD17-2 (5’-
GGCCGTCGACTTAAAAAAATATAGGAATATCC-3’).  The PCR product was cloned 
into pGEM-T (Promega, Madison, WI, USA) to form pGEM-Rad17.  The RAD17 ORF 
was released from pGEM-Rad17 by BamHI and SalI double digestion, and the isolated 
fragment was inserted into pGBT9 (Clontech, Mountain View, California, USA) to form 
pGBT-Rad17.  To constructed pGBT-Mec3, the MEC3 ORF was amplified by PCR with 
primers MEC3-2H-5’ (5’-GGCCGGATCCATGAAATTAAAATTGA TAGTAAATG-3’) 
and MEC3-2H-3’ (5’- GGCCGTCGACTTACAAGCCC TTCGATCTTG-3’).  The PCR 
product was cloned into pGEM-T to form pGEM-Mec3.  pGEM-Mec3 was double 
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digested by BamHI and SalI to release the MEC3 ORF, and the fragment was inserted 
into pGBT9-Bg (Fu and Xiao, 2003) to form pGBT-Mec3.  The procedure to construct 
pGBT-Ddc1 was the same as that of pGBT-Mec3, except using primers DDC1-2H-5’ 
(5’-GGCCGGATCCATGTCATTTAAGGCAACTATC-3’) and DDC1-2H-3’ (5’- 
GGCCGTCGACTTAGTCAAATATACCCCTTG-3’) to amplify the DDC1 ORF from 
genomic DNA by PCR. 
To construct the Rad17-K197R::URA3 integrating cassettes, a fragment 
containing Lys197Arg point mutation was amplified by PCR from pGEM-Rad17 by 
primers Rad17-K197R-5’ (5’-CTGATATCTAGATCTCAGCTA-3’) and RAD17-2 (5’-
GGCCGTCGACTTAAAAAAATATAGGAATATCC-3’).  The PCR product was 
double digested by EcoRV and SalI, and then used to replace the original fragment in 
pGEM-Rad17 to form pGEM-Rad17-K197R.  After validating the point mutation by 
sequencing, pGEM-Rad17-K197R was double digested by EcoRI and SalI to release a 
0.9-kb fragment.  This fragment was inserted into pRS306 (Sikorski and Hieter, 1989) to 
produce YIpU-Rad17-K197R.  For integration, YIpU-Rad17-K197R was digested by 
HindIII prior to yeast transformation.  Meanwhile, the 0.9-kb fragment was inserted into 
pRS403 (Sikorski and Hieter, 1989) to form YIpH-Rad17-K197R.  The Rad17-
K197R::HIS3 integrating cassettes was obtained by digesting YIpH-Rad17-K197R with 
EcoRV. 
Plasmids YEpU-RAD6 and its C88A derivative were obtained from Dr. D. Gietz 
(University of Manitoba, Canada).  Plasmid pGBT-RAD18 was made by cloning the 
RAD18 ORF into pGBT9 and the C28S mutation was introduced by site-directed 
mutagenesis and confirmed by sequencing. 
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To construct YEpDDI2-lacZ, the promoter region of DDI2 was amplified by PCR 
from genomic DNA by the primers YFL061w-1 (5’-GGAAAATCCAAGCTTTCAAG-3’) 
and YFL061w-3 (5’-GCCGCGGCCGCCCTCATTGAAACTTACCT-3’).  The PCR 
product was then cloned into YEp365R (Myers et al., 1986) to form YEpDDI2-lacZ.  For 
the promoter deletion, the plasmid YEpDDI2-lacZ was digested by the corresponding 
restriction enzyme and religated.  The UAS of DDI2 promoter (-358 to -229) was 
amplified by PCR with the primers DDI2-UAS-1 (5'-
ATCGCCCGGGCTTAACAGCAATGAAAATC-3') and DDI2-UAS-2 (5'-
ATCGGCATGCGAAATGATAGTGTCCATGC-3').  The PCR product was inserted into 
pLG669Sm (Guarente and Hoar, 1984; Liu and Xiao, 1997)  to create pDDI2-UAS-
CYC1-lacZ.  
To construct crt10∆::LEU2 disruption cassettes, the 2.8-kb CRT10 ORF was 
amplified by PCR from genomic DNA with primers CRT10-1 (5’-
CCGGAATTCATGCCCCCTCAGATTCCCAATG-3’), and CRT10-2 ( 5’-CGGGTC 
GACCTATTGTTGAGTTGTTCCATG-3’).  The PCR product was cloned into 
pBluescript SK (Stratagene, La Jolla, CA, USA) to form pBS-CRT10.  The resulting 
plasmid pBS-CRT10 was digested by HpaI and MscI to remove the fragment encoding 
aa60-871, and then ligated with a BglII linker to create plasmid pBS-crt10∆.  A LEU2 
marker was inserted into the plasmid to form pcrt10∆::LEU2.  For CRT10 disruption, 
pcrt10∆::LEU2 was digested by AvaI and NcoI prior to yeast transformation. 
 
2.10. β-Galactosidase (β-gal) assay 
The β-gal assay was performed as described previously (Fu and Xiao, 2006).  A 
0.5 ml fresh overnight culture of the yeast transformants was used to inoculate 2.5 ml of 
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minimal medium without Leu, His or Ura, depending on the selectable marker of the lacZ 
fusion plasmids.  Two sets of cells were allowed to grow for another 2 hours.  Methyl 
methanesulfonate (MMS) was added to one set of cells at the desired concentration, and 
both sets were incubated at 30oC for 4 hours.  One ml of cells was used to determine cell 
titer based on optical density at 600 nm.  The remaining 2 ml of cells were collected and 
permeabilized in 1 ml of Buffer Z (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 
mM MgSO4, 40 mM β-mercaptoethanol, pH 7.0), by adding 50 µl of 0.1% SDS, 50 µl of 
chloroform and votexing at top speed for 10 sec.  The reaction was started by adding 200 
µl of 4 mg/ml orthonitrophenyl-β-D-galactosideae (ONPG) and incubating at 30oC for 20 
minutes.  The reaction was stopped by adding 500 µl of 1 M Na2CO3, and 1 ml of 
supernatant was transferred into a cuvet to determine the OD at 420nm.  The β-gal 
activity was determined using the following equation: β-gal activity = (1000 × OD420nm) / 
[Reaction time (minute) × Culture volume (ml) × OD600nm], and is expressed in Miller 
units.  The β-gal assay was performed with several independent yeast transformants from 
the same transformation to avoid internal inconsistency.  Results from various 
transformants/treatments presented for comparison (e.g., treated vs untreated, full length 
promoter vs its derivates) were always from the same experiment to avoid inter-
experimental variation. All the results presented are the average of at least three 
independent experiments. 
 
2.11. RNA isolation, reverse transcription and hybridization to microarray 
Yeast cells were grown to early log phase and treated with or without 0.1% MMS 
for 48 minutes.  Total RNA was isolated by the RNeasy Midi Kit (Qiagen, Valencia, CA, 
USA) according to the manufacturer’s protocol.  The positive control Arabidopsis RNA 
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was generated through in vitro transcription of SacI digested pARAB (UHN Microarray 
Centre, Toronto, ON, Canada).  In vitro transcription was performed by the 
MEGAscriptTM T7 kit (Ambion, Huntingdon, Cambridgeshire, UK), following the 
manufacturer’s protocol.  Ten microgram of total RNA template and 4 ng control 
Arabidopsis RNA were reverse transcribed to generate Cy3 or Cy5 labelled cDNA using 
AncT primer (T20 VN) and Superscript II RT enzyme (Invitrogen) for 2 hours of 
incubation at 42oC.  Four microliters of 50 mM EDTA (pH 8.0) and 2 μl of 10 N NaOH 
were added to stop the reverse transcription, and a further 20 minutes of incubation at 
65oC was performed to hydrolyse the remaining RNA.  Fluorescence-labelled cDNA was 
purified by Microcon columns (Millipore, Billerica, MA, USA).  The yeast 6.4K 
oligonucleotide Arrays (UHN Microarray Centre) were used in this study.  The 
hybridization solution was prepared by mixing DIG Easy Hyb (Roche, Basel, 
Switzerland), sonicated calf thymus DNA (Sigma) and yeast tRNA (Invitrogen) with a 
20:1:1 ratio.  The fluorescence-labelled cDNA was combined with the hybridization 
solution, and the mixture was loaded on the oligonucleotide arrays.  The arrays were 
incubated at 37oC overnight for hybridization under sealed high moisture condition to 
prevent drying up.  The following day, the arrays were washed three times for 15 minutes 
each in the 1 × SSC, 0.1% SDS solution at 50oC, followed by rinsing with 1 × SSC at 
room temperature to remove traces of SDS.  After spinning dry at 500 rpm for 5 minutes, 
the arrays were ready for scanning.  Two independent microarray assays were carried out 
by generating Cy5 labelled cDNA from MMS-treated cells and Cy3 labelled cDNA from 
untreated cells.  In order to avoid biased incorporation of Cy5 and Cy3, the reverse color 
experiments were performed.  In this case, Cy5 was incorporated into first-strand cDNA 
which was synthesized by using the RNA from untreated cells, and the fluorescent dye 
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Cy3 was incorporated into cDNA by using the RNA from cells treating with MMS as the 
templates.  The average values were taken for the further Microarray data analysis.  
 
2.12. Microarray data analysis 
Array images were acquired using a GenePix 4000B microarray scanner (Axon 
Instruments, Union city, CA, USA).  The image from each microarray chip was analyzed 
by the GenePix Pro 6.0 software (Axon Instruments, Union city, CA, USA) to create a 
GenePix Array List (GAL) file.  Microarray data was analyzed by Acuity 3.1 software 
(Axon Instruments).  Transcripts defined as regulated by Rad6/Rad18 met the criteria of: 
(1) after treatment with MMS, gene induction in the wild type strain was at least double 
the untreated levels; (2) the expression levels in the rad6∆ mutant and rad18∆ mutants 
were nearly the same (based on a Self-Organizing Map analysis with Acuity 3.1); (3) the 
expression levels were significantly decreased in the rad6∆ and rad18∆ mutants 
compared to wild type cells (1.5 fold or greater, one way anova test P < 0.01). 
 
2.13. Northern hybridization and real-time PCR 
Northern hybridization was performed as described previously (Zhu and Xiao, 
1998).  Briefly, RNA was isolated by a glass-bead method (Carlson and Botstein, 1982). 
Yeast cells were cultured overnight at 30oC in an appropriate liquid medium, subcultured 
in 4 ml medium next day and incubated for 4 more hours.  Cells were collected by 
centrifuging at 3000g for 4 minutes at room temperature, and washed twice with 0.1 % 
diethylpyrocarbonate (DEPC)-treated water.  Three hundred and fifty microliters of RNA 
lysis buffer (0.5 M NaCl, 10 mM EDTA, 1% SDS, 0.2M Tris-HCl pH7.6), 0.4 g of acid-
washed glass beads and 350 μl of phenol:chloroform:isoamyl alcohol (25:24:1) were 
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added.  The tubes were vortexed at top speed for 2.5 minutes, and centrifuged at 16,000 
xg for 4 minutes.  The aqueous phase was transferred into a new microcentrifuge tube. 
Two volumes of ethanol were added, and the tubes were immediately centrifuged at 
16,000 xg for 4 minutes. The RNA pellet was washed with 200 μl 70% ethanol, dried 
briefly under vacuum, and dissolved in 40 μl DEPC water.  The RNA sample was 
separated by gel electrophoresis, blotted on a GeneScreen Plus membrane (NEN) and 
hybridized with α-32P-labelled DNA probe.  After an overnight hybridization, the 
membrane was washed and exposed to a phosphorimager screen.  The mRNA band 
intensity was measured with a Molecular Imager FX (Bio-Rad) supported by the Quality 
One 4.2.1 software.  The source and preparation of ACT1 probes has been described 
previously (Zhu and Xiao, 1998).  The 0.7-kb DDI2 ORF was amplified by PCR using 
DDI2-2 (5’-GCCGAATTCATGTCACAGTACGGATTT-3’) and DDI2-3 (5’-
GCCGCGGCCGCCCTCATTGAAACCTACCT-3’) as primers. 
For real-time PCR, yeast cells with or without treatment were harvested from 
early log phase culture (2 x 107 cells/ml).  Total RNA was prepared using an RNeasy midi 
Kit (Qiagen).  The extracted RNA was treated with Ambion’s DNA-freeTM Kit to remove 
contaminating DNA.  The treated RNA was used as the template to perform reverse 
transcription with the ThermoscriptTM RT-PCR system (Invitrogen).  Real-time PCR was 
carried out and analyzed with iCycler® Thermal Cycler (Biorad).  The primers used in 
real-time PCR were listed in Table 2-2.  The relative transcript level of each treatment 
was determined by a method and formula as follow: ratio= (Etarget)ΔCt  target (Control-treated) / 
(Ereference)ΔCt reference (Control-treated) (E represents the efficiency for the primers;  ΔCt 
represents the difference in the Ct values, which is the point at which the fluorescence 
crosses the threshold.  ACT1 was used in this study as the reference genes) (Pfaffl, 2001). 
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Table 2-2.  The primers used in Real-time PCR 
 
Primer Sequence 
RNR3-1 5’-GCCTCCGCTGCTATTCAA-3’ 
RNR3-2 5’-CAGATGCCGCCTTTTGTT-3’ 
MAG1-RT1 5’-GCGGTGCATTTCCTGATTA-3’ 
MAG1-RT2 5’-TCGCGAGCCTCCAAAGTAT-3’ 
ACTIN-RT1 5’-TGGCCGGTAGAGATTTGACTGACT-3’ 
ACTIN-RT2 5’-AGAAGCCAAGATAGAACCACCAAT-3’ 
TUP1-1 5'-CCACCACGTCGACGGATAACAATA-3' 
TUP1-2 5'-CTCGGAATCCCAAACT CTCACAGC-3' 
SSN6-1 5'-GCCCAAGCTCCCCAACC-3' 
SSN6-2 5'-CTGTGCGCCAATTACTGAAGG-3' 
CRT1-1 5'-GGTCGCCCGTTAAACAGAGTA-3' 
CRT1-2 5’-CGTGGGCGATATAGAGTTAGAGT-3' 
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2.14. Cell killing by DNA damaging agents 
 A gradient plate assay was one of the methods used to measure MMS sensitivity.  
Thirty millilitres of molten YPD agar were mixed with an appropriate concentration of 
MMS to form the bottom layer.  The gradient was created by pouring the medium into a 
tiled square petri dish.  After brief solidification for one hour, the petri dish was returned 
to a flat position and 30 ml of the same molten agar without MMS was poured to form 
the top layer.  A 0.1 ml sample was taken from an overnight culture, mixed with 400 μl 
sterile water and 0.5 ml of molten YPD agar, and then immediately imprinted onto  
freshly made  gradient plates using a microscope slide.  Gradient plates were incubated at 
30oC for 2 days before photographs were taken. 
 For the HU sensitivity analysis, log phase yeast cells were diluted to 1 x 107 
cells/ml, and 10-fold serial dilutions were made.  Aliquots of 10 µl of diluted cells were 
spotted on the appropriate plates, and the plates were incubated at 30°C for 3 days. 
 
2.15. The yeast two-hybrid assay (Y2H) to assess protein interactions 
 Yeast strain Y190 was received from Dr. D. Gietz and used for Y2H.  Y190 was 
transformed simultaneously with a combination of Gal4BD (e.g., pGBT9, pGBT-Rad17, 
pGBT-Ddc1, pGBT-Mec3) and Gal4AT (e.g., pGAD424, pGAD-Rad18, and pGAD-Rad6) 
plasmids.  For each combination, the co-transformed colonies were initially selected on 
SD-Trp-Leu plates.  At least four independent colonies from each combination were 
further spotted on SD-Leu-Trp-His plates or plates SD-Leu-Trp-His plus different 
concentration of 3- aminotriazole (3-AT) plates to test the activation of PGAL-HIS3 gene.  
Plates were incubated at 30°C for 48 hours. 
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2.16. Yeast protein extraction and western blotting 
Yeast protein crude extraction was performed as previously described (Pellicioli 
et al., 1999).  Ten millilitres of yeast cell culture (0.5-1× 107 cells/ml) were spun down to 
collect cells.  The cell pellet was washed with 1 ml of 20% trichloroacetic aicd (TCA) 
solution.  After centrifugation, the cells were resuspended in 200 μl of 20% TCA.  Glass 
beads were added to the meniscus, and the tube was vortexed for 2-4 minutes.  An 
additional 400μl of 5% TCA were added to the meniscus and the aqueous extract was 
transferred to a new tube.  After spinning at 16,000 xg for 10 minutes, the supernatant 
was discarded, and the pellet was mixed with 100 μl of protein sample buffer (150 mM 
Tris PH 6.8, 6% SDS, 30% glycerol, 0.3% bromophenol blue and 15% β-
mercaptoethanol) and 50 μl of 1 M Tris-base.  The sample was incubated at 100oC for 5 
minutes and further spun in a microfuge at 800 xg for 10 minutes.  The supernatant was 
transferred to a new tube, and the crude extract could be preserved at -20oC. 
 Protein samples were boiled, run on a 10% SDS-PAGE gel, and then transferred 
to a PVDF membrane (polyvinylidene difluoride, Bio-Rad).  Membranes were treated in 
a blocking solution (PBS, 5% non-fat milk) at room temperature for 1 hour.  Anti- Myc 
antibodies (Upstate, Lake placid, NY, USA) were diluted 1:5000 in 20 ml PBST [PBS, 
0.05% Tween (v/v), 1% non-fat milk] and the PBST solution was incubated with 
membranes at 4oC overnight.  The second antibody, anti-rabbit IgG conjugated with HRP, 
was used at a 1:10000 dilution.  The Western Lightning Chemiluminescence Reagent 
(Perkin Elmer Life Science, Boston, MA, USA) was utilized for detecting, and the 
membrane was then exposed to an X-ray film. 
 For Rad17 immunoprecipitation analysis, one liter of log-phase cultures of 
SX46A or SX46A-RAD17-Myc harbouring different plasmid combinations were treated 
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with or without 0.05% MMS for 90 minutes.  The cell pellet was collected by 
centrifugation at 2000 xg at 4oC for 10 min, and washed with ice-cold PBS once and ice-
cold PBS + 0.1% NP40 twice.  After resuspending the cell pellet in 3 ml of PBS + 0.1% 
NP40, 5ml of glass beads, as well as protease inhibitor cocktails (Sigma), 
Phenylmethylsulfonyl Fluoride (PMSF, Sigma) and N-Ethylmaleimide (NEM, Sigma), 
were added to the meniscus.  The yeast cells were disrupted by votexing at top speed on 
ice for 4 minutes.  The supernatant was transferred to new falcon tubes, and was 
sonicated on ice for 10 seconds three times.  The yeast lysate was then spun at 17,000 xg 
for 30 minutes.  The supernatant (crude protein extraction) was carefully transferred to a 
new tube for further experiments. 
 Protein G–sepharose beads (Sigma) were used for immunoprecipitation.   
Approximately 200 μl of beads were washed by 1.6 ml of PBST (PBS + 0.5g/L Tween-
20, Ca2+/Mg2+ -free) 3-4 times in a screw-capped Eppendorf tube.  The beads were re-
suspended in 1.6 ml of PBST containing 5 μl anti-Ubiquitin polyclonal antibody 
(Upstate), 50 mg BSA and 0.01% thimersol.  The tubes were set horizontally on a gentle 
rocking platform to keep the beads in motion.  The rocking was continued overnight at 
4oC.  The following day, the pre-absorbed beads were spun down at 2,000 xg for 2 
minutes. After removing the supernatant, 1 ml of yeast crude protein extract was added to 
the Eppendorf tube.  The mixture was then carefully transferred to a 15 ml Falcon tube, 
and 5 ml of yeast crude protein extract were added.  The Falcon tubes were placed 
horizontally on a gently rocking platform overnight on ice.  The following day, the beads 
were spun down at 2000 xg for 2 minutes.  The supernatant was removed, and pre-chilled 
PBST was added to wash the beads.  The washing was repeated at least 8 times.  To elute 
the protein from the beads, 100 µl of protein loading buffer with fresh 10 mM 
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Dithiothreitol (DTT) was added and heated to 95oC for 5 minutes.  After boiling, 
iodoacetimide was added to Eppendorf tubes to a concentration of 25 mM from a fresh 
0.5 M stock to inhibit disulfide bonds from reforming.  After gentle vortexing, the tubes 
were spun down at 16,000 xg for 1 minute.  The supernatant was carefully collected 
without disturbing the beads and loaded onto a protein gel. 
 
2.17. Screening of yeast gene deletion library 
 The yeast haploid gene deletion library was created by the Saccharomyces 
Genome Deletion Project Consortium and purchased from Research Genetics (Invitrogen, 
Carlsbad, CA). The deletion mutants were replica plated on to YPD and YPD + 80 mM 
HU.  Plates were incubated at 30°C for 3 days before evaluation. 
 
2.18. Yeast tetrad analysis 
 For tetrad analysis, parental haploid strains U953-61A and WX1158 were 
streaked on YPD plates.  Two days later, two strains were cross-streaked in an X-
formation and mixed at the centre of the X on SD-Trp-His-Leu plates which would 
support the growth of the diploid, but neither of the haploid cells could grow.  The plates 
were incubated at 30oC for 2-3 days to obtain individual diploid colonies, which were 
inoculated into 2 ml of YPD medium and cells were allowed to grow overnight at 30oC 
with constant agitation and aeration.  The following day, cells were washed 2 times with 
sterile ddH2O, re-suspended in 5 ml of sporulation media (0.5% potassium acetate, 0.5 × 
auxotrophic nutrients), and incubated at room temperature for 3 to 7 days with agitation 
and aeration.  
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Sporulation was checked by visual inspection with a light microscope after 3 days.  If 
there were tetrads present, 10 μl of media was transferred to a sterile Eppendorf tube and 
10 μl of NEE-154 glusulase (Dupont Company, Wilmington, DE, USA) was added.  
After incubation at room temperature for 10 minutes, 20 μl of ice-cold ddH2O was added 
and the tube was put on ice immediately.  The tetrads were dissected on YPD plates with 
a Singer MSM micromanipulator (Singer Instrument Co. Somerset, England).  The YPD 
plates were incubated at 30oC for 3 days to allow the growth of tetrads.  After 3 days of 
incubation, the genotypes of tetrads were identified by replica plating to YPD and SD 
medium containing appropriate combinations of amino acids. 
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CHAPTER THREE 
Rad6-Rad18 Mediates a Eukaryotic SOS Response by 
Ubiquitinating the 9-1-1 Checkpoint Clamp 
 
3.1. Introduction 
DNA integrity is challenged by the damaging effect of numerous chemicals and 
physical agents, and these damages probably lead to mutations within chromosomal DNA, 
which may cause cancer or premature aging.  Organisms respond to these insults to DNA 
by activating complex DNA damage response pathways.  These pathways regulate DNA 
damage responses through processes such as cell cycle arrest, DNA repair, transcriptional 
regulation and apoptosis (Zhou and Elledge, 2000).  When bacteria are subjected to DNA 
damage, a reaction known as the SOS response co-ordinately regulates DNA repair, 
transcription and cell division (Little and Mount, 1982; Michel, 2005).  Substantial 
progress made in the past several years suggests that the checkpoint pathway, which was 
originally thought to control primarily cell cycle progression, regulates multiple 
responses including transcription, DNA repair and apoptosis in eukaryotes (Zhou and 
Elledge, 2000).  Thus, for purposes of clarity, DNA damage response has been suggested 
to refer to the entire pathway and use “the checkpoint branch” to refer components 
specially involved in controlling cell-cycle progression (Zhou and Elledge, 2000). 
The DNA damage response pathway is a signal transduction cascade consisting of 
sensors, transducers and effectors.  Proteins that initially sense damaged DNA to trigger 
signal transduction are currently unknown.  In principle, a sensor protein should have the 
ability to interact with damaged DNA.  In mammalian cells, poly (ADP-ribose) 
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polymerase (PARP) and DNA-dependent protein kinase (DNA-PK) have been proposed 
as DNA damage sensors due to their ability to bind and be activated by DNA strand 
breaks.  However, genetic evidence indicates that these proteins are not activators of the 
global DNA damage response (Jimenez et al., 1999; Wang et al., 1995; Zhou and Elledge, 
2000).  Human and Schizosaccaromyces pombe Rad9-Rad1-Hus1 (9-1-1) complexes and 
their homologous Ddc1-Rad17-Mec3 complex in S. cerevisiae, which is related in 
structure to PCNA, share some of the properties expected for sensors.  This doughnut-
like heteromer complex can be loaded onto damaged DNA just as PCNA is loaded onto 
primed DNA (Komatsu et al., 2000; O'Connell et al., 2000; Volkmer and Karnitz, 1999).  
Furthermore, the complex is required for the DNA damage checkpoint branch and plays a 
role in DNA repair (Parrilla-Castellar et al., 2004).  Nevertheless, genetic evidence is still 
missing to prove that it is indeed a sensor and to demonstrate its role in transcriptional 
regulation following DNA damage.  DNA repair proteins have also been suggested as 
candidate sensors since they can recognize aberrant DNA structures after DNA damage.  
For example, it was reported that the NER machinery which processes UV photoproducts 
is required to activate a RAD9-dependent checkpoint response in budding yeast 
(Giannattasio et al., 2004; Siede et al., 1994).  Additionally, the MRE11-RAD50-NBS1 
(ScXrs2) complex, which functions in the non-homologous end joining repair pathway, is 
involved in inducing autophosphorylation of ATM kinase in mammalian cells (Carson et 
al., 2003; Uziel et al., 2003). 
If DNA repair proteins function as a sensor to detect DNA damage and induce the 
global DNA damage response, these proteins should play a role in the regulation of gene 
expression in response to DNA damage.  To test this hypothesis, we examined a panel of 
isogenic yeast gene deletion strains for their ability to support MAG1-lacZ and DDI1-
 77
lacZ reporter gene expression in the presence and absence of DNA damage induced by 
MMS, a chemical carcinogen specifically inducing replication blocks.  MAG1 and DDI1 
are two divergently transcribed genes found in the budding yeast Saccharomyces 
cerevisiae (Chen et al., 1990; Liu and Xiao, 1997; Xiao et al., 1993), and are involved in 
DNA repair (Chen et al., 1989) and regulation of exocytosis (Lustgarten and Gerst, 1999), 
respectively.  Both genes are DNA damage inducible and contain common as well as 
unique cis-acting regulatory elements (Liu and Xiao, 1997; Xiao et al., 1993).  Deletion 
of MAG1 (representing base excision repair), RAD2 (representing nucleotide excision 
repair), RAD52 (representing homologous recombination) had little effect on the 
induction of both reporter genes, suggesting that they are not essential for transcriptional 
regulation.  In contrast, deletion of RAD6 or RAD18 (representing postreplication repair, 
PRR) significantly reduced the expression of both reporter genes.  Further analysis 
indicates that this novel regulatory function of RAD6 and RAD18 is independent of its 
PRR activity since deletion of downstream PRR genes MMS2, REV3 or double deletion 
of MMS2 and REV3 had no effect on the induction of MAG1 (Zhu, 2003). 
In this study, by a microarray analysis, we further demonstrated that deletion of 
RAD6 and RAD18 reduces the DNA damage-induced transcription of up to 379 genes.  
These genes include those involved in DNA repair, control of replication and 
transcription, regulation of the cell cycle and cell metabolism.  It was found that Rad18 
shares the pathway with Rad24, rather than Sgs1, to regulate the phosphorylation of 
Rad53 in checkpoint pathway.  Furthermore, the Ddc1-Rad17-Mec3 complex appears to 
play a role in the Rad6/Rad18 regulatory pathway. 
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3.2. Results  
 
3.2.1. RAD6 and RAD18 are involved in the DNA damage induction 
Previous research in our laboratory demonstrated that deletion of RAD6 or RAD18 
(representing postreplication repair, PRR) significantly reduced the expression of both 
MAG1-lacZ and DDI1-lacZ reporter genes, but deletion of RAD2 (representing 
nucleotide excision repair, NAR) and RAD52 (representing homologous recombination, 
HR) has little effect on the induction of both reporter genes (Zhu, 2003).  In order to 
further confirm these observation, the expression of MAG1-lacZ and DDI1-lacZ reporter 
genes were measured in apn1Δ apn2Δ double mutants (representing base excision repair, 
BER), rad51Δ  mutants (representing HR) and pms1Δ mutants (representing mismatch 
repair, MMR).  Unlike deletion of RAD6 or RAD18, deletion of these genes did not 
significantly reduce the expression of reporter genes (Figure 3-1), suggesting that they 
are not required for the signal transduction leading to transcriptional regulation.  Thus, it 
is likely that only the post-replication repair pathway genes RAD6 and RAD18 are 
involved in the DNA damage-induced gene regulation. 
 
3.2.2. Lack of DNA damage induction in rad6 or rad18 strains is not due to the 
severely enhanced sensitivity to DNA damaging agents 
 The rad6Δ and rad18Δ mutants display severely enhanced sensitivity to DNA 
damaging agents (Fabre et al., 1989; Swietlinska et al., 1976).  It remains a possibility 
that lack of DNA damage induction in rad6Δ or rad18Δ is due to their extreme sensitivity 
to DNA damaging agents.  However, there are several lines of evidence that argue against 
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Figure 3-1. MMS-induced expression of MAG1 and DDI1 is compromised in rad6 
and rad18 cells.  MAG1-lacZ (A) and DDI1-lacZ (B) expression in a series of DNA 
repair mutants defective in base excision repair (mag1 and apn1 apn2), nucleotide 
excision repair (rad2), homologous recombination repair (rad51 and rad52), mismatch 
repair (pms1) or PRR (rad6 and rad18) with (solid bars) or without (open bars) 0.05% 
MMS treatment for 4 hours.  All the results are in Miller units and represent the average 
of at least three experiments with standard deviations.  
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 this notion.  Firstly,  it was reported that deletion of SRS2 can significantly alleviate 
DNA damage sensitivity of rad6 and rad18 mutants (Schiestl et al., 1990).  Further 
deletion of SRS2 in a rad18Δ strain alleviated its MMS sensitivity, but did not restore the 
DNA damage inducibility of MAG1-lacZ and DDI1-lacZ (Figure 3-2).  Secondly, 
inactivation of both error-free and error-prone branches of the RAD6 PRR pathway also 
results in severe MMS sensitivity (Broomfield et al., 2001), but does not affect MAG1 or 
DDI1 induction (Zhu, 2003).  Finally, other DNA repair mutant strains, such as rad52∆ 
and apn1Δ apn2Δ double mutants (Hanna et al., 2004), are also extremely sensitive to 
killing by MMS, but they did not affect the MAG1 and DDI1 inducibility (Figure 3-1). 
 
3.2.3. Deletion of RAD6 and RAD18 globally decreases the DNA damage induction 
in budding yeast. 
In order to determine the role of Rad6/Rad18 in DNA damage induction at the 
total genome level, a DNA microarray analysis was performed.  After treating cells with 
0.1% MMS for 48 minutes, the transcript levels of 751 genes were increased  by 2-fold or 
higher in wild type cells, which is comparable to other reports using Gene Chip (Jelinsky 
and Samson, 1999) or cDNA from different sources (Gasch et al., 2001).  Among these 
genes, 379 genes showed similar transcript levels in rad6∆ and rad18∆ mutants based on 
the Self-Organizing Map analysis with Acuity 3.1, and a decreased transcriptional level 
by 1.5-fold or greater with a significance of P < 0.01 (one way anova test) compared to 
wild type cells (Figure 3-3).  The percentage of genes affected by rad6 or rad18 
mutations appears to increase among those with higher level induction (Table 3-1).  Of  
the  379  genes,    39%  of  them  code  for  proteins   whose  functions  have  not     been 
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Figure 3-2.  Deletion of SRS2 suppresses the extreme sensitivity of rad18 but does 
not restore the induction of MAG1 and DDI1.   (A) A gradient plate assay to measure 
relative MMS sensitivity of wild type, rad18Δ, srs2Δ and rad18Δ srs2Δ mutants.  Arrows 
point to higher MMS concentration.  The plates were incubated for two days at 30oC.  
MAG1-lacZ(B) and DDI1-lacZ(C) expression in wild type (W303) and its isogenic 
rad18∆, srs2∆, rad18∆ srs2∆ derivatives.  Log-phase cells were either treated with 
0.05% MMS for 4 hours or without treatment prior to β-gal assays.  All the results are in 
Miller units and represent the average of at least three experiments with standard 
deviations. 
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Wt rad18Δ rad6Δ
 
 
Figure 3-3. Gene expression data from the microarray analysis.  The dendrogram is 
based on 379 genes that passed the filtering criteria.  The list of genes shown in red/green 
ratio (indicated in the bottom) represents the ratio of expression level of MMS-treated vs. 
untreated cells.  A detailed expression profile is given in Appendix A. 
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Table 3-1. Effects of rad6 and rad18 on DNA damage-inducible gene expression 
 
 
  Induced by MMS    ≥ 2 fold ≥ 3 fold ≥ 4 fold 
 
# of genes induced       505                   127                   122 
# of genes affected by rad6/rad18                     213                     74                    92 
% affected                                                           42%                   58%                75% 
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characterized according to the Saccharomyces Genome Database (SGD, 
www.yeastgenome.org, Stanford University).  The remaining 61% of  genes encode 
proteins involved in numerous biological functions as assessed by SGD, including DNA 
repair, control of replication and transcription, regulation of the cell cycle and cell 
metabolism (Figure 3-4).  The complete list of 379 genes is detailed in the Appendix A. 
 
3.2.4. Microarray data validation 
To ensure the accuracy of our microarray data, a validation process was 
conducted by comparing the genes known to be affected by rad6 or rad18 mutation with 
the data collected from the microarray. 
 We have demonstrated that the induction of MAG1 and DDI1 decreases in rad6∆ 
or rad18∆ mutants through both β-gal assays  and northern blot analyses (Zhu, 2003).  
Based on our microarray data, the induction level of MAG1 and DDI1 in wild type cells 
was 2.2- and 5.6-fold, respectively, whereas the induction of MAG1 and DDI1 was 
decreased by  1.3-  and 2.6-fold,  respectively,  in  the rad6∆  mutant, and   by 1.4-  and   
2.2 -fold  in the corresponding rad18∆ mutant. 
The transcript level of RNR3 is induced over 50-fold when yeast cells are treated 
with 0.01% MMS, while the induction level decreases when treated with higher 
concentrations of  MMS (Jia et al., 2002).  In the microarray experiment, yeast cells were 
treated with 0.1% MMS for 48 minutes, which induces RNR3 by only 3.3-fold in wild 
type cells.  In rad6∆ and rad18∆ mutants, the induction level was decreased by 1.2- and 
0.9-fold, respectively. Similarly, the transcript level of PHR1 increased 3.1-fold in wild 
type cells, but only reached 1.5- and 1.6-fold, respectively in rad6∆ and rad18∆ mutants.  
Although the quantitative change for each gene was not exactly the same between 
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Figure 3-4. Distribution of RAD6-RAD18 regulated genes based on their functional 
annotation.  The 379 yeast genes whose DNA damage induction decreased in both rad6 and 
rad18 mutants were analyzed based on SGD and presented as a percentage of the total 
number of the affected genes. 
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northern blot, β-gal assay and microarray analyses, the general trend of being down-
regulated in rad6∆ and rad18∆ mutants was consistent among these experimental results. 
 Under our microarray experimental conditions, the expression of YFL061w and 
YNL335w were induced by MMS over 100-fold, which is consistent with a previous 
report (Jelinsky and Samson, 1999).  Interestingly, these two ORFs are identical and are 
located in a large region of gene duplication, including their promoter regions (SGD, 
www.yeastgenome.org, Stanford University).  We designated the ORFs YFL061w and 
YNL335w as DDI2 and DDI3 for DNA damage inducible gene 2 and 3, respectively.  The 
induction level of DDI2 was found to be decreased in both rad6∆ and rad18∆ mutants by 
about 20-fold in the microarray analysis (Appendix A).  To further validate the 
microarray result, we performed northern blot analysis; the results (Figure 3-5) correlated 
very well with the microarray data. 
 
3.2.5. Domains required for DNA damage induction in Rad6 
 Rad6 functions in PRR as well as sporulation, meiotic recombination (Prakash et 
al., 1993) and telomere silencing (Huang and Elledge, 1997),  In contrast, deletion of 
RAD18 only has a pronounced defect on PRR.  Furthermore, RAD6 has been previously 
reported to participate in transcriptional regulation through ubiquitination of histone H2B 
(Kao et al., 2004).  Construction of specific mutations has already identified regions in 
Rad6 required for different cellular functions.  In order to determine whether these 
regions are required for DNA damage induction, different plasmids harboring specific 
RAD6 mutations were introduced into the rad6Δ mutant together with the RNR3-lacZ 
plasmid and the β-gal assay was performed.  The Cys88 in Rad6 abolishes its ubiquitin-
conjugating activity, and the rad6-C88A mutations  confer a  defect in PRR, mutagenesis, 
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Figure 3-5. Reduced DDI2 induction in rad6 and rad18 mutants as measured by 
northern hybridization.  Wild type and mutant cells were treated with 0.1% MMS for 48 
minutes prior to RNA isolation and northern hybridization.  Each lane contains 15 µg of total 
RNA.  The blot was stripped and hybridized with the ACT1 probe.  The DDI2 transcript level 
in each sample was normalized with reference to that of ACT1, and expressed relative to the 
value of untreated wild-type sample in the same blot.  Strains used in the above studies were 
DBY747 and its isogenic rad6∆ or rad18∆ derivatives. 
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and sporulation (Sung et al., 1990).  After MMS treatment, the induction of RNR3-lacZ in 
rad6-C88A mutant was dramatically decreased compared with that in wild type cells 
(Figure 3-6).  Deleting the highly acidic 23-residue carboxy-terminal tail domain of Rad6 
(rad6-C) results in the loss of histone-polyubiquitinating activity (Robzyk et al., 2000; 
Sung et al., 1988).  However, deleting this region had no effect on DNA damage 
induction of RNR3-lacZ (Figure 3-6).  Removal of the 9-residue N-terminus of Rad6 
(rad6-N) abolishes its N-end rule protein degradation function (Sung et al., 1991; Watkins 
et al., 1993), and this mutation decreased the DNA damage induction of RNR3-lacZ  
equivalent  to  that of  the RAD6  deletion  mutant  (Figure 3-6).  Taken together, these 
observations demonstrate that Cys-88 and the N-terminal 9 amino acid residues in Rad6, 
but not its carboxyl-terminal polyacidic tail,   are  required for its  DNA  damage  
induction function. 
 
3.2.6. PCNA modifications are not involved in the DNA damage induction of 
MAG1 and DDI1 
RAD6 and RAD18 encode a ubiquitin conjugating enzyme (Ubc or E2) and a 
ubiquitin ligase (Ubl or E3), respectively, that form a stable complex (Bailly et al., 1997).  
The only activity known to date of this complex is to monoubiquitinate a POL30 product 
proliferation cell nuclear antigen (PCNA) at the Lys164 residue and to initiate the PRR 
pathway (Hoege et al., 2002), although the Rad6 E2 activity is involved in a number of 
other pathways independent of the Rad18 E3 activity (Broomfield et al., 2001).  It 
remains possible that PCNA monoubiquitination, but not the subsequent translesion 
synthesis (TLS),   is required  for DNA  damage  induction.   To  test  this  hypothesis, we 
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Figure 3-6.  Rad6 domains required for its DNA damage induction function.  RNR3-
lacZ expression was analyzed in rad6Δ mutants harboring different plasmids that contain 
intact Rad6 or Rad6 deletion mutants.  All the results are in Miller units and represent the 
average of at least three experiments with standard deviations. 
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 measured MAG1-lacZ activity in a pol30-K164R mutant.  The pol30-K164R mutation 
overrides the Rad6-Rad18 activity in PRR but has no effect on MAG1-lacZ expression 
(Figure 3-7A).  Hence, PCNA monoubiquitination is not required for DNA damage 
induction.  PCNA can also be modified by a small ubiquitin-like modifier (SUMO) at 
K164 and K127 and a SUMO ligase Siz1 is required for both modifications (Stelter and 
Ulrich, 2003).  We measured MAG1-lacZ activity in the siz1 mutant and observed no 
alteration in the MAG1-lacZ induction (Figure 3-7B).    The above results allow us to 
conclude that covalent modifications of  PCNA by Ub or SUMO and  the subsequent 
PRR activity is dispensable for MAG1 and DDI1 induction. 
 
3.2.7. Rad18 is involved in the phosphorylation of Rad53 
 The yeast cell cycle checkpoints, including replication checkpoints and DNA 
damage checkpoints, are required for the DNA damage induction of a number of genes 
(Jang et al., 1999; Kiser and Weinert, 1996; Navas et al., 1995; Zhou and Elledge, 1993; 
Zhu and Xiao, 1998), and the checkpoint response has been suggested to function like a 
eukaryotic SOS response (Aboussekhra et al., 1996; Zhou and Elledge, 1993).  Indeed we 
have previously shown that inactivation of key checkpoint genes such as POL2 (Polε), 
MEC1, RAD53 or DUN1 severely affects MAG1 induction (Zhu and Xiao, 1998; Zhu and 
Xiao, 2001).  Others have reported that the above checkpoint genes are also required for 
the damage induction of RNR genes (Navas et al., 1995; Zhou and Elledge, 1993) and 
some other genes (Gasch et al., 2001; Kiser and Weinert, 1996).  However, the extent of 
checkpoint gene involvement appears to vary with different target genes.  For example, 
damage   checkpoint   genes   RAD9,   RAD17   and   RAD24   are   reported   to    affect 
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Figure 3-7.  PCNA covalent modifications are not required for MAG1 induction. (A) 
The PCNA K164R substitution does not affect MAG1-lacZ induction.  (B) The SIZ1 
deletion that abolishes PCNA sumoylation does not affect MAG1-lacZ induction. Log-
phase cells were either treated with 0.05% MMS for 4 hours (solid bars) or without (open 
bars) treatment prior to β-gal assays.  All the results are in Miller units and represent the 
average of at least three experiments with standard deviations. 
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RNR gene induction (Aboussekhra et al., 1996), but has little effect on MAG1 (Zhu and 
Xiao, 1998), whereas PHR1 induction requires Rad53 but not Dun1 (Jang et al., 1999).  
The Mec1-Rad53-Dun1 pathway forms a central kinase cascade responsible for the 
transcriptional regulation branch of the checkpoint response, whereas Rad53 
phosphorylation has been utilized as a sensitive and reliable assay for checkpoint 
activation.  Using a strain containing a Myc-tagged Rad53, we found that deletion of 
RAD18 reduced Rad53 phosphorylation to a small extent compared to the reported 
inactivation of other RAD53 upstream genes such as MEC1.  It has been reported that 
RAD24 and SGS1 form two alternative branches required for Rad53 phosphorylation; 
simultaneous inactivation of both genes results in a synergistic reduction of Rad53 
phosphorylation (Frei and Gasser, 2000; Myung and Kolodner, 2002).  We reasoned that 
Rad6-Rad18 may function through one of the above two branches.  Corresponding rad18 
rad24 and rad18 sgs1 double mutants were created and compared with their respective 
single mutants with respect to the effect on damage-induced Rad53 phosphorylation.  As 
seen in Figure 3-8, among all the mutants tested, only the rad18 sgs1 double mutant 
displayed a dramatic reduction in Rad53 phosphorylation.  This result suggests that 
Rad6-Rad18 functions in the Rad24 checkpoint pathway parallel to the Sgs1 pathway to 
induce Rad53 phosphorylation.  This hypothesis predicts that the effect of rad18 and 
rad24 mutations on the induction of DNA damage inducible genes is epistatic, whereas 
that of rad18 or rad24 is additive to the sgs1 mutation.  Indeed, the lacZ reporter gene 
assays for both MAG1 (Figure 3-9A) and RNR3 (Figure3-9B) confirmed the above 
prediction.  In particular, the RNR3-lacZ activity is reduced by four-fold in the rad18 
sgs1 and rad24 sgs1 double mutants, compared to about a 30% reduction in the  rad18 
and  rad24 single mutant or the rad18 rad24 double mutant.  Finally, to determine 
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Figure 3-8.  Rad18 acts in the same pathway as Rad24 in the phosphorylation of 
Rad53 in response to DNA damage.  Log-phase cultures of isogenic strains were treated 
with (+) or without (-) 0.1% MMS for 1 hour and the Rad53 phosphorylation status was 
monitored by western blotting using an anti-Myc antibody against Myc-tagged Rad53.  
The shifted phosphorylated Rad53 (Rad53*P) bands disappeared after treating the protein 
samples with lambda protein phosphatase (data not shown). 
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whether the lacZ reporter assay faithfully represents the expression of endogenous genes, 
we measured the endogenous MAG1 transcript level by a quantitative real-time PCR 
method.  It was found (Figure 3-9C) that in response to MMS treatment, the MAG1 
transcript level is reduced by more than two-fold in rad18 and rad24 single mutants.  
Nevertheless, the rad18 rad24 double mutant has the same MAG1 transcript level as the 
corresponding single mutants.  In contrast, the rad18 sgs1 and rad24 sgs1 double mutants 
displayed MAG1 induction levels barely above those without MMS treatment (Figure 3-
9C).  In summary, with respect to DNA damage induction of MAG1, the effect of rad18 
sgs1 and rad24 sgs1 double mutations is comparable to that of the rad53, mec1 or dun1 
single mutations (Zhu and Xiao, 1998; Zhu and Xiao, 2001), indicating that 
RAD6/RAD18-RAD24 and SGS1 constitute two major signal transduction pathways.  We 
suspect that in the case of RNR3, a third branch exists that is independent of the above 
two pathways but depends on the central MEC1-RAD53-DUN1 signal transduction 
pathway. 
 
3.2.8. Rad18 genetically and physically interacts with Rad17 
 In budding yeast, Rad24 and Rad17 checkpoint proteins are involved in early 
responses to DNA damage in a signal transduction pathway leading to cell cycle arrest.  
Rad24 interacts with the four small subunits of replication factor C (RFC) to form the 
RFC-Rad24 complex (Shimomura et al., 1998).  Rad17 forms a complex with Mec3 and 
Ddc1 (Rad17/Mec3/Ddc1), and this complex shows structural similarities with the 
replication clamp PCNA (Kondo et al., 1999; Majka and Burgers, 2003).  The RFC-
Rad24 clamp loader loads the Rad17/Mec3/Ddc1 clamp around damaged DNA sites in an 
ATP-dependent process (Majka and Burgers, 2003).      In S. pombe and mammalian cells, 
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Figure 3-9. MAG1 and RNR3 expression in response to MMS treatments in rad18, 
rad24, sgs1 single or the corresponding double mutants.   The expression of MAG1-
lacZ (A) and RNR3-lacZ (B) were measured by β-gal assay.  Cells were untreated (open 
bars) or treated with 0.05% (A) or 0.02% (B) MMS for 4 hours (solid bars) prior to β-gal 
assays.  Results are in Miller units and represent the average of at least three experiments 
with standard deviations.  (C) Quantitative measurement of the MAG1 transcript level in 
various mutants by real-time PCR.  Cells were treated with 0.05% MMS for 30 min 
(solid bars) or remained untreated (open bars) prior to RNA isolation and the real-time 
PCR reaction was performed as described. 
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the homolog of Rad17, Mec3 and Ddc1 are Rad1, Hus1 and Rad9 respectively, and this 
complex is also termed the 9-1-1 clamp.  Since the Rad18/Rad6 complex and Rad24 
belong to the same signal transduction pathway, it is possible that the Rad18/Rad6 
complex functions with the PCNA-like complex Rad17/Mec3/Ddc1 (9-1-1 clamp) to 
regulate gene induction.  This hypothesis is supported by the results from β-gal assays of 
MAG1-lacZ in rad17Δ, rad17Δ rad18Δ and rad17Δ sgs1Δ mutants.  Similar to RAD24, 
deletion of RAD17 in rad18Δ mutants did not further decrease the DNA damage 
induction of MAG1-lacZ, while the MMS-induced expression of MAG1-lacZ was 
dramatically decreased in the rad17Δ sgs1Δ double mutant, compared to the expression 
in either the rad17Δ mutant or the sgs1Δ single mutant (Figure 3-10).  This indicates that 
Rad18/Rad6 and 9-1-1 complexes belong to the same pathway that regulates gene 
induction.  Interestingly, in a yeast two-hybrid assay, Rad18 showed weak interaction 
with Rad17 and the level of interaction is comparable to that of Pol30 with Rad18, but 
significantly less than that of Rad6 with Rad18 (Figure 3-11).  In contrast, neither Ddc1 
nor Mec3 showed an interaction with Rad18 (Figure 3-11).  Furthermore, the lack of 
interaction of Mec3 or Ddc1 with Rad18 was not due to lack of expression or proper 
folding, since they were able to interact with Rad17 in the same yeast two-hybrid assay 
(Figure 3-11).  Thus, it is hypothesized that Rda18/Rad6 regulates DNA damage 
induction through ubiquitination of Rad17. 
 
3.2.9. RAD6/RAD18- and DNA Damage-dependent Mono-ubiquitination of Rad17 
To examine whether Rad17 is ubiquitinated in a Rad6/Rad18-dependent manner, 
we used a chromosomally Myc-tagged Rad17 strain and monitored Rad17-Myc 
modifications by western blot analysis (Figure 3-12A). Western blot analysis revealed a 
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Figure 3-10.  MAG1-lacZ expression in response to MMS treatment in rad18, rad17, 
sgs1 single or the corresponding double mutants.  Results are in Miller units and 
represent the average of at least three experiments with standard deviations.    
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Figure 3-11. Rad18 interacts with Rad17, but not with Ddc1 and Mec3.  Yeast strain 
Y190 was co-transformed with various combination of pGBT9, pGBT-Rad17, pGBT-
Ddc1, pGBT-Mec3, pGBT-Pol30, pGBT-Rad6 and pGAD-Rad18, pGAD-Rad17, 
pGAD424.  The co-transformants were dropped on SD-TL and SD-HTL with 1 mM 3-
AT plates.  All plates were incubated at 30°C for 3 days.   
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Figure 3-12.  Rad17 Is the Substrate for Rad6-Rad18 Mono-ubiquitination after 
DNA Damage. (A) Western blot analysis of whole-cell lysates with an anti-Myc 
antibody against Rad17-Myc.  Lanes 1 and 2 were lysates from SX46A and the 
remaining lanes were from SX46A-R17-Myc.  Cells harbor both YEp-RAD6 and pGBT-
RAD18 (+), or their mutant version YEp-RAD6-C88A or pGBT-RAD18-C28S (M), or 
the corresponding vectors (-) as indicated on the top panel and grew under the same 
conditions.  (B) Western blot analysis of anti-Ub IP products with the anti-Myc antibody.  
Lanes 1 and 2 contain whole-cell lysates as controls.  Lanes 3 and 4 contain IP products 
with the anti-Ub antibody, whereas lanes 5 and 6 contain IP products under the same 
experimental conditions but without the anti-Ub antibody.  All yeast cells harbor YEp-
RAD6 and pGBT-RAD18 plasmids.  MMS treatment was at 0.05% for 90 minutes. 
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band consistent in size with the expected Rad17-Myc (63.5 kDa) but failed to detect its 
modification under both MMS-treated and untreated conditions (see lanes 9 and 10).  We 
thought that this was probably due to the limit of either the detection sensitivity or the 
endogenous level of Rad6 and/or Rad18.  Indeed, a modified Rad17-Myc band was 
reproducibly detected in cells overexpressing both RAD6 and RAD18 and treated with 
MMS (lane 4).  This band is deemed specific for the Rad17-Myc modification since the 
isogenic cells without the Rad17-Myc-tag did not reveal both modified and unmodified 
bands (lanes 1 and 2).  This modification also appears to depend on MMS treatment, 
although we cannot rule out the possibility of background modification of Rad17-Myc in 
untreated cells (lane 3). 
The migration of the modified band agrees well with the expected size of mono-
ubiquitinated Rad17-Myc (72 kDa).  Furthermore, in cells harboring plasmids containing 
a single rad6-C88A active-site mutation (lane 6) or a rad18-C28S RING finger mutation 
(lane 8), this modification was not observed, implying that it is indeed the mono-
ubiquitination of Rad17-Myc.  To further confirm the above assumption, we performed 
immunoprecipitation (IP) by first using an anti-Ub antibody for affinity precipitation and 
then probing with the anti-Myc antibody.  As shown in Figure 3-12, the anti-Ub antibody 
precipitated a protein that can be detected by the anti-Myc antibody and comigrates with 
the modified Rad17-Myc band from the whole-cell extract (cf. lanes 2 and 4).  In contrast, 
unmodified Rad17-Myc was not detected after IP (lane 4), confirming the high degree of 
anti-Ub IP specificity.  Cell lysates collected without the anti-Ub antibody during Co-IP 
(lane 6) or with anti-Ub but without MMS treatment (lane 3) did not display the same 
modified Rad17-Myc band.  Furthermore, in all experiments, we did not observe 
additional modified Rad17-Myc bands indicative of poly-ubiquitination.  Taken together, 
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we conclude that Rad17 is mono-ubiquitinated in a Rad6-Rad18 and DNA damage-
dependent manner. 
 
3.2.10.  The rad17-K197R mutant is defective in DNA damage induction  
The amino acid sequence alignment showed that the region around Lys197 in Rad17 
shares significant homology with the region around the Lys164 in Pol30 (Figure 3-13 A).  
Since the Rad6/Rad18 complex ubiquitinates Pol30 at Lys164 residue (Hoege et al., 
2002), it is possible that the Rad6-Rad18 complex could also ubiquitinate Rad17 at the 
Lys197 residue to initiate DNA damage induction.  To test this hypothesis, we created a 
mutant strain in which the single lysine 197 residue present in Rad17 was changed to 
Arginine (rad17-K197R).  In rad17 mutants lacking the putative ubiquitination site K197 
(rad17-K197R), DNA damage induction of MAG1-lacZ decreased to the same level as 
the RAD17 deletion mutants (Figure 3-13B).  Meanwhile, the effect of rad17-K197R 
sgs1Δ on MAG1-lacZ expression is also comparable to the rad17Δ sgs1Δ double 
mutation.  All these data imply that ubiquitin modification of the Lys197 residue in 
Rad17 might be crucial for DNA damage induction. 
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Figure 3-13. The rad17-K197R mutant is defective in DNA damage induction.  (A) 
Sequence alignment of Pol30 (residues 155 to 168) and Rad17 (residues 188 to 202). 
Pol30-K164 and rad17-K197 are marked. (B) The expression of MAG1-lacZ was 
measured in rad17Δ, sgs1Δ, rad17-K197R, rad17Δ sgs1Δ, and rad17-K197R sgs1Δ 
mutants by a β-gal assay.  Cells were untreated or treated with 0.05% MMS for 4 hours 
prior to the β-gal assays.  Results are in Miller units and represent the average of at least 
three experiments with standard deviations.   
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3.3. Discussion 
 
3.3.1. New Roles of RAD6 and RAD18 in DNA Damage-induced Gene Regulation 
We report that two PRR genes, RAD6 and RAD18, are involved in the regulation 
of a large number of DNA damage-inducible genes.  RAD6 has been previously reported 
to participate in transcriptional regulation.  For example, RAD6 is required for the 
transcriptional repression at telomeres and the HM loci (Huang and Elledge, 1997), and 
for the ArgR/Mcm1 repression of ARG1 in the arginine biosynthesis pathway (Turner et 
al., 2002).  The detailed mechanism of the above transcriptional repression has not yet 
been elucidated.  One possibility is that Rad6 mediates the degradation of certain 
transcriptional regulators through the ubiquitin proteosome pathway.  At least one 
transcriptional factor, Gcn4, is regulated by the Rad6 ubiquitination pathway (Kornitzer 
et al., 1994).  Alternatively, Rad6’s involvement in the ubiquitination of histone subunit 
H2B (Robzyk et al., 2000) may lead to an open chromatin structure or mark chromatin 
for recognition by regulatory proteins, which in turn activate the transcription of certain 
target genes (Kao et al., 2004).  In any event, the above two processes involve only Rad6 
but not Rad18.  Indeed, RAD18 has not been linked to the transcriptional regulation of 
any genes prior to this study. 
 To the best of our knowledge, this is the first report that RAD6 and RAD18 
function in transcriptional regulation in response to DNA damage.  Since the only known 
activity of the Rad6-Rad18 complex is in PRR, it strongly suggests that PRR is 
responsible for the observed gene regulation.  To our surprise, among all the PRR 
mutations examined, only rad6 and rad18 affected the expression of damage-inducible 
genes, indicating that the RAD6-RAD18 function in gene regulation is independent of 
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PCNA ubiquitination.  This led to the identification of the PCNA-like clamp 9-1-1 as an 
alternative target of Rad6-Rad18 ubiquitination.  Indeed, both 9-1-1 and its clamp loader 
are required for Rad6-Rad18 mediated DNA damage induction. 
 
3.3.2. Rad6-Rad18 and the Eukaryotic SOS Response 
The roles of Rad6-Rad18 in gene regulation in response to DNA damage is 
reminiscent of the bacterial SOS response, in which RecA functions as a key regulator 
that is activated through binding to ssDNA and catalyzes the autocleavage of the 
repressor LexA, leading to the derepression of more than 30 SOS regulon genes 
(Friedberg et al., 2006).  Interestingly, like RecA, the Rad6-Rad18 complex has also been 
reported to possess ssDNA binding and ATPase activities, as well as a ubiquitin 
conjugating activity (Bailly et al., 1997).  Indeed, our microarray data indicate that RAD6 
and RAD18 are coordinately required for the DNA damage induction of several hundred 
genes. 
In a broad sense, E. coli RecA controls three important cellular responses to DNA 
damage, namely homologous recombination via RecBCD and RecFOR, TLS by working 
with PolIV and PolV, and the SOS response that coordinately provide a survival 
mechanism when cells encounter replication blocks (Figure 3-14).  Our findings 
presented in this report, along with previous reports, argue that the Rad6-Rad18 complex 
assumes most if not all RecA functions to coordinate such broad cellular responses.  
Firstly, Rad6-Rad18 as an E2-E3 ubiquitination complex mono-ubiquitinates PCNA to 
promote Polζ and Polη mediated TLS (Hoege et al., 2002; Stelter and Ulrich, 2003).  
Secondly, this mono-Ub-PCNA is required for PCNA poly-ubiquitination via a Lys63 
chain  linkage  for an  error-free  mode of  DNA  damage  tolerance (Hoege et al., 2002)  
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Figure 3-14.   The comparison between prokaryotic SOS response and putative SOS 
responses in eukaryote.  
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reminiscent of the RecFOR activity in E. coli (Hanna et al., 2004).  Thirdly, although 
Rad6-Rad18 does not have homologous recombinase activity like RecA, it may compete 
with the Ubc9-Siz1 complex that sumoylate PCNA at the same K164 residue; sumoylated 
PCNA recruits the DNA helicase Srs2 that inhibits the recombinase activity of the yeast 
RecA homolog Rad51 (Papouli et al., 2005; Pfander et al., 2005).  Finally, data presented 
in this report demonstrate that Rad6-Rad18 also fulfills yet another core RecA activity in 
the SOS response via mono-ubiquitinating the Rad17 subunit of the 9-1-1 clamp (Figure 
3-14). 
There are several notable differences between bacterial and eukaryotic SOS responses.  
Firstly, unlike RecA, eukaryotic cells employ ubiquitination, a process not found in 
bacteria.  Indeed, the ubiquitination activity of both Rad6 and Rad18 are absolutely 
required for all of the above functions including gene regulation.  Secondly, while all 
SOS regulon genes share a common promoter element recognized by LexA, promoter 
analysis of genes induced by DNA damage and dependent on RAD6-RAD18 did not 
reveal common elements (data not shown).  As a matter of fact, among three sets of well-
characterized yeast DNA damage inducible genes, their effectors and mechanisms of 
damage induction are completely different.  The RNR genes share an X box sequence in 
their promoters that are bound by a Crt1 repressor and two co-repressors Tup1 and Ssn6; 
inactivation of any repressor results in complete derepression (Huang et al., 1998).  PHR1 
is regulated by two repressors, Gis1 and Rph1; simultaneous inactivation of both 
repressors results in a synergistic PHR1 depression (Jang et al., 1999).  In contrast, 
MAG1 and DDI1 are divergently transcribed and share a promoter element recognized by 
an activator  Pdr3 (Zhu and Xiao, 2004).   Lastly,   many  DNA  damage-inducible  genes 
examined are variably regulated by cell cycle checkpoints (Aboussekhra et al., 1996; 
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Kiser and Weinert, 1996; Zhu and Xiao, 2001), which  appear to  converge at the point of 
Rad53 activation, whereas the downstream events are rather different.  In the case of RNR 
genes, the Dun1 kinase activity is required for Crt1 phosphorylation and subsequent 
dissociation from RNR promoters (Huang et al., 1998).  MAG1 induction also requires 
DUN1 (Zhu and Xiao, 2001), whereas PHR1 induction is dependent on RAD53 but does 
not require DUN1 (Jang et al., 1999).  Results presented in this report provide a 
mechanism in which the DNA damage signal recognized by the Rad6-Rad18 E2-E3 
complex is relayed to the cascade of cell cycle checkpoints that have been previously 
regarded as a eukaryotic SOS response.  Since all the genes discussed in this report are 
highly conserved in eukaryotes from budding yeast to humans, it is conceivable that the 
regulatory mechanism described in this report may apply to higher eukaryotes as well. 
 
3.3.3. RAD6-RAD18 and the Damage Checkpoint Pathway 
The 9-1-1 clamp and the RFC-like clamp loader have been implicated as DNA 
damage sensors (Friedberg et al., 2006).  Findings in this study that Rad6-Rad18 is 
required for Rad17 ubiquitination in a DNA damage-dependent manner place the Rad18 
ssDNA binding protein as a strong candidate for a sensor in the damage checkpoint 
pathway.  It is unclear whether the Rad24/9-1-1 and Rad6-Rad18 complexes 
independently recognize the damage site or one serves to recruit the other.  Nevertheless, 
it is conceivable that once in proximity, Rad6-Rad18 will mono-ubiquitinate Rad17, 
which is an important signal for Rad53 phosphorylation and gene regulation. 
Surprisingly, despite numerous efforts, RAD6 and RAD18 have not been 
implicated in the damage checkpoint pathway, which may be explained by several 
scenarios.  Firstly, the 9-1-1 complex may be activated by alternative means, which may 
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undermine the contribution of Rad6-Rad18 in the damage checkpoint.  Indeed, the Ddc1 
subunit of 9-1-1 is phosphorylated in response to DNA damage (Longhese et al., 1997), 
which may be functionally redundant with Rad17 ubiquitination.  Secondly, the Rad17 
ubiquitination may be specifically responsible for gene regulation but not for cell cycle 
arrest, although it is unclear how this could be achieved.  Thirdly, the checkpoint 
response of Rad6-Rad18 may be lesion-specific. Hence, the checkpoint defect of a rad6 
or rad18 mutant may not be readily detected in experiments using UV and ionizing 
radiations as damage sources.  Finally, the dual functions of Rad6-Rad18 in PRR and 
damage checkpoint may undermine detection of its checkpoint function, which is 
reminiscent of the response of the rad9 rad52 double mutant to ionizing radiation 
(Weinert and Hartwell, 1988).  In this case, lack of PRR activity may slow down S-phase 
progression in MMS-treated cells, which may undermine its damage checkpoint activity.  
With the above analysis in mind, we are confident that future experiments will be able to 
determine whether RAD6 and RAD18 are indeed involved in the damage checkpoint. 
 
3.3.4. Coordination of DNA Damage Tolerance by Dual Ubiquitination of PCNA 
and 9-1-1 
Perhaps the most striking finding in this report is the demonstration of 9-1-1 as a 
novel alternative ubiquitination target to PCNA.  Both PCNA (Hoege et al., 2002) and 9-
1-1 are mono-ubiquitinated in a RAD6-RAD18 dependent fashion when cells are treated 
with MMS under similar experimental conditions.  Hence, it is safe to conclude that the 
Rad6-Rad18 ubiquitination complex coordinates cellular tolerance to DNA damage via 
simultaneous ubiquitination of two DNA clamps (Figure 3-15).  In this respect, it is of 
great interest to note that it was recently reported (Barbour and Xiao, 2003) that the 
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damage checkpoint pathway may function as a third branch within the PRR pathway with 
respect to tolerance of MMS-induced damage.  In light of results presented in this report, 
it is now clear that the damage checkpoint pathway represented by RAD9, RAD24 and 9-
1-1 is not a branch of PRR but instead under the same umbrella of RAD6-RAD18.  Hence, 
in the absence of PCNA ubiquitination and the presence of MMS-induced damage, the 
damage checkpoint via Rad17 ubiquitination provides a pivotal role in cell survival.  It is 
also interesting to note a recent report (Sabbioneda et al., 2005) that the 9-1-1 checkpoint 
clamp physically interacts with Polζ and is involved in Polζ-mediated mutagenesis.  
Perhaps like its PCNA counterpart (Bienko et al., 2005; Kannouche et al., 2004), Rad17 
mono-ubiquitination may enhance its affinity for TLS polymerases.  Taken together, the 
Rad6/Rad18 complex is an excellent candidate for the central regulator that coordinates 
eukaryotic cellular response to DNA damage, including damage tolerance, damage 
checkpoint as well as an SOS-like transcriptional regulation. 
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Figure 3-15.  A Model Depicting Coordinated Regulation of DNA Damage 
Tolerance through Rad6-Rad18 Mediated Mono-ubiquitination of Two DNA 
Clamps.  In response to DNA damage, the Rad6-Rad18 ubiquitination complex mono-
ubiquitinates both Pol30 (PCNA) and the Rad17 subunit of 9-1-1.  Ubiquitinated PCNA 
and possibly 9-1-1 recruit translesion polymerases to bypass the replication-blocking 
lesion.  PCNA can be further poly-ubiquitinated by the Rad5-Ubc13-Mms2 complex, 
whereas mono-ubiquitinated 9-1-1 activates the damage checkpoint pathway leading to 
Rad53 phosphorylation, which results in transcriptional regulation and cell cycle arrest. 
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CHAPTER FOUR 
TWO IDENTICAL MMS-INDUCIBLE GENES IN 
SACCHAROMYCES CEREVISIAE 
 
4.1. Introduction 
In Chapter Three of this thesis, the Rad6/Rad18 complex was introduced as a 
DNA damage sensor to mediate an eukaryotic SOS response.  For the investigation of the 
molecular mechanisms of DNA damage induction in S. cerevisiae, the study on how 
ultimate effectors execute the regulation of transcription is also an important issue to 
understand this basic biological process.  Therefore, considerable effort was also spent to 
determine the cis-acting elements and trans-acting factors involved in the DNA damage 
induction of some specific genes. 
As brought forth in the introduction, most of the DNA repair genes are expressed 
at a low level under normal growth conditions and their expression is induced upon 
exposure to DNA damaging agents.  For example, in E. coli, approximately 48 genes are 
co-ordinately induced after UV irradiation (Courcelle et al., 2001; Walker, 1985).  In S. 
cerevisiae, at least 30 genes are known to be DNA damage inducible and their regulation 
has been well studied (Bachant and Elledge, 1998; Friedberg et al., 2006).  The gene 
regulation and biochemical pathways involved in responding to DNA damage in 
mammalian cells share many features with those of S. cerevisiae, and many of DNA 
damage-inducible genes in mammalian cells have been linked to cancer (Criswell et al., 
2003; Friedberg et al., 2006; Weinert, 1997). 
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 During last decade, with the development of microarray technology, significant 
progress has been made towards the understanding of DNA damage induction.  DNA 
microarray technology enables simultaneous examination of how the entire genome 
responds to DNA damaging agents.  In a microarray analysis, 325 budding yeast genes 
were reported to increase more than 4-fold at the transcript level after exposing cells to 
the alkylating agent MMS (Jelinsky and Samson, 1999).  The protein products of these 
325 genes are involved in different biological functions, such as stress response, 
detoxification, DNA repair, DNA replication, cell cycle, signal transduction, cell wall 
biogenesis, protein degradation and membrane transport (Jelinsky and Samson, 1999).  
These genes are likely to protect yeast cells from the damage caused by MMS treatment, 
although the reasons why some genes are induced are difficult to rationalize. 
 To date, with the exception of a few well documented DNA-damaged inducible 
genes (e.g. RNR2, RNR3, MAG1 and PHR1), it still remains unclear how these genes are 
regulated at the transcriptional level in response to MMS treatment.  Results from 
previous studies suggest that upstream cis-acting regulatory elements and corresponding 
trans-acting factors may control MMS-induced transcription.  For instance, RNR3 is one 
of the genes most highly induced by MMS in S. cerevisiae.  The induction of RNR3 after 
MMS treatment is due to the removal of a transcriptional repressor protein known as Crt1 
from the upstream cis-acting element X-box in the RNR3 promoter (Huang et al., 1998).  
After MMS treatment, a checkpoint kinase cascade including Mec1, Rad53, and Dun1 
protein kinases is activated and phosphorylates Crt1, resulting in the derepression of Crt1 
target genes (Huang et al., 1998).  Another MMS-inducible gene MAG1 relies heavily on 
several cis-acting regulatory elements, upstream acting sites (UAS) and upstream 
repressing sites (URS), and the trans-acting factor Pdr3 to regulate its expression level 
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(Liu and Xiao, 1997; Xiao et al., 1993; Zhu and Xiao, 2004).  Furthermore, the DNA 
damage induction of MAG1 is also affected by checkpoint mutants such as mec1∆, 
rad53∆ and dun1∆ (Zhu and Xiao, 1998; Zhu and Xiao, 2001).  However, the promoters 
of these MMS-inducible genes do not appear to share common cis-elements and no 
consensus trans-acting factors that act on all these genes have been identified. 
 Here, we described two identical genes DDI2 and DDI3, which are highly 
induced by MMS treatment.  In the present study, we analyzed their promoter region, and 
identified several cis-acting regulatory regions that regulate the transcription in response 
to MMS treatment. 
 
4.2. Results 
 
4.2.1. Identification of DDI2 and DDI3 
MMS is a DNA alkylating agent known to react with DNA at N and O atoms 
(Beranek, 1990; Friedberg et al., 2006). The O-alkylated bases (for example, O6-
methylguanine) are highly mutagenic (Beranek, 1990), while the N-alkylated purines (for 
example, N3-methyladenine) inhibit DNA synthesis and require repair for proper 
replication (Chang et al., 2002).  We previously performed a study where S. cerevisiae 
cells were treated with 0.1% MMS for 48 minutes and the global transcriptional response 
was assessed by microarray analysis.  During this microarray analysis, two genes, 
YFL061w and YNL335w, showed the highest induction.  After MMS treatment, the 
transcription of these two genes increased by 108-fold and 138-fold, respectively.  Thus, 
we designated YFL061w as DDI2 and YNL335w as DDI3 for DNA damage inducible 
gene.  Interestingly, DDI2 and DDI3 are two identical genes with exactly the same 
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promoter regions, but they are located on different chromosomes (SGD, 
www.yeastgenome.org, Stanford University). 
DDI2/DDI3 encodes a putative 225 amino acid protein, and the predicted 
Ddi2/Ddi3 contains an HD domain [named HD due to the conserved doublet of predicted 
catalytic residues (Histidine-Aspartic acid) in the predicted phosphohydrolases] (Figure 
4-1A).  HD domains are found in a superfamily of enzymes with metal-dependent 
phosphohydrolase activity (Aravind and Koonin, 1998).  These enzymes appear to be 
involved in nucleic acid metabolism, signal transduction and possibly other functions in 
bacteria, archaea and eukaryotes.  No polypeptide sequence in the worm, mouse or 
human genome database shows homology to Ddi2/Ddi3.  However, close homologs of 
Ddi2 are identified in Debaryomyces hansenii (DEHA0A02123g), Pichia stipitis 
(PICST_87356) and Candida albicans (orf19.1449) (Figure 4-1 A).  Interestingly, some 
predicted or known urea hydrolyase (cyanamide hydratase) in fungi show significant 
similarity to Ddi2 (Figure 4-1B). 
In order to validate the microarray result, we performed Northern blot analysis to 
determine the transcriptional level of DDI2/DDI3 after MMS treatment.  The Northern 
blot result (Figure 4-2A) demonstrated that the transcription of DDI2/DDI3 increased by 
110-fold after MMS treatment.  Furthermore, we isolated DDI2 and its promoter (-709 to 
+1), and made a lacZ fusion construct.  As expected, the β-gal assay also showed more 
than 100-fold induction of DDI2-lacZ by MMS treatment (Figure 4-2B).  Taken together, 
DDI2 and DDI3 are two identical genes that can be highly induced by MMS. 
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Figure 4-1.  Protein sequence alignment of DDI2/DDI3 and their homologs. (A) 
Amino acid sequence comparison of S. cerevisiae Ddi2/Ddi3 and its putative homologs 
in Debaryomyces hansenii (DEHA0A02123g), Pichia stipitis (PICST_87356) and 
Candida albicans (orf19.1449). (B) Sequence comparison of Ddi2 and urea hydrolyase 
from Aspergillus fumigatus.  All alignments were performed using the CLUSTALW 
program in EBI with additional manual modifications with ESPript software. The HD 
domain is underlined.  
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Figure 4-2.  The transcription of DDI2/DDI3 is highly induced by MMS treatment.  
(A) Northern blot analysis of DDI2/DDI3.  Yeast cells DBY747 were treated with 0.1% 
MMS for 48 minutes prior to RNA isolation and Northern hybridization.  Each lane 
contains 15 µg of total RNA.  The blot was stripped and hybridized with an ACT1 probe.  
The DDI2 transcript level in each sample was normalized with reference to that of ACT1, 
and expressed as value relative to an untreated wild-type sample in the same blot.  (B) 
The expression of DDI2-lacZ with or without MMS treatment.  Log-phase cells were 
either treated with 0.05% MMS for 4 hours or without treatment prior to β-gal assays.  
All the results are in Miller units and represent the average of at least three experiments 
with standard deviations. 
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4.2.2. DDI2 is only highly induced by SN2 alkylating agents 
Since all of the well-documented DNA damage-inducible genes in budding yeast 
seem to respond to a wide spectrum of DNA damaging agents, we examined the 
inductionof DDI2-lacZ after treating yeast cells with different DNA damaging agents.  
To our surprise, the expression of DDI2-lacZ was only highly induced by SN2 alkylating 
agents MMS and dimethyl sulfate (DMS) up to 322-fold and 150-fold, respectively. 
These compounds alkylate predominantly at nitrogens rather than the oxygens in DNA 
bases (Figure 4-3).  The SN1 alkylating agent N-methyl-N’-nitro-N-nitrosoguanidine 
(MNNG), which efficiently alkylates both nitrogens and oxygens, did not induce the 
expression of DDI2-lacZ (Figure 4-3).  Other DNA damaging agents, such as ethyl 
methanesulfonate (EMS), γ-ray and hydroxyurea (HU), only mildly induced the 
expression of DDI2-lacZ by approximately 8-fold (Figure 4-3). 
 
4.2.3. DDI2-lacZ upstream deletions identify UAS and URS 
In order to identify UAS and URS elements in the DDI2 promoter region, various 
deletions were introduced into the plasmid YEpDDI2-lacZ.  Beta-gal activities of yeast 
transformants harbouring these plasmids were determined with or without MMS 
treatment.  Therefore, any changes in the level of β-gal activity probably reflected the 
functions of the deleted sequences.  As shown in Figure 4-4, deletion of the -709 to -358 
regions increased the basal level of expression by 3-fold and MMS-induced expression 
by 1.7-fold compared to the intact promoter.  This indicated the presence of upstream 
repressing sites in this region. Deletion of the region extending from -358 to -229 reduced 
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Figure 4-3.  The induction of DDI2-lacZ by different DNA damaging agents.  Log-
phase cells were either treated by different chemicals with various concentrations for 4 
hours or without treatment prior to β-gal assays.  All the results are in Miller units and 
represent the average of at least three experiments with standard deviations.
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Figure 4-4. The effects of deletions in DDI2 promoter region on DDI2 expression as 
monitored by β-galactosidase activity.  For each plasmid construct, the blue solid bar 
indicates the promoter region, while deletions are indicated by interruptions in the blue 
solid bar.  The number indicates the distance to the start codon (ATG) of DDI2.  β-gal 
activities are expressed in Miller units and represent the average of at least three 
experiments with standard deviations. 
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basal-level DDI2-lacZ expression by 1.7-fold and MMS-induced expression by 7.6-fold 
(Figure 4-4).  Furthermore, when this  region  was kept  intact   (deletion  of    the -453  to 
-358 region),  both  the basal  level and inducible expression of DDI2-lacZ were restored 
to wild type levels (Figure 4-4).  These observations suggest that the region extending 
from -358 to -229 functions as a UAS in the DDI2 promoter. We designated this region 
as UASDDI2. 
 
4.2.4.  The UASDDI2 confers activation and MMS inducibility to a heterologous 
promoter 
To determine if the UASDDI2 is able to function in the context of a heterologous 
promoter, the UASDDI2 sequence was inserted into the promoter region of the CYC1-lacZ 
reporter gene in pLG669Sm (Guarente and Hoar, 1984).  The CYC1 promoter alone 
exhibited no MMS inducibility, and the β-galactosidase activity of CYC1-lacZ was 
reduced by 1.55 fold following MMS treatment (Figure 4-5).  Insertion of the UASDDI2 
into the CYC1 promoter increased β-galactosidase activity by 1.77-fold in the absence of 
MMS induction.  Furthermore, in contrast to CYC1-lacZ, which showed reduced β-
galactosidase activity following MMS treatment, the insertion of UASDDI2 conferred a 
2.77-fold MMS inducibility (Figure 4-5). 
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CYC1 basal promoter LacZ
CYC1 basal promoter LacZ
UASDDI2
β-gal activity
- MMS + 0.05% MMS
41.36 ± 1.25 26.61 ± 0.67
73.16 ± 5.30 202.61 ± 8.25
 
 
Figure 4-5. Effects of the UASDDI2 on the heterologous CYC1 promoter.  The left 
panel shows promoter the constructs used in this work.  The right panel shows β-
galactosidase activity of corresponding DBY747 transformants with or without MMS 
treatment.  β-gal activities are expressed in Miller units and represent the average of at 
least three experiments with standard deviations. 
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4.3. Discussion 
 In the present work, we report the identification of two identical genes, DDI2 and 
DDI3, which can be highly induced by MMS.  The induction ratio reaches up to 322-fold 
in the β-gal assay, and it is by far the highest DNA damage induction ratio known in 
budding yeast. 
In budding yeast, a feature of the DNA damage responses is that most DNA 
damage-inducible genes analyzed to date can be induced by a variety of DNA damaging 
agents, (Liu and Xiao, 1997).  For instance, DNA repair genes PHR1, MAG1, RAD2 are 
induced by MMS, MNNG, UV irradiation, 4NQO or γ-rays (Chen and Samson, 1991; 
Robinson et al., 1986; Sebastian et al., 1990), irrespective of  whether the gene product is 
involved in the repair of the specific damage.  RNR genes, a protein-degradation related 
gene UBI4, and the putative S-phase checkpoint gene DDI1 can also be induced by 
different DNA damaging agents, such as UV irradiation, 4NQO, HU, MNNG, and MMS 
(Elledge and Davis, 1990; Liu and Xiao, 1997; Treger et al., 1988).  To our surprise, 
DDI2/DDI3 can only be highly induced by the SN2 alkylating agents MMS and DMS, 
slightly induced by EMS, HU and γ-rays, and not induced at all by the SN1 alkylating 
agents MNNG.  Therefore, it implies that the signal for high level induction of 
DDI2/DDI3 by MMS could be generated by specific substrates formed by MMS 
treatment.  It is known that MMS and DMS induce a much higher amount of 1-
methyladenine in DNA than MNNG and MNU (Singer and Grunberger, 1983).  
Meanwhile, the enhanced transcriptional level of DDI2/DDI3 after MMS treatment is 
postulated to protect yeast cells against the damage caused by MMS.  Thus, the protein 
product of DDI2/DDI3 might be involved in the repair of 1-methyladenine directly or 
indirectly. 
 126
 Analysis of the cis-acting regulatory elements in the DDI2 promoter region allows 
us to obtain some clues as to how this gene is regulated.  Since deleting the region 
between -358 and -229 (UASDDI2) decreases both basal-level expression and the 
induction by MMS, our data suggest that this region is required for transcriptional 
activation.  Given that pLG669Sm does not contain native UASCYC1 (Guarente and Hoar, 
1984; Guarente et al., 1984), the observation that UASDDI2 alone conferred a 1.77-fold 
increase in β-gal activity in a heterologous CYC1-lacZ promoter without treatment further 
confirms that it is a UAS and directly influences basal transcription.  Moreover, the 
insertion of UASDDI2 caused a 2.77-fold induction of CYC1-lacZ following MMS 
treatment, indicating that UASDDI2 is required for MMS inducibility. 
   A comparison of sequences within the promoter regions of some damage-
inducible genes, such as RAD2, RAD51, MAG1, RNR2 and RNR3,  have identified the 
presence of a consensus 8-bp sequence [5’-GG(T/A)GGCGA-3’] (Elledge and Davis, 
1989; Liu and Xiao, 1997; Siede et al., 1989; Xiao et al., 1993).  This consensus sequence 
could be responsive to DNA-damage induction (Liu and Xiao, 1997).  However, no such 
consensus sequence was found in the UASDDI2 region.  Instead, we noticed that a 6 bp 
sequence “AAAAGA” is repeated four times in this 129 bp region.  Three of them are in 
one direction, and one is in the opposite direction.  Although this 6-bp sequence shares no 
significant sequence homology with any reported upstream activating sequences in DNA 
damage inducible genes, it is unlikely that these repeats appear by coincidence. 
Compared with the intact promoter, deletion of the region between -709 and -358 
increased both basal level and induced expression.  This observation indicates the 
presence of URS in this region.  Moreover, deletion of the region between -453 and -229 
resulted in higher induced expression than the deletion of UASDDI2.  This suggests that 
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there may be a URS in -453 to -358 region.  Meanwhile, it suggests that the repression 
function of URS in -453 to -358 region is independent of the UASDDI2.  Since extended 
deletion in the -453 to -709 region resulted in increased MMS-induced expression, it is 
likely that there is more than one URS in the region between -709 and -358. 
According to these results, we propose a model explaining the control of DDI2 
expression.  The expression of DDI2 is positively regulated by the UASDDI2.  It is 
possible that the 6-bp repeats are recognized by trans-acting factors, and the binding of 
the factors to this region can significantly activate transcription.   The MMS treatment 
might enhance the binding of these factors so as to obtain high level induction.  The 
region between -709 and -358 is involved in a negative regulation.  However, the 
transcription repression carried out by the URS is not as strong as the transcription 
activation by the UAS.  Consequently, it is unlikely that the mechanism of high level 
induction is mainly due to the competition of transcription factors for the URS and the 
UAS, even though the UAS and URS regions are close to each other in the putative 
promoter region. 
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CHARTER FIVE 
CRT10 IS A NOVEL REGULATOR OF SACCHAROMYCES 
CEREVISIAE RIBONUCLEOTIDE REDUCTASE GENES 
 
5.1. Introduction 
In addition to the general DNA damage sensor and the cis-acting elements in the  
promoter regions introduced in the previous chapters, the trans-acting factors are also 
important for the study of DNA damage induction.  In this chapter, we will introduce a 
novel trans-acting factor that regulates the expression of yeast ribonucleotide reductase 
genes, which are known to be induced by DNA damaging agents. 
Ribonucleotide reductase (Rnr) catalyzes the rate-limiting steps in dNTP synthesis.  
Three classes of Rnr have been identified (Jordan and Reichard, 1998).  Class I enzymes, 
which are found in all eukaryotes and some prokaryotes, consist of an α2β2 tetramer made 
up of two large (α) and two small (β) subunits.  The α subunit possesses binding sites for 
substrate and allosteric effectors, and the β subunit contains a binuclear iron complex that 
interacts with a specific tyrosine residue to form a tyrosyl free radical and is essential for 
Rnr activity (Eklund et al., 2001; Fontecave et al., 1992).  In the budding yeast 
Saccharomyces cerevisiae, the large Rnr subunit is encoded by two highly homologous 
genes, RNR1 and RNR3 (Elledge and Davis, 1990).  RNR1 is an essential gene, whereas 
RNR3 is nonessential.  RNR1 transcription is tightly regulated during the cell cycle and 
moderately induced by DNA damage, whereas RNR3 is barely transcribed under normal 
conditions but is highly inducible by DNA damage, increasing up to 100-fold (Elledge 
and Davis, 1990).  The small Rnr subunit is encoded by RNR2 and RNR4, both of which 
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are essential and DNA damage inducible (Elledge and Davis, 1987; Huang and Elledge, 
1997; Hurd et al., 1987), although RNR4 null mutants in some yeast strains appear to be 
viable (Baskaran et al., 1997). 
The tight regulation of Rnr during the cell cycle and by DNA damage is thought 
to be crucial for the maintenance of balanced dNTP pools for high-fidelity DNA 
replication and repair (Elledge et al., 1993; Zhou and Elledge, 1992).  Failure to provide a 
sufficient and balanced dNTP pool may cause misincorporation of dNTPs into DNA, 
which in turn results in genetic abnormalities and cell death (Chabes et al., 2003).  The 
regulation of Rnr involves multiple mechanisms in budding yeasts, including 
transcriptional regulation (Longhese et al., 2003), protein (Zhao et al., 2001) and 
allosteric (Chabes et al., 2003; Reichard et al., 2000) inhibition and subcellular 
localization (Yao et al., 2003).  The DNA damage-induced transcriptional activation is 
mediated by the cell cycle checkpoint genes.  The stalling of the replication fork or DNA 
damage triggers a DNA damage checkpoint pathway composed of the protein kinase 
cascade Mec1, Rad53 and Dun1 (Zhou and Elledge, 1993).  Activated Dun1 
phosphorylates a Crt1 repressor, and hyper-phosphorylated Crt1 no longer binds the X-
box sequence found in the promoters of RNR genes, resulting in transcriptional 
derepression (Huang et al., 1998). 
A second mechanism is Sml1-dependent. Sml1 inhibits the yeast Rnr activity by 
binding its larger subunit (Chabes et al., 1999; Zhao et al., 2000; Zhao et al., 1998).  
Activated Sml1 levels decrease at S phase and after DNA damage, resulting in 
derepression of Rnr activity (Zhao et al., 2001).  The inactivation of Sml1 is caused by 
post-transcriptional regulation and also requires Mec1-Rad53-Dun1-dependent 
phosphorylation (Zhao et al., 2001; Zhao and Rothstein, 2002), which again testifies to 
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the need for tight Rnr regulation.  The tight regulation of Rnr activity appears to be true 
for other organisms, such as fission yeast (Mirza et al., 2003), indicating that such 
regulation is evolutionarily conserved. 
It is anticipated that additional genes and/or mechanisms may be involved in the 
regulation of Rnr activities.  To investigate this possibility, we utilized the powerful 
budding yeast genetic system to identify such genes, and report here the identification of 
a novel gene, CRT10, whose mutation enhances hydroxyurea (HU) resistance.  Genetic 
characterization indicates that CRT10 is involved in the transcriptional regulation of RNR 
genes. 
5.2.  Results 
 
5.2.1. Identification of CRT10 
HU is a potent inhibitor of Rnr. Inhibition of Rnr leads to depleted dNTP pools, 
the subsequent stalling of the replication forks and S phase cell-cycle arrest (Eklund et al., 
2001; Slater, 1973).  In order to identify S. cerevisiae genes whose mutations alter 
cellular sensitivity to HU, we performed an HU resistance screen with a haploid yeast 
mutant library consisting of 4850 individual gene deletion strains.  Among HU-resistant 
mutants, the YOL063c deletion mutant displayed significant resistance to HU and this 
gene has not been previously characterized.  YOL063c encodes a putative 957-amino acid, 
109 kDa protein and was designated as CRT10, after the nine previously described 
putative CRT (constitutive RNR transcription) regulator genes (Zhou and Elledge, 1992). 
The predicted Crt10 contains leucine repeats at residues 105-145 with a sequence 
L-X9-L-X8-L-X6-L-X6-L-X6-L, a putative transmembrane domain at residues 191-206, 
and one copy of the Trp-Asp (WD) repeat motif at residues 253-267 (van der Voorn and 
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Ploegh, 1992) (Figure 5-1).  WD-repeat proteins are found in all eukaryotes and 
implicated in a wide range of crucial functions.  These proteins typically contain 4-16 
copies of the WD motif (Smith et al., 1999); however, only one WD repeat motif was 
found in Crt10. 
A database search with the Crt10 protein sequence revealed several homologous 
sequences in other organisms.  The closest homologs are found in members within the 
Saccharomyces family.  In addition, a putative protein (ADR329Wp) in Eremothecium 
gossypii and Candida albicans hypothetical protein (CAG58307.1) show significant 
homology to Crt10; a hypothetic protein (SPBC27B12.05) from Schizosaccharomyces 
pombe also shows limited homology to Crt10 (data not shown).  No polypeptide 
sequence in the worm, mouse or human genome database has significant similarity to 
Crt10, suggesting that Crt10 may be unique to lower eukaryotes, possibly within 
unicellular eukaryotic microorganisms. 
 
5.2.2. Deletion of CRT10 enhances survival of the mec1∆ mutant 
The crt10 mutant was originally isolated for its enhanced resistance to HU killing 
in a library screen.  We compared the crt10∆ mutant to its isogenic wild-type strain 
BY4741 and found that it indeed displayed an enhanced resistance to HU (Figure 5-2A). 
In order to rule out the possibility that this crt10 strain contains additional 
unknown mutation(s), we made a crt10∆::LEU2 deletion cassette and created a crt10 null 
mutant in a different strain background.  As shown in Figure 5-2B, targeted deletion of 
CRT10 also resulted in a similar HU-resistant phenotype.  Deletion of CRT10 led to 
slightly enhanced resistance to MMS, but not to UV (data not shown), suggesting that 
Crt10 probably functions specifically in a pathway  in response to either DNA replication 
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MPPQIPNENDDLFTRWLKSRAIIQRAVSTRECFDSEVFLASGGWNITNEIITLKKYYQLK  60 
WPNSSCNSFHPKTVEFIKERLHNLEEHDSSWKIPNPAYSFKKAFLEDTKSAFSNLEPVWG 120 
PSRLLNPAELLLPQDEKLLVQEIPLEFAPFQYTNRFAYGGLQFKNNLFVTYGSYSFLAAG 180 
QCVEVHNFDILLNVSSLEICHALLPVIIPDDGDVRNFRNSSYVKFKDTQFNSIPELCSIN 240 
FMKICNFMHQDFLLACGDNGIVYIWEINKVIKIFNKFTSDILGGKDNSRERYINVDPYMV 300 
LRVEESCWSVDVIDINGIIYIAVGHNKPGVTVFAFDKDVKKERRYIRPLDLPSSHNVPCV 360 
NFVPNSKDSVGYITLSYCSIFGNVVTVKLKEHDCTILTSFLDTQFFGDDLWTITPLTKKD 420 
FAKVDNFELLNLNYQDGFKESMLYSICRDDFLLGYYCDNAYLSGNFGIGTLLNQFQVPVT 480 
DLRLTSSAGIPDEVIPLRFTSFDRNYTTTGSIKYEYSREDFALILHAGDLDDMNDAVTKN 540 
TSCEQHLHQWTFWEDSGYKHYRATERGFSKYKDIINTFPQLITPSGRNKTSQYQNTSGRK 600 
ICEPSTYKLTDLENDIEDISREFNRSIRNLKMDKQRQLRTSKEFKSLSSVNHIPNIESGN 660 
FLWYNTDAAADWRTLFGKDLNTVLKDPEICSLQLNSTEEDDVNSDPENEESGSSLTSFQR 720 
RYRDTEQRAHLKSESQKSWGFHNYVRNVKRLLESAVPGSEDSPLGYQLSEMHDEFFFLTT 780 
AHRLVLMKANPLIIISATHHEIFPLDGVVTCASKSLLQALNRINFVCHIKELNCIAVASQ 840 
LGLISLLRLTEYRGIYSFRQEYILGWEVQDPVNPSPECRCNRNLFDAPMYGADGESSDTY 900 
CGVCDVYFPMGDICGLDYTYASDSEELKRKGYATLYVASRGSLRAFKITTEHGTTQQ    957 
 
 
Figure 5-1.   The deduced S. cerevisiae Crt10/YOL063c amino acid sequence.  The 
putative leucine repeat (underlined), transmembrane domain (bold) and WD repeat (bold 
and italicized) are indicated. 
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Figure 5-2.   Genetic interaction of CRT10 with CRT1 (A), SML1 (B) and MEC1 (C).  
(A,B) Epistasis analysis.  Tenfold serial dilutions of log-phase cultures were spotted on 
YPD plates and on YPD plates containing HU as described.  Plates were incubated for 3 
days at 30oC before photographing.  Strains used: (A) BY4741 (WT), WX1152 (crt10∆), 
WX1153 (crt1∆), and WXY1154 (crt1∆ crt10∆).  (B) HK578-10A (WT), U952-3B 
(sml1∆), WXY1157 (crt10∆), and WXY1159 (sml1∆ crt10∆).  (C) The nonviability of 
mec1∆ is partially rescued by deletion of CRT10.  Tetrads resulting from a cross of 
WXY1158 (MEC1 SML1 crt10∆) and U953-61A (mec1∆ sml1∆ CRT10) were dissected 
and the growth of each spore was followed by microscopic analysis.  The representative 
picture was taken after a 4-day incubation at 30oC. 
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arrest or the endogenous nucleotide pool balance. 
To distinguish the above two possibilities, we took advantage of a cell cycle 
checkpoint mutant, mec1.  It is known that the mec1 null mutant is nonviable; however, 
its nonviability is due to the decreased expression of RNR genes rather than the loss of 
checkpoint functions.  Hence, its viability can be rescued by deletion of either the Rnr 
inhibitor gene SML1 (Zhao et al., 1998) or the RNR repressor CRT1 (Huang et al., 1998), 
or by overexpression of RNR1 (Desany et al., 1998).  We reasoned that if Crt10 acts upon 
Rnr expression/activity, deletion of CRT10 may be able to rescue the mec1∆ nonviability, 
whereas if it acts upon a stalled replication fork, the CRT10 deletion should not be able to 
rescue mec1∆.  The mec1∆ sml1∆ double mutant was crossed to crt10∆ in an isogenic 
background.  Haploid spores recovered from 40 tetrads were genotyped by replica plating 
on appropriate media.  No viable crt10 mec1 double mutant colonies were obtained.  
However, under the microscope, it was found that the mec1∆ mutant cells did not extend 
beyond two cell divisions, whereas the crt10∆ mec1∆ double mutant cells formed 
microcolonies containing up to several hundred cells (Figure 5-2C).  This is in contrast to 
the sml1 mec1 double mutant from the same experiment, which formed visible colonies 
(data not shown).  Hence, deletion of CRT10 appears to rescue mec1∆ cells from 
immediate death. 
 
5.3.3. CRT10 belongs to the CRT1 regulatory pathway 
Since deletion of CRT10 results in HU resistance and partially rescues the mec1∆ 
mutant, it is most likely involved in the regulation of Rnr activity.  CRT1 and SML1 are 
two genes regulating Rnr by different mechanisms, the former at the transcriptional level 
(Huang et al., 1998) and the latter at the protein activity level (Zhao et al., 1998).  Indeed, 
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we isolated both crt1 and sml1 during the initial mutant library screen.  In order to ask if 
CRT10 belongs to one of the two regulatory pathways, epistasis analysis was performed 
by creating crt10∆ crt1∆ and crt10∆ sml1∆ double mutants and comparing them to the 
corresponding single mutants with respect to HU resistance.  The crt10∆ crt1∆ double 
mutant showed the same level of resistance to HU as the crt1∆ single mutant (Figure 5-
2A), indicating that CRT10 belongs to the same pathway as CRT1.  In contrast, the 
phenotypic effect of crt10∆ appears to be additive with sml1∆ (Figure 5-2B), suggesting 
that CRT10 does not belong to the same regulatory pathway as SML1. 
  
5.3.4. The transcript level of RNR is elevated in crt10∆ mutants 
Crt1 is an X-box DNA binding protein and represses the transcription of RNR2, 
RNR3 and RNR4 through recruitment of the corepressor complex Tup1-Ssn6; deletion of 
CRT1 elevated the basal level expression of RNR3 25-fold (Huang et al., 1998).  The 
above epistatic analysis predicts that deletion of CRT10 may result in an elevated RNR 
gene expression as well.  The β-gal activities of RNR3-lacZ and RNR2-lacZ 
transformants were measured in the wild type and isogenic crt10∆ mutants with or 
without MMS or HU treatment.  Indeed, the RNR3-lacZ and RNR2-lacZ levels were 
elevated about twofold in crt10∆ mutants compared to wild type cells after treatment 
with DNA damaging agents (Figure 5-3).  This result is consistent with a real-time PCR 
assay of the endogenous RNR3 transcript (Table 5-1), suggesting that Crt10 functions as a 
transcriptional repressor to regulate RNR2 and RNR3 in budding yeast. 
In order to further demonstrate that CRT10 and CRT1 belong to the same 
regulatory pathway, we measured the expression of RNR3-lacZ in wild type, crt1∆, 
crt10∆ single and the crt1∆ crt10∆ double  mutants by β-gal assays.    As shown in Table  
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Figure 5-3.  RNR gene expression in wild type and crt10∆ cells.  RNR3-lacZ (A, B) 
and RNR2-lacZ (C, D) expression was monitored after MMS (A, C) and HU (B, D) 
treatments.  β-gal activity was determined as described in Materials and Methods.  (?) 
BY4741 (wild type) and (?) WXY1152 (crt10∆) were transformed with either pZZ2 
(pRNR3-lacZ) or pZZ18 (pRNR2-lacZ) and several independent transformants were 
picked for analysis.  The results are the average of at least three independent experiments 
with standard deviations.  β-gal activity is given in Miller units. 
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Table 5-1.  Relative steady-state transcript level 
 
 Relative transcript levela 
Strain                 HK578-10D (WT)                            WXY1158 (crt10∆) 
Treatment -HU +0.2 M HU -HU +0.2 M HU 
RNR3            1           9.14           2.71      26.74 
MAG1            1           2.32           1.27        2.19 
TUP1            1           1.20           0.94        1.09 
SSN6            1           0.99           1.02        0.99 
CRT1            1           2.06           0.38        0.50 
 
a Transcript levels were measured by real-time PCR with total mRNA from cells with or 
without treatment with 0.2 M HU for 1 h, and normalized to the ACT1 transcript control.  
Untreated wild-type cells were used as a reference.  Experimental variations due to 
PCR reaction are negligible. 
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5-2, the basal level of RNR3-lacZ was moderately elevated in the crt10∆ mutant and 
dramatically elevated in the crt1∆ mutant.  Nevertheless, deletion of CRT10 does not 
further enhance RNR3-lacZ expression in the crt1∆ mutant.  The same effect holds true 
after MMS treatment.  These results are consistent with the hypothesis that CRT10 and 
CRT1 function in the same pathway to regulate the transcription of RNR genes. 
 
5.3.5. CRT10 functions downstream of DUN1 
The observation that crt1 is epistatic to crt10 with respect to both HU resistance 
and RNR gene activity suggests that Crt1 most likely acts downstream of Crt10.  The 
activity of Crt1 is regulated by its phosphorylation state, and the phosphorylation of Crt1 
requires the protein kinase Dun1, although whether Dun1 directly phosphorylates Crt1 
remains to be determined (Huang et al., 1998).  In order to determine the genetic 
interaction between CRT10 and DUN1, a crt10∆ dun1∆ double mutant was created and 
compared to its corresponding single mutants with respect to HU sensitivity.  As seen in 
Figure 5-4A, whereas deletion of DUN1 enhances HU sensitivity and deletion of CRT10 
results in HU resistance, cells carrying both deletions display a phenotype 
indistinguishable from that of dun1∆ mutant.  Similarly, dun1 is epistatic to crt10 with 
respect to RNR3 expression, as deletion of CRT10 did not alter the reduced RNR3 
induction in the dun1 mutant (Figure 5-4B).      These  observations  indicate  that the HU 
resistance and increased RNR expression caused by CRT10 deletion require functional 
Dun1. 
Crt10 may act either upstream or downstream of Dun1.  Dun1 is a multi-
functional protein involved in gene regulation (Zhao and Rothstein, 2002) as well as cell 
cycle checkpoints (Gardner et al., 1999; Maiti et al., 2005).  Deletion of DUN1 not only 
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Table 5-2.  β-gal activities of RNR3-lacZ in crt1∆ and crt10∆ mutants 
 
Straina       β-Galactosidase Activity (Miller units)b 
    -MMS +0.02% MMS 
BY4741   1.6 ± 0.12   48.9 ± 1.75 
WXY1153 (crt1∆) 72.5 ± 2.72 101.3 ± 3.51 
WXY1152 (crt10∆)   4.2 ± 0.32   85.5 ± 1.60 
WXY1154 (crt1∆ crt10∆) 73.8 ± 3.51 100.8 ± 2.74 
 
a All strains were transformed with pZZ2 (RNR3-lacZ). 
b β-gal activity was measured as described in Materials and Methods.  Data represent the 
averages of at least three independent experiments with standard deviations. 
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Figure 5-4.   DUN1 is epistatic to CRT10.  (A) Deletion of DUN1 abolishes the HU 
resistance caused by the crt10 mutation.  Ten-fold serial dilutions were spotted on YPD 
plates and on YPD plates containing 0.1 M HU.  Plates were incubated for 3 days at 30oC 
before photographing.  Strains used: BY4741 (WT), WXY1152 (crt10∆), WXY1155 
(dun1∆), WX1156 (crt10∆ dun1∆).  (B) The CRT10 effect on RNR3 expression is 
dependent on DUN1.  RNR3-lacZ expression was monitored with or without MMS 
treatment and expressed in Miller Units.  The results are the average of at least three 
independent experiments with standard deviations. 
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affects RNR gene induction, but also other DNA damage-inducible gene expression (Zhu 
and Xiao, 2001).  We reasoned that if Crt10 acts upstream of Dun1, its inactivation would 
alter all Dun1-mediated activities.  If, as previously observed, Crt10 only affects a subset 
(i.e., RNR) of Dun1-mediated gene expression, inactivation of Crt10 should not affect 
other gene expression.  For example, MAG1 induction by DNA damage requires Dun1 
(Zhu and Xiao, 2001); we found that its expression and induction was not altered by 
deletion of CRT10 (Table 5-1), suggesting that indeed Crt10 acts downstream of Dun1 
and is specific for RNR gene expression. 
 
5.3.6. CRT10 is required for CRT1 expression and induction 
The above genetic analyses fit into a model that Crt10 functions as a positive 
regulator of Crt1 and/or its co-repressors Tup1-Ssn6.  We thus measured the transcript 
levels of CRT1, TUP1 and SSN6 with or without HU treatment.  As shown in Table 5-1, 
deletion of CRT10 does not affect TUP1 or SSN6 mRNA regardless of HU treatment, but 
significantly reduced the basal level as well as HU-induced expression of CRT1.  Hence, 
Crt10 appears to serve as a positive regulator of Crt1 at the transcriptional level. 
 
5.3.7. Expression of CRT10 is elevated in response to DNA damage and HU 
 Many genes involved in DNA metabolism (replication, repair and recombination) 
are induced after treatment with DNA damaging agents or replication blocking agents.  In 
addition, regulatory genes such as CRT1 itself are up-regulated in response to DNA 
damage or HU treatment in a DUN1-dependent manner (Huang et al., 1998), indicative of 
an auto-regulatory circuit.  We measured the CRT10 transcript level in the presence or 
absence of DNA damaging agents and found that the CRT10 transcript level is increased 
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after treatment with MMS, HU and γ-rays (Figure 5-5A).  Interestingly, there appear to 
be two transcripts with slightly different sizes; the treatments induce expression of both 
transcripts, but the higher molecular weight transcript is induced more dramatically than 
the lower molecular weight transcript.  In order to address whether the transcriptional 
regulation of CRT10 is dependent on other regulators in this pathway such as Crt1 and 
Dun1, we compared the CRT10 transcript levels in the wild type and mutant backgrounds.  
The induction of CRT10 requires DUN1, as the dun1 mutation completely abolished 
CRT10 induction, whereas deletion of CRT1 has no effect on CRT10 expression (Figure 
5-5B). 
 
 
 145
                
MMS         - +     - +     - +
WT      crt1∆ dun1∆
CRT10
ACT1
CRT10
ACT1
A
B
- MMS    HU    γ-ray
 
Figure 5-5.  CRT10 is a DNA damage-inducible gene. (A) CRT10 expression in 
response to DNA damage and HU treatment.   Log-phase wild type HK578-10A cells 
were either untreated (lane 1) or treated with 0.3% MMS for 2 h (lane 2), 0.2 M HU for 2 
h (lane 3), or exposed to 40 krad of γ radiation (lane 4).  (B) CRT10 induction is DUN1-
dependent.  Log-phase wild type BY4741 and its derivatives WXY1153 (crt1∆) and 
WXY1155 (dun1∆) were either untreated (-) or treated with 0.1% MMS for 2 h (+).  
Northern hybridization was performed as described in Materials and Methods.  The 
membranes were hybridized with CRT10 (upper panel), stripped and then hybridized with 
ACT1 (lower panel) as an internal control.  Each lane contains 15 µg of total RNA. 
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5.4. Discussion  
We report here the isolation and initial characterization of CRT10 as a novel yeast 
gene involved in the transcriptional regulation of RNR genes.  Rnr catalyzes a rate-
limiting step in the production of dNTPs, whose levels are critical to many cellular 
functions (Zhou and Elledge, 1992).  Imbalanced or insufficient dNTP pools lead to 
enhanced misincorporation, high mutation frequencies and impaired DNA repair (Chabes 
et al., 2003).  Due to its vital importance to cellular physiology, it is not surprising that 
Rnr is tightly regulated via multiple mechanisms and at different stages.  Our results 
suggest that Crt10 is a newly discovered negative regulator of RNR genes and acts at the 
transcriptional level.  First, deletion of CRT10 results in enhanced cellular resistance to 
HU, an Rnr inhibitor.  Second, deletion of CRT10 enhances the survival of the mec1 null 
mutant, reminiscent of other suppressors that rescue the nonviability of  mec1 and rad53, 
all of which lead to increased Rnr activities (Chabes et al., 1999; Desany et al., 1998; 
Huang et al., 1998; Zhao et al., 1998).  Third, deletion of CRT10 in wild type cells results 
in an increased expression of RNR genes coding for both large and small Rnr subunits, in 
the presence and absence of DNA damage, which provides the underlying mechanism of 
HU resistance.  Results obtained from epistasis analyses suggest that Crt10 functions 
downstream of Dun1 and probably upstream of or together with Crt1 (Figure 5-6).  
Nevertheless, both dun1 and crt1 are epistatic to crt10, suggesting that Crt10 is probably 
a regulatory component in the Dun1-Crt1 signal transduction pathway leading to the 
control of RNR gene expression.  Finally, our observation that deletion of CRT10 reduces 
CRT1 expression and abolishes the DNA damage induction of CRT1 provides direct 
evidence that CRT10 functions through positive regulation of CRT1 expression. 
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Figure 5-6.   A proposed model for CRT10 in Rnr regulation.  Note that the CRT10 
functions and regulation are based on its genetic data instead of protein activity.  Note 
that Rnr catalyzes the rate-limiting step in dNTP production. 
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The physiological significance of RNR suppression by CRT10 is presently unclear. 
However, one interesting observation through this study is that CRT10 itself is induced 
after DNA damage and HU treatment, suggesting that Crt10 plays a critical role in 
responding to replication blocks.  Several pieces of evidence indicate that Crt10 achieves 
this objective through delicate regulation of the endogenous dNTP pool, as illustrated in 
Figure 5-6.  Firstly, Crt10 acts as a negative regulator to maintain a balanced dNTP pool.  
In the presence of replication blocks (DNA damage) or with an exhausted dNTP pool 
(HU treatment to inhibit Rnr activity), all four RNR genes are upregulated and Sml1 
activity is inhibited, leading to enhanced dNTP production.  The increased Crt10 activity 
may be required to bring Rnr activity back to a normal level once order is restored.  In 
this respect, it is of great interest to notice that the optimal dose required to induce CRT10 
is higher than that required to induce RNR genes (Jia et al., 2002), which is consistent 
with the notion that CRT10 induction may lag behind that of RNR genes.  Secondly, like 
CRT1 (Huang et al., 1998), the induction of CRT10 itself depends on DUN1, suggesting 
that Crt10 functions downstream of Dun1 and forms another component of the 
autoregulatory circuit.  However, the effect of CRT10 deletion on RNR gene expression is 
much less than that of CRT1 deletion and, unlike CRT1, the CRT10 promoter does not 
contain the X-box sequence recognized by Crt1 (Huang et al., 1998).  This is not 
unprecedented since DNA damage induction of several other genes also requires DUN1 
in the absence of the X-box sequence (Zhu and Xiao, 2001).  Finally, in addition to its 
roles in modulating and maintaining an optimal dNTP pool under stress conditions, 
CRT10 appears to be required for optimal growth in the absence of exogenous DNA 
damage/replication blocks, since a recent genetic footprinting study (Dunn et al., 2004) 
showed that deletion of CRT10 causes an apparently severe growth defect in rich medium 
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after 20 generations, in minimal medium, as well as medium containing NaCl.  These 
observations imply that vigorous modulation of the endogenous dNTP pool by CRT10 is 
critical to achieve optimal cell growth, possibly by maintaining proper DNA synthesis 
and cell division.  Alternatively, CRT10 may play roles in optimizing cell growth by a 
mechanism other than affecting Rnr activity. 
Despite the strong genetic evidence that Crt10 is involved in the transcriptional 
regulation of RNR genes and CRT1, its biochemical activity remains obscure.  The 
leucine repeats and a single WD motif suggest that Crt10 may interact with other 
protein(s), although to date no such proteins have been identified through systematic 
studies.  It does not contain a domain/motif indicative of its catalytic function. However, 
the protein is apparently conserved and widespread within unicellular lower eukaryotes.  
Future investigations will attempt to uncover biological and biochemical functions of 
Crt10. 
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CHAPTER SIX 
 
SUMMARY 
 
In summary, this study elucidates the DNA damage induced transcription 
regulation network in budding yeast from both the general DNA damage sensor and the 
detailed regulatory mechanisms of specific genes.   
In general, a straightforward DNA damage induction pathway model comprises 
damage sensor, signal transducer and downstream effector.  It has been hypothesized that 
DNA repair proteins recognize DNA lesions in the early stage of DNA repair so that they 
may also regulate the transcription in response to DNA damage by sensing lesions or 
replication blocks.  By analyzing the expression of two co-ordinately regulated damage 
inducible genes MAG1 and DDI1 in different DNA repair defective mutants, it was found 
that among major DNA repair pathways, only mutations in RAD6 and RAD18 of the PRR 
pathway affected the damage induction of MAG1 and DDI1.  Furthermore, the 
microarray analysis showed that rad6 and rad18 mutations appear to variably affect the 
expression of 379 DNA damage inducible genes.  Rad6 and Rad18 form a heterodimer in 
vivo, and Rad18 possesses the ability to bind single-stranded DNA and displays single-
stranded DNA dependent ATPase activity.  All these make the Rad6-Rad18 complex a 
strong candidate to activate DNA damage induction by sensing damage signals.  
In budding yeast, the protein kinase Rad53 is one of the transducers in the DNA 
damage induction pathway, which has prominent effect on DNA damage induced 
transcription of many genes.  Rad53 can be activated by phosphorylation in response to 
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DNA damage, and the phosphorylation of Rad53 is regulated by two parallel pathways 
represented by RAD24 and SGS1.  This study showed that Rad53 phosphorylation in 
response to MMS treatment is dramatically reduced in the rad18Δ sgs1Δ double mutant 
but not in the rad18Δ rad24Δ double mutants.  It suggests that the Rad6-Rad18 complex 
functions in the Rad24 checkpoint pathway parallel to the Sgs1 pathway to induce Rad53 
phosphorylation.  This conclusion is also supported by the results obtained from gene 
expression assays for two DNA damage inducible genes MAG1 and RNR3: the effect of 
rad18 and rad24 mutations on the induction of both MAG1 and RNR3 is epistatic, 
whereas that of rad18 or rad24 is additive to the sgs1 mutation.  
Moreover, the mechanism by which the Rad6-Rad18 complex transfers the DNA 
damage signal downstream has been investigated.  Rad6-Rad18 is a ubiquitination 
complex, and its only activity reported to date is to mono-ubiquitinate the POL30 product 
PCNA at the Lys164 residue and initiate the PRR pathway.  Therefore, it has been 
examined whether Rad6-Rad18 also initiates DNA damage induction through 
ubiquitinating PCNA.  However, my study reveals that neither the ubiquitination nor the 
sumoylation of PCNA is involved in DNA damage induction.  In budding yeast, the 9-1-1 
complex is a PCNA-like clamp involved in DNA damage responses.  Combined with the 
fact that Rad24 functions as a clamp loader for the 9-1-1 complex in DNA damage 
responses, it is likely that Rad6-Rad18 initiates DNA damage induction through 
ubiquitinating a subunit of the 9-1-1 complex.  In a yeast two-hybrid analysis, only the 
subunit Rad17 in the 9-1-1 complex showed a physical interaction with Rad18.  Further 
studies revealed that Rad17 can be ubiquitinated and the ubiquitination is both Rad6-
Rad18 and DNA-damage dependent.  The results from β-gal assays suggest that the 
putative ubiquitination site lysine 197 in Rad17 is required to mediate the DNA damage 
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induction by Rad6-Rad18.  It is conceivable that the Rad6-Rad18 complex passes down 
the DNA damage signal to the transducer Rad53 through ubiquitination of the Rad17 
subunit of the  in 9-1-1 complex.   
Among all components in the DNA damage induction pathway, the downstream 
effectors are mostly uncharacterized.  Unlike the upstream components, such as sensors 
and transducers, which regulate the expression of many genes, each downstream effector 
seems to only control a particular set of inducible genes in the DNA damage response.   
These downstream effectors interact with unique cis-acting elements to accomplish the 
optimized regulation by either derepression or direct activation.    In this study, we also 
investigated some cis-acting elements and trans-acting factors for specific DNA damage 
inducible genes. 
During the microarray assay, we found that the transcription of two genes 
YFL061w and YNL335w were induced up to 100-fold by MMS treatment.  These two 
genes are identical genes with similar promoter region.  We designated them DDI2 and 
DDI3 respectively.  Northern hybridization and β-gal assay further confirm that MMS 
treatment can highly induce the transcription of DDI2/DDI3.  Interestingly, only the SN2 
alkylating agents, such as MMS and DMS, highly induced the transcription of 
DDI2/DDI3.  Other DNA damaging agents like SN1 alkylating agents, HU and γ-ray 
hardly induced the transcription.  In order to elucidate the mechanisms of induction, the 
cis-acting elements in the promoter region have been mapped.  Deletion of the region 
extending from -358 to -229 in the DDI2 promoter area decreased both basal-level 
expression and the induction by MMS, suggesting that a UAS is located in this region.  
This UAS also functioned in the context of a heterologous promoter to result in MMS 
induced expression of the CYC1-lacZ reporter gene.  Meanwhile, a URS was identified in 
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the region between -709 and -543.  According to our data, it is likely that UAS and URS 
regulate the MMS induced transcription of DDI2 cooperatively.  
In budding yeast, RNR genes are well-documented DNA damage inducible genes.  
The DNA damage induction of this gene family is regulated by the trans-acting effectors 
binding to their promoter region, such as repressor Crt1.  In this study, I cloned a novel 
gene CRT10, which encodes a negative regulator of the ribonucleotide reductase activity.  
Deletion of CRT10 increased basal level and DNA damage-induced expression of RNR 
gene, and the Crt10 function appears to be achieved by positive regulation of the CRT1 
transcript level.  Furthermore, dun1 is epistatic to crt10 with respect to both HU 
sensitivity and RNR gene regulation. Interestingly, the expression of CRT10 itself is 
induced by DNA damaging agents and this induction requires DUN1.  Taken together, it 
seems that CRT10 is a component of the regulatory circuit controlling the Rnr activity.  
Overall, this thesis elucidates that transcription regulation of a number of yeast 
DNA damage-inducible genes occurs through a signal transduction pathway mediated by 
the Rad6-Rad18 complex, and this complex might function as a DNA damage sensor in 
the signal transduction pathway.  In addition, this study investigated the transcriptional 
regulation of specific damage-inducible genes and identified novel cis-acting elements 
and trans-acting factors contributing to the DNA damage induction cascade.       
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CHAPTER SEVEN 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
6.1. CONCLUSIONS 
• The Rad6-Rad18 complex is involved in the transcriptional regulation in response 
to DNA damage.   
• It appears that the DNA damage signal recognized by Rad6-Rad18 is relayed to 
the cascade of cell cycle checkpoints. 
• The Rad17 subunit of the 9-1-1 complex is subject to Rad6/Rad18- and DNA 
damage-dependent mono-ubiquitination.    
• The Rad6-Rad18 complex is likely to mediate a eukaryotic SOS response by 
coordinating translesion synthesis, error-free bypass, homologous recombination, 
cell cycle checkpoints as well as transcriptional regulation.  
• DDI2 and DDI3 are two identical genes whose transcription can be highly 
induced by MMS treatment.  
• The high level induction of DDI2/DDI3 is specific for the treatment by SN2 
alkylating agents.  
•  The promoter region UASDDI2 (-358 to –229) is responsible for the high level 
induction of DDI2/DDI3. 
• CRT10 encodes a negative regulator of ribonucleotide reductase activity, and 
deletion of CRT10 increases basal level and DNA damage-induced expression of 
RNR genes. 
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• The Crt10 function appears to be achieved by positive regulation of the CRT1 
transcript level.    
• It seems that CRT10 is a component of the regulatory circuit controlling Rnr 
activity.  
 
6.2. FUTURE DIRECTIONS 
A number of future considerations were brought up in each study of this thesis. 
The future directions of immediate interest are discussed below:  
• To obtain direct evidence to show that the Lys197 residue in Rad17 is the 
ubiquitination site for the Rad6-Rad18 complex   
In previous studies, we hypothesized that Lys197 in Rad17 is the putative 
ubiquitination site according to the strong conservation of flanking sequence 
between Rad17-Lys197 and Pol30-Lys164.  We further demonstrated that the 
effects of the rad17-K197R mutation on MAG1 and RNR3 induction are 
indistinguishable from that of rad17∆ cells.  However, direct evidence is still 
missing.  Further experimental approaches include the creation of a chromosomally 
Myc-tagged rad17-K197R strain and monitoring its ubiquitination by western blot 
analysis and Co-IP.  Moreover, the effect of this point mutation along with the 
rad17 null mutation on Rad53 phosphorylation will also be examined.  These tests 
will provide direct evidence that Lys197 is the ubiquitination site for the Rad6-
Rad18 complex.  
• To investigate the role of RAD18/RAD6 in DNA damage checkpoint   
Data presented in Chapter Three imply that Rad18/Rad6 could function in 
the DNA damage checkpoint. As mentioned in the Discussion section of Chapter 
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Three, the previous checkpoint studies normally used UV and ionizing radiation as 
the main damage sources of DNA damage, but RAD6 and RAD18 have not been 
implicated in the damage checkpoint pathway in these studies.  In future studies, we 
will use MMS or HU to induce DNA damage and cause replication stress, which are 
likely to trigger the intra-S phase checkpoint.  Cells of a wild type and its isogenic 
deletion mutant will be synchronized in early G1 by α-factor and immediately 
released in media containing appropriate concentrations of MMS or HU.  Cell cycle 
progression can be monitored as a function of time by flow-cytometric analysis of 
DNA content.  Since the dual functions of Rad6-Rad18 in PRR and damage 
checkpoint may undermine detection of its checkpoint function, we will compare the 
cell cycle progression between pol30-K164R mutants and pol30-K164R rad18∆ 
double mutants.  If RAD18 is involved in the DNA damage checkpoint, compared 
with the single mutant, the double mutant should show faster cell cycle progression 
after treatment.  These studies could help us to assess whether RAD6/RAD18 
function in the DNA damage checkpoint pathway.  
• To identify the trans-acting regulatory factors of DDI2/DDI3   
Results presented in Chapter Four show that the transcription of DDI2/DDI3 
can be highly induced by MMS treatment.  The promoter region of DDI2/DDI3 has 
been analyzed and several cis-acting elements were identified.  However, the trans-
acting regulatory factors functioning in the DDI2/DDI3 promoter region remain 
unclear.  A new technique called synthetic genetic array (SGA) provides us with a 
powerful tool to identify these regulatory factors at the total genome level.  A query 
strain which contains a chromosomally integrated DDI2-lacZ will be constructed.  
Since the expression level of DDI2/DDI3 is very low without treatment and increases 
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dramatically after MMS treatment, the query strain should show no color on X-gal 
plates and show blue color on X-gal + MMS plates.  The query strain will be crossed 
to an array of approximately 5000 viable yeast single deletion mutants. Through a 
series of replica-pinning procedures, the strain containing both single deletion and 
DDI2-lacZ will be selected and scored for blue colour display on X-gal + MMS plates.  
Applying SGA analysis may enable us to identify all positive or negative trans-acting 
regulatory factors in the yeast genome.  It will shed light on the understanding of 
molecular mechanism by which DDI2/DDI3 is regulated in response to MMS 
treatment.  A similar strategy can also be applied to study other DNA damage-
inducible genes such as RNR3 and MAG1. 
• To investigate how Crt10 contributes to the transcriptional regulation of Crt1.   
In Chapter Five, we demonstrated that Crt10 is a positive regulator for the 
transcription of CRT1.  So far, its biochemical activity remains obscure.  Future 
studies are proposed to first determine whether Crt10 physically interacts with the 
CRT1 promoter region with a super-shift assay and chromatin immunoprecipitation.  
As mentioned in the Discussion section of Chapter Five, the existence of leucine 
repeats and a single WD motif in Crt10 suggest that it may interact with other 
protein(s).  A yeast two-hybrid screen can be carried out to identify the protein(s) 
interacting with Crt10.  Recently,  Crt10 has been suggested to physically interact 
with Cdc34 (Krogan et al., 2006) and Rtt101 (Collins et al., 2007) in global Affinity 
Capture-MS experiments.  Both proteins are components of the ubiquitin conjugating 
complexes involved in cell cycle regulation.  Thus, it remains possible that Crt10 is 
modified by ubiquitination in response to cell cycle stress.  Since the transcription of 
RNR genes is cell cycle regulated, it would be interesting to verify whether Crt10 can 
 158
be modified by these ubiquitin conjugating complexes and to determine its functional 
alteration after the modification. 
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APPENDIX A 
 
Microarray Raw Data 
Saccharomyces cerevisiae genes whose DNA damage induction is affected by both 
rad6∆ and rad18∆. 
 
ID        Gene  Wt  rad18  rad6   
YAL043C  PTA1  2.117  0.837  0.923   
YAR009C    2.538  0.957  0.842   
YBR005W  RCR1  2.049  0.664  0.796   
YBR008C  FLR1  7.919  4.452  2.999   
YBR053C    2.176  0.805  1.121   
YBR056W  ECM2  2.311  1.266  1.07   
YBR068C  BAP2  2.808  0.809  1.161   
YBR072W  HSP26  5.149  1.999  1.355   
YBR126C  TPS1  2.064  0.725  1.255   
YBR149W  ARA1  2.364  0.968  1.123   
YBR169C  SSE2  3.246  1.467  1.598   
YBR170C  NPL4  2.06  1.066  1.274   
YBR256C  RIB5  5.531  1.998  2.291   
YCL026C    2.047  1.193  1.262   
YCL030C  HIS4  3.7  0.337  0.441   
YCL032W  STE50  2.12  0.867  0.951   
YCL034W  LSB5  3.188  0.876  1.382   
YCL038C  AUT4  2.49  0.886  0.876   
YCL039W  GID7  3.435  1.318  1.688   
YCL040W  GLK1  2.792  0.85  0.797   
YCL049C    2.037  0.5  1.052   
YCLX04W    3.697  1.088  1.704   
YCLX07W    4.178  1.183  0.797   
YCLX08C  FRM2  6.434  1.122  1.906   
YCR011C  ADP1  2.258  0.789  1.127   
YCR030C  SYP1  2.162  0.711  0.965   
YCR036W  RBK1  2.22  1.257  0.973   
YCR107W  AAD3  7.005  2.536  1.562   
YCRX21C    2.612  1.217  1.122   
YDL019C  OSH2  2.318  0.627  1.079   
YDL021W  GPM2  3.424  0.751  1.164   
YDL025C    5.12  1.769  1.279   
YDL048C  STP4  4.04  0.649  0.689   
YDL066W  IDP1  2.522  0.79  0.698   
YDL070W  BDF2  3.149  1.232  0.954   
YDL122W  UBP1  2.119  0.969  0.628   
YDL123W  SNA4  3.188  1.243  1.162   
YDL126C  CDC48  2.914  1.169  1.003   
YDL132W  CDC53  3.36  1.6  0.944   
YDL196W  GYP7  2.618  0.093  0.425   
YDL234C  GYP7  3.66  1.472  1.136   
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YDR003W  RCR2  4.189  1.858  1.325   
YDR035W  ARO3  3.322  1.007  0.845   
YDR036C  EHD3  2.076  0.793  0.851   
YDR074W  TPS2  2.533  0.568  0.578   
YDR085C  AFR1  2.87  0.805  0.817   
YDR117C  TMA64  2.236  0.961  1.463   
YDR124W    4.334  1.103  1.147   
YDR137W  RGP1  2.408  1.397  1.22   
YDR168W  CDC37  2.283  1.347  1.343   
YDR171W  HSP42  25.116 5.488  4.674   
YDR175C  RSM24  2.841  0.931  1.168   
YDR202C  RAV2  2.167  0.822  1.108   
YDR204W  COQ4  2.386  0.62  1.137   
YDR254W  CHL4  2.447  1.747  1.621   
YDR257C  RMS1  3.536  1.215  0.666   
YDR258C  HSP78  6.022  2.377  1.564   
YDR259C  YAP6  2.349  0.536  0.983   
YDR264C  AKR1  2.542  1.054  1.072   
YDR293C  SSD1  2.839  0.689  0.515   
YDR380W  ARO10  6.171  2.626  2.035   
YDR389W  SAC7  2.167  1.045  0.617   
YDR391C    2.567  1.056  1.341   
YDR394W  RPT3  3.987  2.581  2.222   
YDR443C  SSN2  25.446 2.154  5.611   
YDR516C    2.078  0.552  1.011   
YDR531W  EMI2  2.38  0.886  1.045   
YEL060C  PRB1  2.75  1.447  0.979   
YER035W  EDC2  2.125  0.863  0.911   
YER053C  PIC2  2.056  0.788  1.018   
YER054C  GIP2  2.173  1.084  0.899   
YER073W  ALD5  2.676  0.841  0.78   
YER087C-A       SBH1  2.736  0.692  1.268   
YER090W  TRP2  2.452  0.87  0.934   
YER103W  SSA4  5.975  1.132  0.711   
YER124C  DSE1  2.4  0.72  0.954   
YER142C  MAG1  2.176  1.372  1.299   
YER143W  DDI1  5.644  2.224  2.624   
YER150W  SPI1  4.999  1.687  1.718   
YER169W  RPH1  2.81  1.032  0.959   
YER175C  TMT1  13.247 0.656  1.39   
YER176W  ECM32  2.689  1.107  0.888   
YFL014W  HSP12  2.638  1.101  1.188   
YFL049W  SWP82  3.273  0.549  0.885   
YFL056C  AAD6  8.438  1.796  0.906   
YFL057C  AAD16  11.06  3.636  3.036   
YFL061W  DDI2  107.884 18.854 17.908   
YFR003C  YPL1  2.21  1.179  1.559   
YFR005C  SAD1  2.243  1.267  0.871   
YFR040W  SAP155 2.823  1.426  0.992   
YFR053C  HXK1  4.056  1.309  1.002   
YFR055W  IRC7  2.493  0.439  0.715   
YGL006W  PMC1  2.268  0.434  0.871   
YGL037C  PNC1  5.639  3.011  3.056   
YGL059W    2.197  1.308  1.308   
YGL117W    19.279 1.218  1.909   
YGL121C  GPG1  2.046  0.973  1.328   
YGL160W    2.025  1.012  1.284   
YGL180W  APG1  4.14  1.36  1.259   
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YGL181W  GTS1  3.417  2.429  1.91   
YGL184C  STR3  4.923  1.048  1.438   
YGL185C    2.006  0.636  1.041   
YGL218W    3.001  0.717  0.679   
YGL224C  SDT1  2.474  1.619  1.263   
YGL228W  SHE10  3.439  1.843  1.367   
YGL229C  SAP4  2.833  0.981  1.09   
YGL236C  MTO1  2.058  0.49  0.87   
YGL248W  PDE1  5.496  1.73  1.064   
YGL250W  RMR1  2.161  1.359  1.694   
YGL254W  FZF1  2.352  0.946  0.872   
YGR010W  NMA2  2.171  0.911  1.137   
YGR023W  MTL1  2.379  1.135  1.476   
YGR130C    5.051  1.575  1.424   
YGR138C  TPO2  4.094  1.056  0.823   
YGR142W  BTN2  47.226 6.946  7.3   
YGR154C  GTO1  2.033  0.728  1.029   
YGR186W  TFG1  2.438  1.231  0.724   
YGR189C  CRH1  2.393  0.821  1.152   
YGR194C  XKS1  2.222  0.418  0.67   
YGR196C  FYV8  2.285  1.228  1.089   
YGR211W  ZPR1  5.224  1.551  1.055   
YGR213C  RTA1  3.548  0.819  0.908   
YGR237C    4.086  1.639  2.116   
YGR248W  SOL4  2.124  1.027  1.217   
YGR250C    4.482  0.958  1.159   
YHL002W  HSE1  4.118  1.753  2.548   
YHL021C  FMP12  5.909  1.23  1.028   
YHL027W  RIM101 2.728  0.885  0.681   
YHR018C  ARG4  10.62  2.236  1.696   
YHR022C    3.52  0.478  0.828   
YHR027C  RPN1  3.374  1.155  1.335   
YHR028C  DAP2  2.497  1.042  1.318   
YHR030C  SLT2  6.42  0.534  0.786   
YHR071W  PCL5  3.469  1.039  1.109   
YHR082C  KSP1  2.227  0.651  0.935   
YHR087W    5.216  1.577  2.063   
YHR097C    2.558  1.267  1.276   
YHR104W  GRE3  2.078  1.223  1.36   
YHR107C  CDC12  4.193  0.654  1.178   
YHR137W  ARO9  3.369  1.882  1.616   
YHR195W  NVJ1  2.24  0.912  1.031   
YHR199C  FMP34  2.472  1.686  1.255   
YHR209W  CRG1  5.739  1.61  0.836   
YIL001W    2.678  1.194  1.444   
YIL002C  INP51  2.197  0.767  1.237   
YIL005W  EPS1  2.277  1.36  1.172   
YIL044C  AGE2  2.139  1.219  1.001   
YIL055C    3.107  1.577  1.232   
YIL056W  VHR1  3.316  1.732  1.241   
YIL066C  RNR3  3.264  0.908  1.248   
YIL082W    2.634  0.969  1.006   
YIL101C  XBP1  2.615  1.873  1.711   
YIL107C  PFK26  3.271  1.476  1.228   
YIL108W    2.333  0.606  1.097   
YIL113W  SDP1  2.778  0.464  1.055   
YIL116W  HIS5  6.353  1.239  0.888   
YIL117C  PRM5  5.592  1.669  0.872   
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YIL136W  OM45  3.304  1.36  1.058   
YIL137C  TMA108 2.147  1  1.025   
YIL151C    2.281  1.292  1.048   
YIL164C  NIT1  4.624  0.815  0.874   
YIL165C    5.88  1.655  2.143   
YIL168W  SDL1  2.231  0.979  1.206   
YIL170W  HXT12  2.401  0.893  1.101   
YIR002C  MPH1  2.073  1.06  1.005   
YIR003W    2.332  0.871  1.231   
YIR016W    2.376  1.372  1.686   
YIR039C  YPS6  3.979  0.887  1.173   
YIR044C    3.488  1.162  0.929   
YJL017W    2.406  0.729  0.9   
YJL023C  PET130 3.321  1.841  2.077   
YJL034W  KAR2  2.731  1.576  1.631   
YJL053W  PEP8  2.728  1.183  0.908   
YJL057C  IKS1  2.1  1.615  1.356   
YJL060W  BNA3  2.132  1.415  1.295   
YJL084C  ALY2  2.33  1.57  1.433   
YJL085W  EXO70  2.857  1.312  1.391   
YJL094C  KHA1  2.661  1.017  1.382   
YJL099W  CHS6  2.145  1.18  1.093   
YJL111W  CCT7  2.266  1.068  1.084   
YJL139C  YUR1  2.178  1.065  1.015   
YJL141C  YAK1  3.008  1.765  1.353   
YJL144W    20.719 2.639  2.019   
YJL155C  FBP26  4.661  1.968  1.36   
YJL159W  HSP150 2.616  0.928  0.522   
YJL160C    4.018  0.415  0.892   
YJL164C  TPK1  4.73  1.737  1.302   
YJL165C  HAL5  2.569  1.074  0.942   
YJL213W    4.65  0.628  1.244   
YJL219W  HXT9  2.212  0.686  1.231   
YJR025C  BNA1  2.597  0.925  0.951   
YJR035W  RAD26  2.284  0.867  1.188   
YJR045C  SSC1  3.196  0.622  0.934   
YJR046W  TAH11  4.197  1.708  1.168   
YJR052W  RAD7  2.862  1.189  0.933   
YJR059W  PTK2  2.947  0.651  1.082   
YJR062C  NTA1  2.938  0.851  0.897   
YJR096W    3.727  2.03  1.86   
YJR109C  CPA2  9.036  0.567  1.463   
YJR110W  YMR1  3.506  0.801  1.253   
YJR130C  STR2  10.032 1.895  1.427   
YJR152W  DAL5  2.109  0.928  0.731   
YKL010C  UFD4  2.31  0.87  1.345   
YKL015W  PUT3  2.597  0.972  1.308   
YKL022C  CDC16  2.728  1.601  1.603   
YKL023W    3.633  1.441  1.107   
YKL025C  PAN3  3.438  1.267  1.13   
YKL035W  UGP1  2.818  0.828  0.512   
YKL051W  SFK1  2.023  1.112  0.79   
YKL052C  ASK1  2.157  1.17  0.974   
YKL062W  MSN4  2.065  1.037  0.719   
YKL064W  MNR2  2.498  0.619  0.985   
YKL070W    6.789  1.876  2.294   
YKL071W    49.892 7.362  13.157   
YKL088W    2.106  0.591  0.983   
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YKL091C    2.369  1.456  1.307   
YKL103C  LAP4  8.236  2.793  1.763   
YKL104C  GFA1  3.027  0.542  0.814   
YKL105C    2.154  0.843  1.16   
YKL107W    2.565  1.335  1.003   
YKL133C    2.944  1.149  1.292   
YKL146W  AVT3  3.689  1.856  1.602   
YKL148C  SDH1  2.64  0.65  0.757   
YKL151C    3.455  1.663  1.036   
YKL163W  PIR3  4.461  1.066  0.465   
YKL170W  MRPL38 3.467  1.052  0.994   
YKL193C  SDS22  2.298  1.254  1.273   
YKL211C  TRP3  4.242  1.014  0.784   
YKL213C  DOA1  2.783  1.702  1.495   
YKL222C    2.065  0.869  0.804   
YKR002W  PAP1  3.533  1.902  1.572   
YKR003W  OSH6  2.129  1.19  1.361   
YKR008W  RSC4  3.49  1.697  0.981   
YKR011C  TOS5  7.187  3.973  2.578   
YKR015C    2.013  1.003  1.06   
YKR061W  KTR2  3.074  0.951  1.069   
YKR069W  MET1  2.808  0.513  0.571   
YKR104W    3.369  1.747  1.525   
YLL019C  KNS1  2.169  0.814  0.949   
YLL026W  HSP104 10.415 2.028  2.752   
YLL028W  TPO1  2.057  0.569  0.816   
YLL056C    3.321  2.619  2.26   
YLL060C  GTT2  10.206 4.547  2.416   
YLR001C    3.201  1.32  1.309   
YLR023C  IZH3  2.373  1.047  0.709   
YLR025W  SNF7  2.106  1.099  1.043   
YLR080W  EMP46  3.442  1.22  1.077   
YLR090W  XDJ1  2.929  1.006  0.98   
YLR120C  YPS1  3.186  0.734  0.823   
YLR128W  DCN1  2.364  0.521  1.072   
YLR161W    2.434  0.762  1.312   
YLR162W    2.705  0.587  1.234   
YLR164W    2.442  1.43  0.974   
YLR177W    2.933  1.245  1.252   
YLR178C  TFS1  4.963  2.471  2.107   
YLR195C  NMT1  2.658  0.953  0.703   
YLR225C    6.591  2.378  1.268   
YLR226W  BUR2  3.467  1.198  0.759   
YLR251W  SYM1  4.095  2.015  1.318   
YLR252W    3.979  2.101  1.598   
YLR327C  TMA10  11.178 3.356  2.24   
YLR330W  CHS5  2.594  1.216  1.134   
YLR347C  KAP95  2.264  0.407  0.749   
YLR375W  STP3  2.124  1.25  0.865   
YLR392C    2.401  1.541  1.401   
YLR411W  CTR3  2.474  0.586  0.662   
YML042W  CAT2  2.755  1.375  1.106   
YML088W  UFO1  2.406  1.149  1.477   
YML100W  TSL1  10.747 1.428  1.32   
YML117W  NAB6  4.647  0.712  1.09   
YML130C  ERO1  5.434  3.369  3.375   
YML131W    6.445  3.798  2.613   
YMR033W  ARP9  3.379  2.045  1.464   
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YMR044W  IOC4  2.094  1.404  1.399   
YMR092C  AIP1  2.663  1.009  1.232   
YMR094W  CTF13  2.977  0.995  1.591   
YMR096W  SNZ1  11.705 1.547  1.425   
YMR103C    2.941  0.923  0.622   
YMR105C  PGM2  3.76  1.037  1.398   
YMR106C  YKU80  2.388  1.288  1.072   
YMR153W  NUP53  2.393  1.23  1.457   
YMR155W    2.466  0.71  1.098   
YMR160W    2.187  0.663  1.166   
YMR165C  SMP2  2.565  1.199  1.192   
YMR169C  ALD3  2.541  1.255  1.428   
YMR172C-A         2.758  1.093  1.403   
YMR172W  HOT1  2.288  1.337  1.368   
YMR181C    3.714  1.091  0.711   
YMR250W  GAD1  2.285  1.764  1.6   
YMR315W    3.517  2.05  1.97   
YMR316W  DIA1  2.542  1.779  1.453   
YNL063W  MTQ1  3.223  1.886  1.7   
YNL077W  APJ1  11.679 2.015  1.937   
YNL092W    2.769  0.953  1.355   
YNL094W  APP1  3.921  1.357  0.756   
YNL096C  RPS7B  3.332  1.014  1.242   
YNL100W    2.184  1.026  1.326   
YNL104C  LEU4  2.689  0.829  1.003   
YNL115C    2.983  1.668  1.808   
YNL117W  MLS1  2.869  1.62  1.674   
YNL127W  FAR11  3.746  0.927  1.28   
YNL134C    11.291 5.736  6.825   
YNL152W    2.891  1.436  1.623   
YNL158W  PGA1  2.058  0.925  0.778   
YNL192W  CHS1  2.842  1.005  0.919   
YNL250W  RAD50  2.265  0.71  1.085   
YNL274C  GOR1  5.384  2.207  1.321   
YNL275W  BOR1  2.629  1.697  1.297   
YNL279W  PRM1  2.281  1.511  1.694   
YNL294C  RIM21  3.736  0.992  0.603   
YNL331C  AAD14  7.875  2.954  1.398   
YNL335W  DDI3  137.865 18.647 22.388   
YNR001C  CIT1  6.808  1.514  1.207   
YNR002C  FUN34  3.226  1.301  1.416   
YNR011C  PRP2  2.305  0.817  1.163   
YNR019W  ARE2  2.622  0.546  0.731   
YNR037C  RSM19  2.371  1.327  1.092   
YNR039C  ZRG17  2.015  1.31  1.146   
YNR044W  AGA1  2.595  1.462  1.221   
YNR060W  FRE4  17.136 5.196  2.991   
YNR063W    8.657  2.215  3.903   
YNR064C    3.66  1.406  2.155   
YNR065C    2.558  0.556  1.149   
YNR068C    16.132 1.469  3.346   
YOL017W  ESC8  3.095  2.101  1.876   
YOL028C  YAP7  3.002  1.082  1.331   
YOL036W    2.356  1.368  1.219   
YOL047C    3.967  1.301  1.242   
YOL058W  ARG1  36.656 2.202  2.421   
YOL059W  GPD2  3.551  0.645  0.976   
YOL060C  AMI3  4.744  0.482  1.107   
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YOL113W  SKM1  2.038  0.724  0.731   
YOL119C  MCH4  3.868  0.881  1.504   
YOL128C    2.233  0.638  0.665   
YOL165C  AAD15  7.905  3.181  2.535   
YOR003W  YSP3  2.083  1.428  1.246   
YOR014W  RTS1  3.49  1.196  0.566   
YOR019W    2.389  1.876  1.595   
YOR024W  IRC12  2.074  0.68  0.974   
YOR025W  HST3  2.434  1.059  0.949   
YOR027W  STI1  3.586  2.322  1.678   
YOR077W  RTS2  3.217  1.409  0.976   
YOR081C  TGL5  2.135  1.211  0.786   
YOR130C  ORT1  3.318  1.361  1.347   
YOR138C  RUP1  2.545  1.162  1.582   
YOR141C  ARP8  2.238  0.954  1.453   
YOR154W  SLP1  2.952  0.768  1.08   
YOR221C  MCT1  2.86  0.949  0.744   
YOR262W    2.102  1.359  1.125   
YOR267C  HRK1  3.515  0.946  1.382   
YOR273C  TPO4  2.411  0.629  1.164   
YOR286W  FMP31  4.131  1.894  1.406   
YOR299W  BUD7  2.192  1.174  1.028   
YOR328W  PDR10  2.005  0.793  1.116   
YOR329C  SCD5  4.498  1.938  1.478   
YOR363C  PIP2  2.062  1.123  1.293   
YOR371C  KRH2  2.298  1.487  1.531   
YOR386W  PHR1  3.122  1.566  1.531   
YPL005W  AEP3  2.105  1.178  0.859   
YPL019C  VTC3  2.148  0.54  0.949   
YPL046C  ELC1  2.249  0.403  0.673   
YPL055C  LGE1  4.105  1.803  1.805   
YPL088W    4.138  0.587  0.765   
YPL119C  DBP1  4.191  1.91  1.411   
YPL123C  RNY1  4.445  2.608  1.726   
YPL204W  HRR25  2.827  1.979  1.751   
YPL207W  TYW1  4.196  0.806  1.761   
YPL211W  NIP7  2.147  1.033  1.167   
YPL250C  ICY2  9.8  1.692  2.407   
YPL257W    2.007  0.527  1.045   
YPL265W  DIP5  3.128  1.008  1.014   
YPL271W  ATP15  4.146  1.006  1.251   
YPL277C    2.204  0.951  0.865   
YPR019W  CDC54  2.113  1.255  1.408   
YPR030W  CSR2  2.388  1.319  1.003   
YPR031W  NTO1  6.324  1.611  1.423   
YPR156C  TPO3  3.221  1.047  0.904   
YPR193C  HPA2  2.06  1.506  1.391   
YPR194C  OPT2  2.264  1.091  1.601   
 
 
